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ABSTRACT
The adoption of identification standards and its associated technology in the healthcare supply
chain has been slow over the past twenty five years, despite the evidence of the benefits that can
be achieved. The widespread use of identification standards in the form of barcode labeled
medical products can contribute to the reduction of point of care errors and can increase the
efficiency of healthcare supply chain related processes. This research is focused on the analysis
of the adoption of identification standards in the healthcare supply chain with a particular focus
on the healthcare provider adoption challenges. The research is divided into two phases.

The first phase develops an extensive literature review on technology adoption with a particular
focus on data standards. This adoption process is compared with the adoption of Electronic
Health Records (EHR) and Electronic Data Interchange (EDI); main conclusions from the
identification standards literature are presented, and a conceptual model to explain the
identification-standards adoption process is proposed.

The second phase proposes a model for identification standards adoption using a system
dynamics modeling approach. The model builds on previous findings associated to the factors
affecting identification standards adoption and relates the specific elements to the adoption rate
via a causal loop diagram (CLD). The model is formulated in two stages. In the first stage, the
Bass Diffusion Model (BDM) of technology adoption is adapted to simulate the adoption of
identification standards supporting technologies. The second stage uses most of the factors
defined in the CLD to develop a simulation model. A sensitivity analysis identifies relevant
model parameters that facilitated the design of interventions to move the adoption process

forward. Finally, the effects of some possible interventions are simulated using the validated
model. The model provides an illustration of the use of system dynamics models and diffusion
theory to understand an important policy problem reported in the literature and not yet solved.
Also this research informs real world practitioners and the academic community on issues like
the lack of data and other challenging aspects of empirical research that can be addressed with
the proposed model and methodology.
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1. Introduction

1.1 Motivation and Brief Research Topic Description
Data standards also referred to as identification standards, have been around since 1974 when the
Universal Product Code (UPC) was developed within the grocery industry. Since then other
industries have tried to adopt similar standards in order to realize the benefits achieved by the
grocery industry with the UPC adoption, which according to (Garg, Jones, & Sheedy, 1999) have
been estimated to be approximately 17 billion dollars.

Currently the healthcare supply chain lacks identification standards for the products that flow
through the supply chain and for the locations associated with this product flow. Several benefits
regarding identification standards adoption associated with supply chain process efficiency and
patient safety improvements have been identified in many studies. The broad benefits of
adopting identification standards include efficient traceability (Rosenfeld & Stelzer, 2006),
improved ordering, invoicing and receiving processes (CSC, 1996), reduced data cleansing
efforts (Accenture, 2006), ability to better monitor product recalls, track expiration dates and
product authentication (Hefflin, 2005) among others.

Despite the estimated benefits of identification standards adoption the healthcare industry is
moving at a slow pace. As reported by (Simpson & Kleinberg, 2009) the main contributors for
the slow adoption include market drivers and technology issues. There is a major "chicken
versus egg" problem on unit of use bar coding (i.e printing a barcode label at the smallest unit of
use on every pharmaceutical and medical supply). Initially manufacturers were unwilling to
barcode their products since they knew hospitals did not have the scanners to read them and
1

hospitals were reluctant to invest in barcode scanning technology if the products did not come
labeled with barcodes. In the technology side, major healthcare information systems vendors
have lagged behind in providing robust barcode enabled applications to support supply chain
processes.

This research project investigated the identification standards adoption process within the
healthcare supply chain and developed a theoretical model based technology diffusion theory; a
system dynamics modeling approach was used to model this process. The model allowed for the
identification of the factors affecting the identification standards adoption process, also
facilitated the understanding of the system (healthcare supply chain) behavior and allowed for
the design and test of policies to move the system forward.

In Section 1.2 background information on relevant elements related to this research topic are
provided. The research problem is defined in Section 1.3 along with the research questions. The
document overview is presented on Section 1.4.

1.2 Background

1.2.1 Healthcare supply chain

The healthcare supply chain includes a variety of members, including manufacturers,
distributors, transportation companies, hospital receiving and materials management
departments, nursing units, hospital floors and finally the patient. Figure 1 below illustrates the
basic product flow within the healthcare supply chain.

2

Figure 1. Healthcare Supply Chain (adapted from CSC, 1996)

Each healthcare supply chain member performs specific processes with the ultimate goal of
assuring product availability for clinical use (i.e consumption at the point of use). These
processes can be classified as: external to the healthcare provider, such as, manufacturing and
distribution; and internal, such as, ordering, receiving, storage, picking and floor replenishment.
According to (ERG, 2006) the healthcare supply chain members can be grouped in the following
categories:


Transacting members
o Manufacturers
o Distributors
o Group Purchasing Organizations (GPO)
o Healthcare providers (hospitals)



Payers
o Centers for Medicare and Medicaid Services
o Insurance companies



Industry Groups
3

o Association for Healthcare Resource and Materials Management (AHRMM)
o GS1 Healthcare User Group (HUG)
o Healthcare Information and Management Systems Society (HIMSS)
o Department of Defense (DoD)
o Strategic Marketplace Initiative (SMI)


Food and Drug Administration (FDA)



Technology providers

Transacting members differentiate from other members because they are directly involved in the
transactions required to move the product from the manufacturing plant to the point of use at the
hospital location.
The healthcare supply chain can be compared to other supply chains. There are a number of
important distinctions as presented by (Simpson & Kleinberg, 2009), (CTL, 2006) between the
healthcare supply chain and other supply chains like the Consumer Packaged Goods (CPG) that
represent a challenge for identification standards adoption, those include:


The fragmentation of the healthcare supply chain. There are no dominant players to drive
favorable changes in industry practices, to force investment in new technology and to
promote process change.



The segregation of product, information and money flow. The actual user or consumer of
the products is not the payer in most cases; also the decision maker (e.g. doctor or a
nurse) is neither the consumer of the product nor the payer (insurance or government).
This makes product, information and money flow along disjointed paths as opposed to
paralleling each other.
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1.2.2 Identification Standards

Identification standards as defined by (Hubner & Elmhorst, 2008) are a building block for the
efficient product flow and its associated transactions for a given supply chain. The issue of lack
of data standards has been reported in a recent survey (Nachtmann & Pohl, The State of
Healthcare Logistics: Cost and Quality, 2009) as a major challenge to achieve supply chain
excellence in the healthcare sector. Two types of identification standards will be addressed
within this research: product identification standards and location identification standards.

Product Identification Standards

For healthcare supply chain management purposes, having a unique identifier at the smallest unit
of use would streamline pharmaceutical and medical supply chain processes and payment
systems. This could also make point of care scanning possible (Simpson & Kleinberg, 2009).
The point of care scanning concept is similar to the retail store Point of Sale (POS) checkout
process where every product leaving the store must be checked out for billing purposes. The
same concept should be transferable to the hospital setting.
Different identification standards exist within the healthcare supply chain which means no
standard is really in place. Pharmaceutical products have used the National Drug Code (NDC)
since 1974 due to specific Food and Drug Administration (FDA) regulations. The most recent
regulation requiring manufacturers labeling pharmaceutical products at the smallest unit of use
have forced most pharmaceutical manufacturers to print NDC numbers in linear barcode (one
dimensional) format. For medical devices and general medical surgical supplies the use of the
Universal Product Number (UPN) since 1995 has been the norm because of the efforts of the
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Department of Defense on various internal pilot projects. About 75% of medical products carry
a UPN (Hefflin, 2005).
GS1 standards (formerly EAN UCC) and Health Industry Business Communication Council
(HIBCC) standards are also identification standards used by some healthcare supply chain
members. A survey referenced by (Bix, Clarke, Lockhart, Twede, & Spink, 2007) reports 59%
of the respondents using GS1 standards and 39% using HIBCC standards. One major difference
between GS1 standards and HIBCC standards is that the former is a global standard used in
many other industries and HIBCC standards were developed specifically for the healthcare
industry. As of today the issue of having a unique identifier at the smallest unit of measure, unitdose for pharmaceuticals and unit-of-use for medical products, has not been solved.

Location Identification Standards

Location identification standards are referred to as the unambiguous identification of every
supply chain transacting member in order to facilitate ordering, contract pricing and rebate
processing. Currently supply chain members are identified by customer account numbers issued
by each transacting member (e.g. each health care provider can assign a different number to
describe the same manufacturer). Under these conditions is not possible to uniquely identify any
supply chain transacting member. The lack of unique location identifiers generates supply chain
process inefficiencies which can be reduced by the proper use of the standards.

Technology

Technology plays an important role in identification standards adoption and implementation
(Langabeer, 2005). The level of current process automation at the healthcare provider level or

6

any other transacting member in the healthcare supply chain will have an impact on how
identification standards can be adopted.
Technology allows for capturing the product related information as it moves through the supply
chain and also helps to store and process product related information as well as the transactions
associated with it. Figure 2 illustrates the relationship between identification standards and
technology.
The technology associated with identification standards, which should be implemented by any
given transacting member within the healthcare supply chain in order to adopt identification
standards, can be classified in two groups:


Auto Identification and Data Capture technologies (Auto ID DC). Auto ID DC
technologies such as barcode or Radio Frequency Identification (RFID) technology, can
increase process efficiency, reduce data entry errors and free staff to perform more value
added functions.



Information systems (supply chain, materials management or purchasing systems).
Information systems such as Materials Management Information System (MMIS) are
applications used to support internal and external supply chain processes within a given
supply chain member.

7

Figure 2. Supply Chain Standards (adapted from Hubner and Elmhorst, 2008)

As an example, at the healthcare provider level, the technological capabilities related to barcode
enabled processes for internal supply chain management transactions and the information
systems supporting those specific transactions will have an impact on the identification standards
adoption process. According to a 2007 American Hospital Association (AHA) survey (AHA,
2007), less than 16% of hospitals are fully using barcode technology for supply chain
management purposes; the use of RFID is less than 3%. Technology has been referenced as one
of the major barriers to identification standards adoption (Nachtmann & Pohl, The State of
Healthcare Logistics: Cost and Quality, 2009).
This research is focused on the adoption of identification standards along with the required
technology to automate the transactions and business processes that make possible the efficient
flow of product from the manufacturer to the point of use at the healthcare provider level.
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1.2.3 Several attempts and initiatives

The adoption of identification standards and barcode technology began within the grocery
industry around the mid seventies. The sequence of relevant events documented by (HIMSS,
2003) illustrates how the healthcare industry has tried to adopt identification standards but have
not been successful, those events include among others:



In 1983 the Health Industry Business Communications Council (HIBCC) was established
to promote the adoption of identification standards. The standards developed by HIBCC
where specific for the healthcare industry and where adopted mainly by manufacturers.



In 1989 the use of barcode technology for point of care applications was promoted among
hospitals.



In 1995 the Efficient Consumer Response (ECR) in grocery industry was defined as the
reference point to determine how ECR practices could apply to healthcare supply chain,
since major industry parallels between grocery and healthcare industry were identified.
The result from this effort is the Efficient Healthcare Consumer Response (EHCR) (CSC,
1996) study, which identified more than six billion in potential savings for barcode
technology adoption within the hospital supply chain.



In 2000 the Institute of Medicine presented a report (Kohn, Corrigan, & Donaldson,
2000) which estimated that up to 98,000 lives are lost a year due to preventable medical
errors. Many of these errors could likely be avoided by the use of technology such as
barcode technology, in particular for the purpose of Bedside Point of Care (BPOC)
scanning.

9



The 2004 FDA rule for human drug and blood products mandated that manufacturers
print a barcode (one dimensional) on every product at the unit of use addressing the issue
of lack of unique identifiers and suggesting the use of either GS1 or HIBCC standards.



In September 27 2007, the FDA Amendments Act of 2007 was signed into law; this Act
includes the establishment of a unique device identification system. This new system
when implemented will require the label of a device to bear a unique identifier. This
unique identifier must be able to identify the device through distribution and use.



In 2008 (25 years after the first attempt) an industry movement towards GS1 standards
system adoption was initiated. Currently the industry is building consensus regarding the
adoption of GS1 standards.

Results from pilot projects developed at the Department of Defense (DoD) which go back to
1995 have demonstrated the benefits of a Product Data Utility (PDU) and unique identifiers such
as the UPN. The current DoD pilot project is testing the GS1 Global Data Synchronization
Network (GDSN) as a PDU for healthcare industry using the Global Trade Identification
Numbers (GTIN) as the unique identifier for products flowing through the healthcare supply
chain. The industry established deadlines for the adoption of the different standards; the
deadline for the location identifiers adoption was December 31st of 2010 and the deadline of the
product identifiers adoption is December 31st of 2012.

1.3 Research Problem

The adoption of identification standards and it associated technology in the healthcare supply
chain has been slow over the past twenty five years despite empirical evidence of the benefits
that can be achieved. The first movement towards identification standards adoption was initiated
10

in the year 1983 as referenced by (HIMSS, 2003). The EHCR initiative (CSC, 1996) identified
in 1996 more than six billion in potential savings for barcode technology use within the hospital
supply chain. Today, more than twenty five years after the first attempt to identification
standards adoption, the standards are not widely adopted and the benefits are still to be realized.
This slow adoption process is preventing the healthcare supply chain from reaching the benefits
and process efficiencies other industries have realized, and, most importantly, it is affecting the
healthcare delivery process since identification standards are known to be useful on preventing
medical errors (e.g. wrong dose to right patient, right dose to wrong patient) and facilitating the
recall process of pharmaceuticals, medical supplies and devices.
As reported by (Simpson & Kleinberg, 2009) the main contributors for the slow adoption include
market drivers and technology issues. There is a major "chicken versus egg" problem on unit of
use bar coding (i.e printing a barcode label at the smallest unit of use on every pharmaceutical
and medical supply). Initially manufacturers were unwilling to barcode their products since they
knew the hospitals did not have the scanners to read them and hospitals were reluctant to invest
in barcode scanning technology if the products did not come labeled with barcodes. In the
technology side, major healthcare information systems vendors have lagged behind in providing
robust barcode enabled applications to support supply chain processes.

1.3.1 Research questions

The main research questions to be addressed with this research project are the following:

1. How does the identification standards adoption process compare with the same or similar
adoption process in other industries such as retail?
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2. How does the identification standards adoption and diffusion process compare with the
adoption of other technologies within the healthcare industry in general. (e.g. the
diffusion of medical technologies or Electronic Health Records EHR)?
3. What is preventing healthcare supply chain members and healthcare providers in
particular from adopting identification standards and it supporting technologies? What
are the major barriers?
4. How could existing diffusion models be extended or modified to model the healthcare
identification standards adoption process?
5. What are the cost implications and benefits for the healthcare supply chain members and
stakeholders to adopt identification standards?
6. What actions (strategies, incentives and policies) are required to increase the number of
healthcare supply chain members and healthcare providers adopting identification
standards?

In order to answer the proposed research questions, this research is divided in two phases. Phase
I is related to questions 1, 2 and 3. Phase II is related to questions 4, 5 and 6. Each phase
develops a main objectives and a main hypothesis as explained in the following paragraphs.

Phase I

Main objective. To identify the main barriers affecting the data standards adoption process
(research question number 3) in order to explain the adoption process from the technology
adoption perspective, and to develop a conceptual model.
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Main hypothesis. The identification standards adoption process can be understood, explained
and improved with information related to similar adoption processes within and outside of the
healthcare domain.

Phase II

Main objective. To develop a theoretical model to investigate the dynamics of the adoption of
identification standards in the U.S healthcare supply chain (research question number 4). The
model will be based on the diffusion of innovations theory; a systems dynamics modeling
approach will be used to model this process.
Main hypothesis. Technology diffusion models can help to explain and model the adoption of
identification standards. Classic diffusion models can be extended to model identification
standards adoption; the developed model will facilitate the understanding of the system
(healthcare supply chain) behavior and allows for the design and test of policies to move the
system forward.

1.3.2 Methodology

Phase I

An extensive literature review followed by a comparative analysis is the methodology to be used
to answer the research questions related to this phase. An extensive review of the literature on
data standards adoption, healthcare and non healthcare related adoption processes is developed.
The most relevant conceptual models for factor identification and adoption modeling are
explained. The literature review provides the necessary information to identify the factors that
are affecting the identification standards adoption process, a conceptual model is proposed.
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Phase II

The second phase is related to the model development and is based on the system dynamics
methodology. As defined by (Coyle, 1983), system dynamics is a rigorous method of system
description, which facilitates feedback analysis, usually via a continuous simulation model of the
effects of alternative system structures and control policies on system behavior.
As implied by the system dynamics methodology, the purpose of a model is to understand the
structure of the system and to provide insights into the possible solutions to the existing
problems.
The basic steps of the system dynamics methodology are the following:


Definition of the real world symptoms to be understood and improved



System description by the use of a Causal Loop Diagram



Model formulation



Model verification and validation



Simulation experiments, leading to improved understanding on the problem underlying
the symptoms



Redesign and implement change on system structures or policies in order to improve its
dynamic behavior
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Figure 3. Research methodology

The complete research methodology including Phases I and II is summarized in Figure 3.

1.3.3 Summary of expected contributions

The expected contributions from this research include the following: (1) Categorization of data
standards related literature, (2) Conceptual model to explain barriers to adoption, (3) Diffusion
model formulation and resulting simulation model, and (4) Model extensions to include cost and
benefits estimations and policy related considerations.
Contributions from Phase I: Identification of the major barriers affecting the identification
standards adoption process:


Identification and classification of documents related to technology adoption and
diffusion within the healthcare domain, characterization of main adoption process.



Identification and classification of documents related to technology adoption and
diffusion outside the healthcare domain, characterization of main adoption process.
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Identification and classification of documents related to data standards adoption.



Comparative analysis of findings and development of a conceptual model to explain data
standards adoption.

Contributions from Phase II: Development and implementation of a modeling approach for data
standards adoption:


Identification and classification of documents related to technology adoption modeling
within and outside the healthcare domains, identification of main methods.



Diffusion model formulation to model data standards adoption.



Simulation model implementation and experimentation.



Model extensions to include the cost and benefits estimations and policy interventions.

1.3.4 Research importance

The study of the data standards adoption process provides an opportunity to enhance the
understanding of the adoption process by exploring related adoption processes that could lead to
the analysis from an academic perspective of previous failed data standards adoption attempts.
A similar standards movement was started in 1983 with no successful outcome.

Technology adoption and diffusion are important challenges as revealed by (Sheng, R., Jen Hwa,
Wei, Higa, & A., 1998). The adoption and diffusion of technology within healthcare is
important since its widespread use can contribute to the reduction of costs, through the increase
of efficiency and most important improvements in patient safety (Kohn, Corrigan, & Donaldson,
2000).
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1.4 Dissertation document structure

This document is divided into six chapters. The background information, the description of the
research problem, the research questions along with the description of the methodology are
introduced in Chapter 1. A literature review, related to non-healthcare and healthcare related
adoption processes, is presented in Chapter 2. In this chapter the findings related to the main
conceptual models and adoption determinants are explained. The literature review related to data
standards literature with specific focus on barriers is presented in Chapter 3 along with the
development of the proposed conceptual model to explain the identification standards adoption
process. The model formulation and development is presented in Chapter 4, this chapter
includes the development of the causal loop diagram along with the proposed formulation stages.
The model implementation, sensitivity analysis and interventions design is presented in Chapter
5. The conclusions and future work are presented in Chapter 6.
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2. Literature Review

The goal of this chapter is to answer the following research questions as established in Chapter 1:


How does the identification standards adoption process compare with the same adoption
process in other industries such as retail?



How does the identification standards adoption and diffusion process compare with the
adoption of other technologies within the healthcare industry in general (e.g. the
diffusion of medical technologies or Electronic Health Records EHR)?

The characterization of a main adoption process within the non healthcare and healthcare
domains was established. A literature review was conducted in order to achieve that goal. The
main findings of the literature review are presented in this chapter. The comparison of the
identification standards adoption process and healthcare and non healthcare adoption processes is
developed in Chapter 3.

The Management of Technology (MOT) approach (Gaimon, 2008), is defined as a key element
of the literature review. Under this approach researchers attempt to explain a given adoption
process by defining conceptual models that could lead to generalizations. Since the goal if this
research is to understand the identification standards adoption process the MOT approach was
found suitable for this purpose. In this research it was assumed that findings related to specific
adoption processes could help to understand the identification standards adoption process under
study. Adoption processes within the healthcare and non healthcare domains were explored.
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For non healthcare related adoption processes, the initial technology used in the search was
Electronic Data Interchange (EDI). For healthcare related adoption processes, the search started
by focusing on the adoption of Electronic Health Records (EHR). The search was conducted
using various search engines such as Engineering Village, EBSCO and Pro Quest. In order to
start the search the terms EDI and EHR were used. For Engineering Village data base the terms
EDI and EHR plus the term adoption and United States as a location element to conduct the
search were used. The starting date for the search was 1980; the goal was to include the research
work developed over the past three decades. For the Pro Quest and EBSCO databases the search
was conducted with the terms EDI and EHR plus adoption, conceptual model and mathematical
model using the same date range and location parameters. The initial goal was to keep the search
just for US adoption processes but some outside cases were considered. As a result 85
documents were reviewed (title and abstract) and reduced to 41 documents divided in two
categories. Category 1, non-healthcare related documents and category 2, healthcare related
documents as shown in Tables 1 and 2.

For both categories the documents were classified in the following document types: Journal (J),
Dissertation (D), Book chapter (B), Conference proceedings (C) and Report (R). In total, there
are 27 Journals, 3 Dissertations, 3 Book chapters, 3 Conference proceedings and 5 Reports. The
journals are mainly from the areas of information systems (12), decision sciences (4) and
engineering management fields (4), and the remaining (7) belong to healthcare related
publications.
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Table 1. Category 1 literature review
Technology

IOS

EDI

References
1
2
3
4
5
6

Alexander
Hoffer et al
Grover
Vlosky et al
Nelson
Ramamurthy et al

7
8

Iacovou et al
Arunachalan
McGowan and
Madey a
McGowan and
Madey b
Niederman
Palmer
Iskandar et al

9
10
11
12
13

14 Kuan et al
15 Narayanan et al
16 Cooper and Zmud
MRP / ERP 17 Kerimoglu et al

Others

18
19
20
21

Zhu et al
Hwang et al
Quan et al
Hossain

Year Journal / source
Unpublished Ph.D. Dissertation, Indiana
1989 University
1992 Data Base
1993 Decision Sciences
1994 Report, IBMPS
2003 Unpublished Ph.D. Dissertation
1995 IEEE Transactions on Engineering Management

Type Focus

Country

D
J
J
R
D
J

DBM
DBM
CIOS
Retail IO
IOS
Large firms

US
US
US
US
US
US

1995 MIS Quarterly
1995 Journal of Systems Management

J
J

SMB
EDI users

US
US

1998 Information Resources Management Journal

J

EDI users

US

1998
1998
1998
2001

B
B
B
J

EDI
EDI
EDI
Automotive

2001 Information & Management
2009 Decision Sciences
1990 Management Science
Journal of High Technology Management
2008 Research

J
J
J

SMB
EDI
MRP

US
US
US
US
Hong
Kong
US
US

J

ERP

2006
2009
2010
2008

J
J
J
J

e-business
M -phones
M-service
RFID

Information Systems Innovation and Diffusion
Information Systems Innovation and Diffusion
Information Systems Innovation and Diffusion
IEEE Transactions on Engineering Management

Management Science
Telecommunications Policy
Journal of Computers
IEEE Transactions on Engineering Management

Turkey
10
countries
Vietnam
China
Bangladesh
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Table 2. Category 2 literature review
Technology
Medical
technology
Assisting
technology

EHR

HIT / EHR

References

Year Journal / source

1 Greer

1985 Intl. journal of technology assessment in health care

2
3
4
5

Sheng et al
Paul et al
Hung et al
Miller and Sim

1998
1999
2009
2004

6 Ash and Bates

2005

7
8
9
10
11
12
13
14
15

2005
2007
2007
2008
2009
2009
2005
2005
2005

19 Daim et al
20 Daim et al

2005 RAND report
2005 RAND report
2009 RAND report
Proceedings of the 41st Hawaii Intl. Conference on
2008 System Sciences
2009 Int. Journal of Behavioural and Healthcare Research

Middleton et al
Woodside
Chang et al
Erdil
Erdil a
Erdil b
Hillestad et al
Shortliffe
Bower
Fonkych and
16 Taylor
17 Girosi et al
18 Conklin et al

Journal of Organizational Computing
IEEE Transactions on Engineering Management
Decision Support System
Health Affairs
Journal of the American Medical Informatics
Association
Journal of the American Medical Informatics
Association
JHIM HIMSS
Decision Support System
SD 2008 Conference proceedings
SD 2009 Conference proceedings
Unpublished Ph.D Dissertation
Health Affairs
Health Affairs
RAND report

Type Focus
12
J
technologies

Country

J
J
J
J

US
Hong
Telemedicine Kong
Telemedicine US
CRM
Taiwan
EMR
US

J

EHR

US

J
J
J
C
C
D
J
J
R

EHR
EHR
e-signature
EHR
EHR
EHR
HIT / EMR
HIT
HIT/EHR

US
US
Taiwan
US
US
US
US
US
US

R
R
R

HIT
HIT/EHR
RFID

US
US
Europe

C
J

HIT
PHR

US
US
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2.1 Category 1 (Non Healthcare)

The documents (21) were fully reviewed and classified according to the year of publication,
document type and focus. Among the non-healthcare related adoption documents the following
technologies were identified: Inter Organizational Systems (IOS), Electronic Data Interchange
(EDI), Manufacturing Resource Planning (MRP), Enterprise Resource Planning (ERP) and a
category of others. The documents were also reviewed according to the scope, modeling
approach and factor identification methods. The date range was from the year 1989 to the year
2010. The summary of the documents within category one is shown in Table 1.

2.2.1 IOS

The study of Inter Organizational Systems (IOS) was initiated with the work of (Alexander, The
Adoption and Implementation of Computer Technology in Organizations: The Example of
Database Machines, 1989) and (Grover, 1993). In his work (Alexander, The Adoption and
Implementation of Computer Technology in Organizations: The Example of Database Machines,
1989) the author developed a conceptual model in order to explain the adoption and
implementation of Data Base Machines (DBM). This work considered the organizational
perspective and was based on Diffusion of Innovations (DOI) theory. The sample size of the
survey was expanded by (Hoffer & Alexander, 1992). The authors proposed ten factors are
related to the implementation of database machines those were: compatibility, relative
advantage, complexity, training, vendor involvement, organization structure, management
support, planning, champions and awareness of technology. In a more generic way (Grover,
1993) developed a conceptual model to explain the adoption of Customer-based Inter
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Organizational Systems (CIOS). This conceptual model was tested with a sample of industry
leaders. Among the main findings was the development of a composite model which included
organizational factors, policy factors, environmental factors and technology specific factors; and
the identification of a proactive technological orientation and the internal push for the system as
the two most relevant factors affecting adoption.

The adoption of IOS was also studied by (Volsky & Wilson, 1994) using the relationship
between a buyer and a seller in the retail context. The model developed four hypotheses which
were tested with a survey. Among the most relevant findings was the fact that channel
relationship deterioration occurs during the early stages of IOS technology adoption, mainly due
to the low value perceived relative to the investments made by the parties involved.

The adoption and diffusion of Inter Organizational System standards and process innovations
was studied by (Nelson, 2003). The author developed a conceptual model which linked the
adoption and diffusion (deployment) to three main constructs which are organizational,
technology and environment factors. The author found a difference between the factors affecting
adoption and the factors affecting deployment.

2.1.2 EDI

The results of a survey on the use of EDI among 900 firms were presented by (Arunachalam,
1995). The survey identified the main reasons for adopting EDI, the perceived barriers and
realized benefits. According to the survey some of the main reasons to adopt EDI were: to
remain competitive, customer's request, provide better customer service and to reduce
paperwork. The perceived barriers were related to the lack of awareness of EDI benefits, lack of
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automation, high costs and training. According to the survey, most customers were able to
improve customer service and reduce transaction errors. In the same way, the work developed
by (Ramamurthy & Premkumar, 1995) introduced a conceptual model based on DOI to explain
the implementation of EDI in large firms and its impact on the business performance. The
results from testing the conceptual model among industry leaders in the form of a survey
indicated that the greater internal and external diffusion of EDI facilitated the achievement of
improved organizational outcomes. The work of (Iacovou, Benbasat, & Dexter, 1995) presented
a conceptual model to study the EDI adoption on small and medium businesses. This model
described the effect of three explanatory factors (perceived benefits, organizational readiness and
external pressure) on the adoption of EDI. The authors tested the model with the use of case
studies and recommended the establishment of a long term EDI partner expansion plan and the
individual assessment of each partner preparedness level, as key elements in the adoption
process.

Similarly, the work of (McGowan & Madey, Adoption and implementation of Electronic Data
Interchange, 1998) started with the definition of a conceptual model for EDI adoption and
implementation based on DOI using a case study approach; four organizations were studied. The
results of the study suggested that the factors that influence the adoption decision might be
different from the factors influencing the extent of the EDI implementation within the
organization. Among one of the main factors affecting the adoption was the customer influence.
On a subsequent work (McGowan & Madey, The influence of organization structure and
organizational learning factors on the extent of EDI implementation in U.S. firms, 1998)
developed a survey to establish the aspects related to the EDI implementation and diffusion
within the organization. The EDI implementation extent was assessed through the volume,
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diversity and sophistication of EDI use within the organization. The results showed that the size
of the organization explains much of the extent of EDI implementation which could be related to
resource availability. The EDI adoption was reviewed by (Niederman, 1998) from the diffusion
of innovations perspective and the author suggested the introduction of risk and critical mass as
factors to be considered when analyzing technology adoption. The conceptual model developed
by (Palmer, 1998) was used to study the adoption and diffusion of EDI under a quick response
strategy. The study findings suggested that the factors affecting the adoption might be different
from the factors affecting implementation. Firm size was confirmed as a key factor affecting
adoption, however, the results regarding implementation were inconclusive.

The adoption and integration of EDI within the automotive industry was studied by (Iskandar,
Kurokawa, & LeBlanc, 2001), the authors proposed a conceptual model and developed a survey
in order to gather information to test the proposed hypothesis. The results from the study
indicated that the factors affecting the adoption are different from the factors affecting the
implementation even though both can be considered simultaneously taking into consideration a
short implementation period.

The work developed by (Kuan & Patrick, 2001) included the development of a conceptual model
to study the adoption of EDI among small and medium businesses. The proposed conceptual
model was based on the Technology, Organization, and Environment (TOE) model previously
developed by (Tornatzky & Fleisher, 1990). The model differentiated among adopters and non
adopters. Some of the main findings included the fact that direct benefits were perceived to be
higher by adopter firms compared to non-adopter firms and the indirect benefits did not reveal
any difference among the two groups. The work developed by (Narayanan, Marucheck, &
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Handfield, 2009) summarized the findings on EDI adoption and implementation research over
the past 20 years. The study synthesized the EDI literature and with the development of a metaanalysis of findings, the authors were able to clarify some conflicting results regarding EDI
adoption and implementation benefits. In this paper the authors established that no unified
model exist to analyze the adoption and implementation of EDI. No agreement on results from
adoption and implementation has been reached and most of the results related to the estimation
of the benefits are inconclusive.

2.1.3 MRP/ERP

(Cooper & Zmud, 1990) studied the adoption and implementation of Manufacturing Resource
Planning (MRP) systems and indicated that the factors affecting the adoption are different from
the factors affecting the internal implementation or infusion, as also noted by (Palmer, 1998)
(Iskandar, Kurokawa, & LeBlanc, 2001) regarding EDI. The adoption of Enterprise Resource
Planning (ERP) systems from the end user perspective was studied by (Kerimoglu, Basoglu, &
Daim, 2008) and the authors constructed a model based on the Technology Acceptance Model
(TAM) developed by (Davis, Bagozzi, & Warshaw, 1989). Results from the study indicated that
organizational adoption can be achieved if the end user satisfaction is achieved; there were also
indications of special project management efforts during the implementation phase that can
contribute to end user satisfaction.

2.1.4 Others

The adoption of electronic business was studied by (Zhu, Kraemer, & Xu, 2006). The authors
developed a three stage model including the phases of: initiation, adoption and routinization. The
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model was based on the TOE model (Tornatzky & Fleisher, 1990) and some of the findings
indicated that competition positively affects adoption and initiation, and that resource availability
had an impact on initiation. The analysis of the telecommunication services in Vietnam was
performed by (Hwang, Cho, & Long, 2009) with the use of a diffusion model. The findings of
the model implementation suggested that a regulation that could guarantee competition could be
a factor to positively influence the diffusion process. An extension of TAM (Davis, Bagozzi, &
Warshaw, 1989) was developed by (Quan, Hao, & Jianxin, 2010) in order to study the adoption
of mobile services. The authors did so by introducing the perceived credibility and perceived
constructs into the model. The adoption of RFID from the end user perspective was studied by
(Hossain & Prybutok, 2008), the authors developed a model based on TAM and proposed that
convenience, culture, privacy, regulation and security were important factors related to the RFID
adoption among end users.

2.1.5 Conceptual models elements and mathematical modeling (specific findings)

A conceptual model was identified in 17 documents as shown in Table 3. The most widely used
technique to test a proposed conceptual model and its related hypothesis was a survey or industry
panel. The main adopting unit (U) referenced in most of the documents is the organization (O)
in contrast to the end user perspective (E). There are 9 documents related to both adoption and
implementation, 9 documents with a specific focus on adoption and 2 dealing with only
implementation. The exploration of the benefits (B) was found in 5 documents. There is one
document related to the development of a mathematical diffusion model. The summary of the
findings is presented in Table 3.
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For the conceptual models the dominant approach is the Diffusion of Innovations (DOI), about
half of the identified documents used that approach. The Technology, Organization and
Environment (TOE) model was also present, both DOI and TOE are used to analyze the adoption
from the organizational point of view, as in the case of database machines, EDI, MRP and
electronic business. The Technology Acceptance Model (TAM) was used to study the adoption
of technology from the end user perspective as in the case of ERP, RFID and mobile services.

The realization of the benefits comes after the implementation phase. As described by
(Narayanan, Marucheck, & Handfield, 2009) , (McGowan & Madey, Adoption and
implementation of Electronic Data Interchange, 1998), (Nelson, 2003) there is a difference
between the factors affecting adoption and the factors related to the implementation. In general,
the adoption phase is the early stage of the adoption process while the implementation requires
the continued use of the technology within the organization.
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Table 3. Category 1 findings

Tech.

IOS

EDI

MRP /
ERP

Others

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

References
Alexander
Hoffer et al
Grover
Vlosky et al*
Nelson
Ramamurthy et al
Iacovou et al
Arunachalan*
McGowan and Madey a
McGowan and Madey b
Niederman
Palmer
Iskandar et al
Kuan et al
Narayanan et al
Cooper and Zmud

Year
1989
1992
1993
1994
2003
1995
1995
1995
1998
1998
1998
1998
2001
2001
2009
1990

Approach / Method
Lit. review + survey
Lit. review + survey
Lit. review + survey
Survey
Lit. review + survey
Lit. review + survey
Case studies
Lit. review + survey
Lit. review + survey
Lit. review+ case studies
Lit. review
Lit. review + case studies
Qualitative / Survey
Literature review
Literature review
Lit. review + survey

17 Kerimoglu et al
18 Zhu et al

2008 Lit. review + survey
2006 Lit. review + survey

19 Hwang et al
20 Quan et al
21 Hossain
* barrier related

2009 Literature review
2010 Lit. review + survey
2008 Lit. review + survey

Scope
143(60.8% rr)
142( 47 ans.s )
1069(21.14%rr)
540 (227 ans.)
590 (102 ans.)
1200 (17% rr)
7 case studies
900(180 ans.)
1200 (22,17% rr)
4 sites
review paper
175(45.7% rr)
547( 24% rr)
575 firms
Literature review
52 firms

U A
O x
O x
O x
O x
O x
O
O x
O
O
O x
O x
O x
O x
O x
O x
O x

223 (585 rr)
1857 firms
Dataset 19952006
228 surveys
307(83.4%rr)

E
O

x
x

E
E
E

x
x
x

A
& B Conceptual Math
I I
model
.
x x
DOI
N
x x
DOI
N
DOI
N
None
N
x x
TOE
N
x DOI
N
x
x x x general
N
x None
N
DOI
N
x
DOI
N
x None
N
x x
DOI
N
x x
general
N
TOE
N
x x x general
N
x x
general
N

x

x

TAM
TOE

N
N

None
TAM
TAM

Y
N
N
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According to the mathematical models explored, (Hwang, Cho, & Long, 2009) developed a
diffusion model to investigate the factors affecting the diffusion of mobile telephone services in
Vietnam. The logistic regression model was found to perform better as a descriptive tool for the
period under study (1995-2006) and it was used to determine the factors affecting the speed of
diffusion. The findings suggest that a regulation that could guarantee competition in the market
is one of the most important factors for a positive diffusion process.

2.2 Category 2 (Healthcare)

There were 20 healthcare related adoption documents in total. The documents were fully
reviewed and classified according to the document type and focus. The healthcare related
documents were grouped in the following categories: medical technology, assisting technology,
Electronic Health Records (EHR) and Health Information Technology (HIT). The documents
were also reviewed according to the scope, modeling approach and factor identification methods;
most of the documents were within the present decade. The summary of the documents within
category two is shown in Table 2.

2.2.1 Medical technology

The work developed by (Greer, 1985) reported on the findings of the analysis of adoption of 12
medical technologies among 25 healthcare institutions. The author found that within the
explored healthcare institutions there were three decision systems involved in the adoption
decision (medical-individualistic, fiscal-managerial and strategic-institutional). With the use of
case studies the author found that each technology was related to a specific system. This finding
highlights the importance of establishing the distinction among technologies in order to analyze
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the adoption process. For example there are technologies that require the end user (physician) to
be comfortable to use, while others that could serve the purpose of improving the efficiency of a
given department do not require physician involvement; then a different system would be
considered in the decision process.

2.2.2 Assisting technology

In the case of telemedicine, (Paul, Pearlson, & McDaniel, 1999) explored the technological
barriers to its adoption by the use of case studies. The authors found that end user training was
one of the most relevant barriers. The work developed by (Sheng, R., Jen Hwa, Wei, Higa, &
A., 1998) introduced a conceptual model for the internal adoption of telemedicine and described
the individual-organizational space in which the adoption takes place. The adoption of Customer
Relationship Management (CRM) systems in the hospital setting was studied by (Hung, Hung,
Tsai, & Jian, 2009) the authors proposed a conceptual model based on TOE (Tornatzky &
Fleisher, 1990) and found that hospital size, capabilities of staff, innovation of senior executives,
knowledge management capabilities and relative advantage have significant influence on CRM
systems adoption.

2.2.3 Electronic Health Records - EHR

The study developed by (Miller & Sim, 2004) focused on the identification of barriers to EHR
adoption among physicians. The study was based on interviews with healthcare professionals.
Among the identified barriers are the high initial cost, uncertain financial benefits, inadequate
support and lack of incentives. According to (Ash & Bates, 2005) the barriers to Computarized
Physician Order Entry (CPOE) can be grouped in four factors, organizational, technical,
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environmental and end user related. Among the recommendations to promote EHR adoption,
(Middleton, Hammond, Brenan, & Cooper, 2005) discussed five options, expand the Health
Information Technology HIT research agenda, establish financial benefits to stimulate the EHR
marketplace, coordinate HIT standards development, establish enabling policy and promote
educational activities.

The research conducted by (Chang, Hwang, Hung, Lin, & Yen, 2007) studied the adoption of
electronic signature among hospitals and developed a conceptual model based on TOE. The
authors reported that there are four significant factors that distinguish adopters from non
adopters: hospital size, adequate resources, vendor support and government policy.

(Woodside, 2007) developed a model based on game theory to explain the EHR adoption. In this
model the author assumed the EHR adoption as a zero sum game with three players, the payer,
the healthcare provider and the consumer; all players were assumed to act rationally which
means all players tended to maximize their payoffs. The model identified the payoffs for each
player as well as the stages of the game in order to reach equilibrium or recommended path.
Two equilibriums were reached during the game. The first one, when the payer subsidizes the
provider to the extent that it is profitable and the second one, when the payer subsidizes the
provider indirectly through the consumer, to the extent that it is profitable.

The research developed by (Erdil & Emerson, Modeling the dynamics of Electronic Health
Records adoption in the U.S healthcare system, 2008) was related to the study of EHR adoption.
The research started with the identification of the barriers to EHR adoption in the form of a
causal loop diagram. The causal loop diagram captured the cause and effect relationship in the
form of feedback loops amongst the factors influencing the EHR adoption process. Then, the
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structure of the causal loop diagram is used to construct a model to simulate the hospital's EHR
adoption rate over time (Erdil & Emerson, Simulation modeling of electronic health records
adoption in the U.S healthcare system, 2009). Cost was identified as one of the main factors
affecting adoption. The details of the model development and preliminary findings are presented
in the dissertation (Erdil, Systems analysis of Electronic Health Record adoption in the U.S.
healthcare system, 2009).

2.2.4 Health Information Technology - HIT

The work developed by RAND Corporation on the adoption of Health Information Technology
HIT was associated in particular to the adoption of HIT in the context of Electronic Health
Records. As reported by (Bower, The Diffusion and Value of Healthcare Information
Technology, 2005) the penetration of EHR can be approximated by measuring the number of
hospitals having a set of applications such as clinical decision support systems, computerized
patient records and a clinical data repository. Using that definition the author was able to
establish that the penetration of EHR by the year 2002 was about 32%. An assessment of causal
diffusion variables was developed and seven variables were identified: relative advantage to
clinicians, compatibility, complexity, external influence, social pressure, network effects and
specialization. The potential value of system wide HIT diffusion was estimated by defining
different scenarios for productivity gains related to EHR adoption. The intervention of the
government in order to speed up diffusion was also discussed. The analysis of the pattern of HIT
adoption among for profit and non for profit hospitals was developed by (Fonkych & Taylor,
2005), the report findings suggest there is high heterogeneity in HIT adoption across HIT
applications and types of hospitals.
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The report by (Girosi, Meili, & Scoville, 2005) identified the cost and benefits of HIT. The
potential health and financial benefits of health information technology HIT adoption were
examined by (Hillestad, et al., 2005). In order to do that, a comparison of the use of IT in
healthcare with the use of IT in other industries was developed; additionally the potential savings
and costs of widespread adoption of Electronic Medical Record (EMR) systems were estimated.
The authors concluded that effective EMR implementation could save more than 81 billion
annually by improving health care efficiency and safety. Some of the identified factors affecting
adoption were: the high starting and implementation costs, the slow and uncertain payoffs and
the disruption of current practice. The work developed by (Shortliffe, 2005) described the
current opportunities and challenges of medical records automation; among the challenges,
cultural barriers, business case absence and structural barriers were identified.

Another HIT report by RAND Corporation (Oranje-Nassau, Schindler, Valeri, Vilamovska,
Hatziandreau, & Conklin, 2009) commented on the identification of drivers and barriers of RFID
adoption in healthcare. Among the main barriers to RFID adoption are organizational issues such
as change management and end user resistance; technical issues such as scalability, integration
and market maturity; and security and privacy issues such as data integrity and reliability.

The work by (Daim, Tarman, & Basoglu, Exploring Barriers to Innovation Diffusion in
Healthcare Service Organizations: An issue for effective integration of service architecture and
information technologies, 2008) focused on HIT adoption in general. The main barriers to
adoption were identified through a literature review and an initial conceptual model was
proposed. The assessment of the barriers related to Personal Health Records adoption (PHR)
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were explored by (Daim, Chan, Amer, & Aldhaban, 2009), this assessment was developed using
the TAM conceptual model.

2.2.5 Conceptual model elements and mathematical modeling (specific findings)

A conceptual model was identified within 6 documents. There were 7 documents associated to
the identification of barriers. There were 4 documents related to the estimation of the benefits,
most of those are RAND reports, based on the estimation of the value of HIT and EHR in
particular. The summary of the findings is presented in Table 4. Among the conceptual models
there was no dominant approach. The unit of analysis in the case of healthcare related
technology adoption processes included the end user (E), which could be the physician or the
nurse. The end user perspective was not present in the non-healthcare related technology
adoption (IOS/EDI) documents. The adoption and implementation studies (5) were found in the
review but there were no specific studies related to the specific implementation phase. This issue
can be associated to the lack of studies linked to the estimation of the benefits of EHR adoption.
This can be an indication of the early stage of this adoption process according to the phases
defined by Rogers (Rogers E. M., 1983).

The two specific mathematical modeling efforts are summarized in the work developed by
(Erdil, Systems analysis of Electronic Health Record adoption in the U.S. healthcare system,
2009) and (Woodside, 2007). These authors explored the use of game theory and system
dynamics modeling to understand the EHR adoption process.
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2.3 Theoretical findings

2.3.1 Technology adoption conceptual models

The documents referenced in this section belong to the group of 23 documents associated to
specific conceptual models as shown in Tables 3 and 4. There were 17 documents related to a
conceptual model within the category 1 reviewed documents and there were 6 documents related
to a conceptual model within the category 2 reviewed documents. The main conceptual models
identified through the literature review were Diffusion of Innovations (DOI), Technology
Organization and Environment (TOE) model and Technology Acceptance Model (TAM).

DOI

The work initiated by (Rogers, Diffusion of Innovations, 1983) developed most of the foundation
for the diffusion of innovations approach. The author defined the different adoption stages and
how the characteristics of the innovation influence the adoption process. The adoption stages are
illustrated in Figure 4. According to (Rogers, Diffusion of Innovations, 1983), there are different
factors affecting the adoption rate. Those factors are mostly related to the characteristics of the
technology and the most relevant ones include: relative advantage, complexity and compatibility.
This conceptual model was present in 8 of the 23 documents included in the analysis of
conceptual models.

36

Table 4. Category 2 Findings
Technology
Medical
technology
Assisting
technology

EHR

HIT/ EHR

References
1
2
3
4
5
6
7
8

Greer
Sheng et al
Paul et al*
Hung et al
Miller and Sim*
Ash and Bates*
Middleton et al
Woodside

Year Focus
12
1985 technologies
1998 Telem.
1999 Telem.
2009 CRM
2004 EMR
2005 EHR
2005 EHR
2007 EHR

9
10
11
12
13

Chang et al
Erdil*
Erdil a
Erdil b
Hillestad et al

2007
2008
2009
2009
2005

14 Shortliffe*
2005
15 Bower
2005
Fonkych and
16 Taylor*
2005
17 Girosi et al
2005
18 Conklin et al*
2009
19 Daim et al
2008
20 Daim et al
2009
* barrier related document

Approach / Method

U

A&
A I I

HIT
HIT/EHR

Case studies
O x
Case studies
E,O x x
Site visits + interv.
O x
Surveys + H. testing O x
Experts opinion
E,O x
Experts opinion
O x
Experts opinion
O x
Model
O x x
Lit. review +
surveys
O x
Lit. review
O x
Lit. review
O x x
Lit. review + survey O x
Report summary
O x x
Lit. review +
opinion
O x
Lit. review + interv. O x

HIT
HIT/EHR
RFID
HIT
PHR

Report summary
Report summary
Lit. review + interv.
Lit. review + interv.
Lit.review + survey

e-sign.
EHR
EHR
EHR
HIT / EMR

O
O
O
O
E

x
x x
x
x
x

Conceptual
B model

Math.

None
General
None
TOE
None
None
None
None

N
N
N
N
N
N
N
Y

x

TOE
None
None
None
None

N
N
Y
Y
N

x

None
DOI

N
N

None
None
None
TAM
TAM

N
N
N
N
N

x

x

x
x

x

x
x
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According to (Niederman, 1998) the first goal of diffusion theory is to develop a general
understanding of individual and organizational reactions to the introduction of new technologies.
This general understanding includes the identification of factors that can influence the processes
or outcomes of the innovation project to varying degrees under varying circumstances. The
second goal of diffusion theory is to provide a method of analyzing the characteristics of a
proposed new technology in order to forecast likely patterns of diffusion within and or outside
the organization as well as to anticipate problems and intervene in positive ways to overcome
these problems. The analysis of an adoption process requires the definition of a unit of adoption
or perspective.

Figure 4. Adoption stages (adapted from Rogers, 1983)

From the DOI perspective the unit of adoption can be defined as the end user (E) or the
organization (O). The work developed by (Wolfe, 1994) introduced the concept of
organizational innovation and presented a conceptual model for its understanding.
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TOE

The Technology, Organization, Environment (TOE) model was proposed by (Tornatzky &
Fleisher, 1990) in order to explain the factors that influence an organization's adoption process.
This conceptual model is consistent with (Rogers, Diffusion of Innovations, 1983) theory of
innovation adoption but adds the organizational and environment factors to the analysis of the
adoption process. Under the DOI approach the factors affecting the adoption can be related to
the characteristics of the technology, however there are other factors to be considered such as
organization and external related factors. This model was present in 5 of the 23 documents
related to conceptual models. The TOE conceptual model (Tornatzky & Fleisher, 1990) has
been examined by a number of empirical studies on technology adoption, in particular on the
adoption of EDI.

TAM

The Technology Acceptance Model (TAM) (Davis, Bagozzi, & Warshaw, 1989) is used to
explain the adoption of technology from the end user perspective. According to TAM there are
two key determinants of end user adoption; those are the perceived usefulness and the perceived
ease of use. The perceived usefulness is defined as the degree to which a person believes that
using a particular technology would increase his or her job performance, while the perceived
ease of use is defined as the degree to which the end user expects the technology to be free of
effort. The model provides strong empirical evidence on the contribution of these two variables
in the end user adoption decision. This conceptual model has been widely applied to explain
different end user related innovations, such as the adoption of Personal Health Records (PHR)
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and ERP systems. There are 5 of the 23 documents related to conceptual models using this
approach.

2.3.2 Mathematical models

From the complete set of reviewed documents (41), 4 documents are related to a mathematical
modeling approach. Those are described in the following paragraphs.

Diffusion curves

The research developed by (Teng, Grover, & Guttler, 2002) on diffusion curves and
mathematical modeling provided evidence of the relationship between factors affecting a
diffusion process and the diffusion pattern. The authors used adoption related data from 21
technologies and established that the mixed influence diffusion model was one of the models that
best fit the available data. Based on that information, a classification of the different
technologies was made by using some of the parameters of the model.

Game theory

The adoption of EHR was explained by (Woodside, 2007), this work illustrated game theory as a
modeling approach for EHR. In this model the author assumed the EHR adoption as a zero sum
game with three players: the payer, the healthcare provider and the consumer. In the game all
players were assumed to act rationally which means all players will tend to maximize their
payoffs. The model identified the payoffs for each player as well as the stages of the game in
order to reach equilibrium or recommended path. Two equilibriums were reached during the
game. The first one was reached when the payer subsidizes the provider to the extent that it is
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profitable and the second one, when the payer subsidizes the provider indirectly through the
consumer to the extent that it is profitable.

System dynamics

The research developed by (Erdil & Emerson, Modeling the dynamics of Electronic Health
Records adoption in the U.S healthcare system, 2008) was associated to the study of Electronic
Health Records EHR adoption initiated with the identification of the barriers to EHR adoption in
the form of a causal loop diagram. The causal loop diagram captured the cause and effect
relationship in the form of feedback loops amongst the factors influencing the EHR adoption
process. Following a system dynamics methodology (Erdil & Emerson, Simulation modeling of
electronic health records adoption in the U.S healthcare system, 2009) and by using the structure
of the causal loop diagram, a model to simulate the hospital's EHR adoption rate evolution over
time was developed. Cost was identified as one of the main barriers to EHR adoption. The
details of the model development and preliminary findings are presented in the dissertation
(Erdil, Systems analysis of Electronic Health Record adoption in the U.S. healthcare system,
2009).

2.4 Comparative analysis (barriers, conceptual models and adoption determinants)

For the comparative analysis two technologies were considered: IOS/EDI and EHR.

The comparative analysis included the analysis of the main conceptual model elements
(including barriers) among the selected technologies, 26 documents were reviewed as shown in
Table 5. This analysis led to the identification of the main adoption determinants.
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2.4.1 Non healthcare adoption process (IOS/EDI)

From the main set of non healthcare related adoption documents 13 documents associated with
IOS/EDI adoption and implementations were reviewed. As noted by (Narayanan, Marucheck, &
Handfield, 2009) there was no single model to explain the adoption and implementation of EDI
from an organizational perspective, however, the main conceptual model is DOI and the
adopting unit is the organization. The factors related to the adoption were classified into three
groups (organizational factors, technology related factors and external or environmental factors)
those groups can be identified in the work developed by (Grover, 1993) and (Nelson, 2003).

External factors, internal factors, organization related factors, expected benefits and inter
organizational factors are among the factors affecting the adoption. The implementation and the
expected outcomes are related to the intensity of the internal integration. The barriers to EDI
adoption were explored by (Arunachalam, 1995).

2.4.2 Healthcare adoption process (Electronic Health Records)

As shown in Table 5 there are 13 documents related to the adoption of EHR. There are 2
documents related to conceptual models and 5 related to the identification of barriers to adoption.

Compared to IOS/EDI adoption, there are fewer adoption and implementation studies for EHR.
Most of the studies are related to adoption, fewer documents are related to EHR implementation
which gives an indication of the current EHR’s adoption stage. Among the revised documents,
the exploration of the barriers to EHR adoption is more predominant. This could be an
explanation to the absence of a conceptual model for identification standards. The barriers can
be considered in the absence of a conceptual model.
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Table 5. Comparison
Category Reference/ Author
Year Type
+
Grover
1993
J
Vlosky et al
1994 R
Nelson +
2003 D
+
Ramamurthy et al
1995
J
+
Iacovou et al
1995
J
1
Arunachalan
1995
J
McGowan and Madey b
1998 B
Niederman
1998 B
+
Palmer
1998 B
McGowan and Madey a + 1998
J
Iskandar et al
2001
J
+
Kuan et al
2001
J
Narayanan et al +
2009
J
Miller and Sim
2004
J
Ash and Bates
2005
J
Middleton et al
2005
J
Woodside
2007
J
+
Chang et al
2007
J
2
Erdil
2008 C
Erdil a
2009 C
Erdil b
2009 D
Hillestad et al
2005
J
Shortliffe
2005
J
Bower
2005 R
Fonkych and Taylor
2005 R
Girosi et al
2005 R
+
adoption determinant related document

Focus
CIOS
Retail IO
IOS
Large firms
SMB
EDI users
EDI
EDI
EDI
EDI users
Automotive
SMB
EDI
EMR
EHR
EHR
EHR
e-signature
EHR
EHR
EHR
HIT / EMR
HIT
HIT/EHR
HIT
HIT/EHR

Unit
O
O
O
O
O
O
O
O
O
O
O
O
O
E,O
O
O
O
O
O
O
O
O
O
O
O
O

Conceptual model
Conceptual model
None
Conceptual model
Conceptual model
Conceptual model
Findings report
Conceptual model
Literature review findings
Conceptual model
Conceptual model
Conceptual model
Conceptual model
Conceptual model
Identification of barriers
Identification of barriers
Recommendations
None
Conceptual model
Identification of barriers
Simulation model
Report on model findings
None
Identification of barriers
Conceptual model
Identification of barriers
None

Approach
DOI & IS
None
TOE
DOI
general
None
DOI
DOI
DOI
DOI
general
TOE
general
None
None
None
None
TOE
SD-CLD
SD
SD
None
None
DOI
None
None
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2.4.3 Adoption determinants

In order to identify the adoption determinants, 9 documents were selected, eight of those
documents were related to IOS/EDI and one was related to EHR adoption. The findings from
each document related to the explored and empirically tested relationships between a given
factor and adoption was analyzed; this way the main adoption determinants were identified. A
detailed summary of the reviewed documents is presented in Appendix A. he summary of
adoption determinants is presented in Table 6.

Table 6. Adoption determinants

TOE
categories Determinants
T
T
T
T
T
O
O
O
O
O
O
E
E
E
E
E
E

References
Grover (1993); Ramamurthy et al. (1995); Narayanan et
Compatibility
al.(2009)
Complexity
Grover (1993)
Iacovou et al. (1995); Kuan et al. (2001); Narayanan et al.
Direct benefits
(2009)
Iacovou et al. (1995); Ramamurthy et al. (1995); Narayanan et
Indirect benefits
al. (2009)
Relative advantage
Grover (1993); McGowan and Madey (1998a)
Adequate resources
Chang et al. (2009)
Championship
Grover (1993)
Cost
Kuan et al. (2001)
Chang et al. (2009); McGowan and Madey (1998a); Palmer
Hospital size
(1998);Narayanan et al.(2009)
Technical competence
Kuan et al. (2001)
Grover (1993); Nelson (2003); Ramamurthy et al.
Top management support (1995);McGowan and Madey (1998a)
Competitive pressure
Iacovou et al. (1995); Narayanan et al. (2009)
Customer influence
McGowan and Madey (1998a)
Government policy
Chang et al. (2009)
Imposition by partners
Iacovou et al. (1995)
Industry influence
Narayanan et al.(2009)
Vendor support
Chang et al. (2009)
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Those determinants were grouped according to the TOE model categories. In the organizational
category are: hospital size, top management support, adequate resources, championship, cost and
technical competence. In the category of technology related factors are: compatibility, direct
benefits, indirect benefits, relative advantage and complexity. In the category of environment
related factors are: competitive pressure, vendor support, government policy, imposition by
partners, customer influence and industry influence.

2.5 Summary of findings

This section presents a summary of the findings from the literature review related to technology
adoption within healthcare and non healthcare domains.

2.5.1 Non healthcare vs. Healthcare (timing)

The adoption of technology to support basic manufacturing processes started at the end of the
1980s, and there is lag compared with the adoption of technology to support healthcare supply
chain processes. Based on the date range of the documents in both groups, there is a difference
of about 15 years, between the time EDI started to penetrate in the manufacturing setting and the
initial time for EHR adoption initiation. According to the adoption phases defined by (Rogers E.
M., 1983) the EDI adoption process includes both, adoption an implementation phases
(Narayanan, Marucheck, & Handfield, 2009), however the EHR adoption is in an early stage.
No implementation phase for EHR was found or documented in any of the reviewed documents.
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2.5.2 Estimation of benefits

During early stages of the adoption process the benefits were estimated usually by comparison
with similar industries. In the case of the healthcare supply chain a comparison with retail
industry was usually referenced. An example of this fact is the work developed by RAND
Corporation on Health Information Technology HIT. In the case of EDI the results of the meta
analysis developed by (Narayanan, Marucheck, & Handfield, 2009) show inconclusive results
regarding the benefits of EDI adoption.

2.5.3 Conceptual models (characterization)

As defined by the MOT approach, a conceptual model is used to explain a given adoption
process. The explanation (characterization) of the adoption process is associated to the nature of
the conceptual model (e.g DOI, TOE, TAM), the unit of adoption defined for the analysis (e.g.
end user, organization), the phases (e.g. adoption, implementation) and the main adoption
determinants or the barriers, in the absence of a conceptual model.

The non healthcare related adoption processes explored through the literature review can be
characterized by the IOS/EDI adoption. The most relevant approach used to develop a
conceptual model is the Diffusion of Innovations (DOI) approach. In the case of DOI the
adopting unit can be defined as the organization. There are different stages of adoption as
described by (Rogers, Diffusion of Innovations, 1983). The work developed by (Ramamurthy &
Premkumar, 1995) and (Narayanan, Marucheck, & Handfield, 2009) in the case of EDI illustrate
the different phases and its relationship between implementation and outcomes. Factors
affecting adoption are different from implementation factors, the work of (McGowan & Madey,
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Adoption and implementation of Electronic Data Interchange, 1998), (Nelson, 2003),(Iskandar,
Kurokawa, & LeBlanc, 2001), and (Palmer, 1998) provide an indication of that fact even though
some authors note that the difference is not significant when a short implementation time is
considered.

The healthcare related adoption processes explored through the literature review can be
characterized by EHR adoption. There is no dominant conceptual model among the healthcare
related adoption processes explored in Section 2.2, however the TAM model was useful in
explaining adoption from the end user perspective as in the case of (Daim, Chan, Amer, &
Aldhaban, 2009) for Personal Health Records PHR, where an individual is making the decision
or whether or not to adopt PHR. During the initial stage of an adoption process usually the
barriers to adoption are explored as in the case of EDI (Arunachalam, 1995) and EHR (Ash &
Bates, 2005), (Miller & Sim, 2004).

2.5.4 Modeling approach

As explained in Section 2.3.2, among the reviewed documents there is no dominant approach to
model an adoption process. The relevant findings are related to techniques used in isolation. The
more predominant technique was diffusion curves in particular for the non-healthcare related
adoption processes. The use of game theory and system dynamics modeling was used to model
EHR adoption.

2.6 Conclusion

The characterization of adoption process within the healthcare and non-healthcare domains was
established, conceptual models were identified, as well as the adoption determinants and main
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barriers. The findings presented a conceptualization of a given adoption process within
healthcare and outside of the healthcare domain. This is a partial answer for the two research
questions initially proposed. The need for the review of the data standards related literature in
order to establish a comparison was evident; the comparison is developed in the next chapter.
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3. Factors affecting identification standards adoption

The goal of this chapter is to answer the following research question as established in Chapter 1:


What is preventing healthcare supply chain members and healthcare providers in
particular from adopting identification standards and its supporting technologies? What
are the major barriers?

This chapter reports on a literature review associated to data standards related literature in order
to identify the main factors affecting the adoption process. Based on the findings from this
literature review and the findings from the previous chapter, a comparison of the identification
standards adoption process and the adoption of Electronic Data Interchange (EDI) and Electronic
Health Records (EHR) was developed. A conceptual model to explain the factors affecting the
identification standards adoption process was proposed. The link between the proposed
conceptual model with subsequent modeling efforts is explained along with the implications of
current findings.

3.1 Data standards related literature review

The literature review was initiated with the review of the documents available through the main
trade journals (periodicals). The following periodicals were explored: Health Purchasing News
(HPN), Modern Materials Handling (MMH), Healthcare Financial Management Association
(HFMA) Journal and the Journal of the Healthcare Information and Management Systems
Society (JHIMS). The ProQuest data base was used for the HFMA journal and for the MMH
and HPN periodicals. The HFMA journal had full coverage since 1987, MMH had full coverage
since 2004 and HPN had full coverage since 2001. The JHIMS was accessed from the
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Healthcare Information and Management Systems Society (HIMSS) website, and the issues since
2005 were reviewed by topic, title and abstract. The basic terms for the search were data
standards and health care supply chain; 93 articles matched the criteria. The initial set of
documents was reviewed in order to establish if any of those documents had an explicit
relationship to data standards adoption in total 27 articles were identified.

The 27 articles were fully reviewed and the review process led to the identification of 33
additional documents. A total 60 documents were identified and those documents were grouped
in the following categories:


Trade journals (27)



Surveys and studies (8)



Industry reports and white papers (13)



GS1 related documents (6)



Others (6)

The final set of documents was grouped by category in two parts A and B as shown in Tables 7
and 8 respectively. The classified documents were fully reviewed in order to establish the
barriers to data standards adoption; the terms conceptual model and mathematical modeling were
also included in the review. The results from the review by category are presented in the
following section.
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3.1.1 Findings by category

Trade journals

The industry perception of the identification standards adoption movement can be explained
through the trade literature documentation. 27 documents were reviewed as shown in Table 7.
The Department of Defense (DoD) pilot showed promising results for synchronizing data in
healthcare, (Garvin, 2006) and the use of a Product Data Utility (PDU) as a centralized and
standardized source of product related information. The concept of data synchronization was
initially embraced by the DoD pilot. The results demonstrated the concept of a PDU for
healthcare as a feasible one (Levine, 2007).

The efficiency of supply chain processes is clearly reduced due to the lack of a standardized or a
unique numbering scheme. The FDA in 2004 established a rule requiring the labeling of drugs
using the National Drug Code (NDC) number which was created to help reduce medication
errors. However, medical devices were excluded from this barcode rule due to the lack of a
unique numbering system for medical devices and supplies (Barlow, Sync or swim: Who should
blink first and why?, 2007). The FDA’s current authority only applies to device manufacturers;
it cannot reach the provider side (Barlow, FDA Negotiates through device data standards
stalemate, 2010). The FDA also presents the option of multiple standards and not to endorse a
particular one. They believe the industry would benefit more with the presence of multiple
standards since it could leave the door open for the development of options that could address
identification issues that neither GS1 nor HIBCC can adequately address (e.g. ISBT 128 standard
for tissues).
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Table 7. Identification standards literature review Part A
Category Author
Date
Garvin*
may-06
Barlow
abr-07
Levine
abr-07
Barlow f
jun-08
Barlow d*
abr-09
Barlow e
may-09
Perrin
sep-09
Barlow*
dic-09
Barlow c
feb-10
Barlow b*
feb-10
Barlow a*
feb-10
Langabeer
2005
Trade Thompson et al.
2007
Literature Murphy*
2008
Blachowicz et al.
2008
Krohn
2009
Burke et al.
2009
Edwards et al.
2010
Berling and Geppi 1989
Moynihan
1997
Brennan
1998
Brody
2007
Belkoski*
2008
Kowalsky
2009
Burke
2008
Burke
2008
De John
2008
* barrier related document

Journal or Document Title
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
Healthcare Purchasing News
JHIMS
JHIMS
JHIMS
JHIMS
JHIMS
JHIMS
JHIMS
Healthcare Financial Management
Healthcare Financial Management
Healthcare Financial Management
Healthcare Financial Management
Healthcare Financial Management
Healthcare Financial Management
Materials Management in Healthcare
Materials Management in Healthcare
Materials Management in Healthcare

Topic
Data synchronization
Sync or swim+
DoD Pilot results
Data Standards precautions
Stimulus package
Premier
Supply chain standards
Year end
FDA viewpoint
VHA viewpoint - Alliance
Deadlines
Supply Chain IT
Benefits EHR+
HIT adoption
Future EHR ROI
Interoperability
Best of Breed strategies
Barriers related to HIE and EHR
Early supply chain concepts
EHCR related - EDI adoption+
EHCR related+
Data synchronization
Retail model+
Strategic approach
DoD Pilot lessons learned
DoD Pilot lessons learned
Standards in motion+
+
benefits related document
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Table 8. Identification standards literature review Part B
Category Author
EHCR
AHA Survey*
Surveys AHA Report
and
AHA Survey*
Studies HFMA Survey
HFMA Survey
CHIL Survey*
HIMSS report*
Garg et al
HIMSS report*
McKesson white paper
ATKS report
Industry Hefflin (ECRI)*
Reports ERG*
Rosenfeld
Accenture
Shemm et al
MIT CTL report
The academy study
Lawson white paper
Simpson and Kleinberg
Bix et al
DoD Pilot Report
GS1
GS1 and HCSC
related Seton
GS1 System of standards
ChES HIGPA Survey*
* barrier related document

Date
1996
2005
2006
2007
2005
2008
2009
2010
1999
2003
2004
2004
2005
2006
2006
2006
2007
2006
2008
2008
2009
2007
2007
2009
2009
2010
2009

Journal or Document Title
Improving the efficiency of the healthacare supply chain
Forward Momentum
Adopting Technological Innovations in Hospitals
Continued Progress
HFMA 2005 healthcare supply chain benchmarking survey
HFMA 2008 healthcare supply chain survey
The State of Healthcare Logistics
E-procurement for supply chain management
17 Billion Reasons to Say Thanks
Guide for the Use of BC Technology in Healthcare
Healthcare supply chain management and the internet
Connect the dots
Automatic Identification of Medicel Devices
Unique identification for medical devices
Data Synchronization in Healthcare: A Solvable Problem
Synchronization
Global Data Synchronization
Transforming the Healthcare Supply Chain
SCM Practices of the Largest Health Systems
Getting Started with Standards Based Operating Procedures
Implementation Guide to Bar Coding ain Healthcare
Global Data Standards in the Healthcare Supply Chain
Results from DoD HealthcareGDSN Pilot Phase IIA
GS1 Standards in the Healthcare Supply Chain
A GS1 Healthcare US Success Story
The Value and Benefits of the GS1 System of Standards
Putting the Pieces Together

Topic
Supply Chain Strategies+
HIT = EHR most of the time
focus HIT
focus HIT in general
Opportunities+
Opportunities+
Barriers to IdS adoption
EDI adoption
Cost and benefits UPC+
Focus on drug administration
eCommerce focus+
EPC and GDS focus+
UDI challenges
UDI challenges+
GDSN Healthcare roadmap+
GDSN benefits (retail)+
GDSN trends+
HCSC problems+
Best practices+
Implementation road map+
Pharmaceutical adm. Related
Costs and benefits+
Lessons learned GDSN pilot+
Definitions+
Perfect order definition
Definitions
IT solution provider focus
+
benefits related document
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Some Integrated Delivery Networks (IDNs) have called for the government to support the use of
GS1 standards as they support and promote the use of Electronic Medical Records (EMR)
(Barlow, Alliance subgroup throws down device data standards gauntlet, 2010). According to
the authors there is no sense if a hospital has an EMR and still has to key in the product numbers
due to the lack of standards and automation at the point of use.

The Efficient Healthcare Consumer Response (EHCR) initiative (CSC, 1996) was referenced as
the main starting point addressing the issues such as: the lack of unique identifiers for products
and locations, the lack of EDI capabilities at the healthcare provider level and the low
penetration of point of use barcode enabled technology (Moynihan, 1997). However, just until
2007 standards movement started to take shape. This movement was followed by the positive
results from the Department of Defense (DoD) pilot (Burke, Hospitals lessons in data
synchronization, 2008), (Burke, Progressive Pilots, 2008) on testing the Product Data Utility
(PDU) as a feasible concept for the healthcare industry.

Industry groups are collaborating to promote data standards adoption (Barlow, Alliance subgroup
throws down device data standards gauntlet, 2010). The FDA is also working on the draft of a
UDI regulation for medical devices and supplies. Technology adoption plays an important role
on data standards adoption as explained by (Langabeer, 2005). This is a key issue to be
addresses in this research, the relationship between technology adoption and adoption of
standards at the healthcare provider level. It is assumed that the underlying technology should be
installed and running for identification standards adoption and use.
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Surveys and studies

Within the surveys and studies category, 8 relevant documents were identified. The initial study
(CSC, 1996) identified three main strategies and four main enablers for healthcare supply chain
improvement. Among the strategies were efficient product movement, the efficient order
management and the efficient information sharing. The four enablers were categorized in
strategic and tactical. At the strategic level: partnerships and alliances, and change management.
At the tactical level: information technologies and activity based costing. Within the information
technologies enablers, the critical technologies identified were: unique identifiers, bar code
labeling and EDI. The main elements on the third strategy include solution sets directly related
to the implementation and use of identification standards and its supporting technologies.

The surveys developed by the American Hospital Association (AHA) (AHA, 2006),(AHA,
2007), (AHA, 2005) were related to the adoption of HIT for clinical and non clinical purposes by
US hospitals. From these documents the current status of one of the most important clinical
applications, the EHR, was inferred. The penetration rate for EHR is about 32%. The barriers to
adoption were also explicitly mentioned but those barriers were usually associated with the
adoption of HIT in the context of Electronic Health Records. The main barriers were: the initial
costs, ongoing costs, interoperability with current systems, acceptance by clinical staff,
availability of trained IT staff and the inability of technology to meet the process requirements.

The survey developed by (Nachtmann & Pohl, The State of Healthcare Logistics: Cost and
Quality, 2009) referenced the technological component as one of the main barriers to data
standards adoption. Among the other barriers were the lack of resources, supply chain partners,
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universal acceptance, lack of knowledge, system diversity, management buy-in, data issues,
organization size, government, low priority and cultural resistance.

The surveys showed that the data standards movement initiated in 2007 had an impact on
industry perceptions. The HFMA surveys of 2005 and 2008 (HFMA, 2005), (HFMA, 2008)
provided an indication of that fact. The HFMA survey of 2005 did not show data standardization
as an explicit opportunity for improvement, but it appeared in the 2008 survey as a significant
one. The survey developed by (Nachtmann & Pohl, The State of Healthcare Logistics: Cost and
Quality, 2009) also indicated that data standards are a major issue, labeling it as one of the main
challenges to achieve supply chain excellence. Some confusion still exists regarding the
definition of data standards, as pointed out by (Kohn, Corrigan, & Donaldson, 2000). The data
standards concept is too broad. It could mean: standardization within the hospital, process
standardization or the use of standard identifiers for products and locations. A specific reference
to the definition of data standards in the context of the explored surveys was not found.

Industry reports

Within the industry reports category, 13 relevant documents were identified. The report by
(Garg, Jones, & Sheedy, 1999) described the methodology followed in order to establish the
gains of the Universal Product Code (UPC) adoption by the grocery industry; the gains were
estimated to be approximately 17 billion dollars. Hard savings and soft savings were initially
estimated and the report showed how most of the gains can be attributed to hard savings,
however, the soft savings are still to be realized.
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The report by (HIMSS, 2003) referred to the use of barcode technology in healthcare but is
directly related to drug administration. This report highlighted the importance of the National
Drug Code (NDC) as an identifier for most of pharmaceutical products but calls the attention of
most of the healthcare supply chain players on its proper use. Following the report by HIMSS,
two reports were published. The first one, developed by (McKesson, 2004) related to electronic
commerce and the second one developed by ATKS (ATKS, 2004), related to Electronic Product
Code (EPC) adoption. Both reports highlighted the importance of standards for electronic
transactions and identified the critical elements required for electronic commerce in healthcare.
The Unique Device Identification (UDI) initiative was discussed by (ERG, 2006) and (Hefflin,
2005). Among the main barriers to UDI implementation were the lack of a unique identifier for
medical devices and supplies and the low technology (auto identification and data capture)
penetration at the healthcare provider level in particular at the point of use.

The report by Accenture (Accenture, 2006) described the benefits of data synchronization in the
retail context and presented an estimation of benefits of its adoption within healthcare. The
report by (Shemm, Legner, & Otto, 2007) discussed the Global Data Synchronization Network
(GDSN) from a global perspective. The report by (Rosenfeld & Stelzer, 2006) described the
synchronization concept in healthcare and compared it with what has been done in retail.
According to the authors, the gains from data synchronization could be significant, if healthcare
industry moves in that direction. The report also presented some tools to estimate the benefits of
data synchronization in healthcare.

The (CTL, 2006) report described the main problems identified within the healthcare supply
chain, in fact, some of the identified problems were: cost growth, lack of a big player at the end
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of the chain, process inefficiency and lack of integration of the last echelon; from the receiving
dock to the doctor. The lack of a unique identifier for healthcare products is also highlighted as
one on the major challenges. The study developed by (The Academy and Broadlane, 2008)
revealed a set of practices common among the best performer hospitals. Among the best
practices were: leadership and corporate office presence for supply chain related issues,
existence of system wide policies and physician engagement. The report by (Lawson, 2008)
described a roadmap for data standards implementation along with a check list for information
technology and system readiness. The book by (Simpson & Kleinberg, 2009) was related to the
implementation of barcode technology in clinical and supply chain applications. This book made
explicit reference to the need of a standard for product identification and revealed the
implications of its absence for all healthcare supply chain players.

The retail industry was used as a reference point to estimate data synchronization benefits. The
UDI initiative was presented as a possible solution to fix the problem of the lack of unique
identifiers for medical devices and supplies. The main problems related to healthcare supply
chain are associated to the lack of a unique identifier as a main source of process inefficiencies.
In this regard, having a unique identifier for products and locations would help to increase supply
chain related processes efficiency and also facilitate information exchange and synchronization
among healthcare supply chain members.

GS1 documentation

Within the GS1 related documentation category, 6 documents were identified. The effort on data
standardization within the medical surgical supply chain was initiated by the Department of
Defense (DoD, 2007). The conceptualization of the Universal Product Number (UPN) as a
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unique identifier for medical surgical supplies (including devices) and the development of the
PDU concept as a unique repository for product related information were among the main
contributions of the initial phases of the DoD pilot. This pilot in recent versions involved major
healthcare supply chain players and it was proving the Global Data Synchronization Network
(GDSN) as a feasible concept for the healthcare industry. The study developed by (Bix, Clarke,
Lockhart, Twede, & Spink, 2007) was an extensive study on the costs and benefits of standards
adoption. It gave basic definitions regarding the hospital supply chain and presented a
compilation of previous studies dealing with cost benefit estimation of automation within the
healthcare supply chain.

Basic definitions about standards and health care supply chain are given by (GS1, 2009), (GS1,
2010). The main source for GS1 data standards related information is the official GS1
Healthcare US website. Specific deadlines for product and location identification standards
adoption have been established by the industry. The deadline for location identifiers adoption
was December 31st 2010 and the deadline for product identifiers is December 31st 2012.
Currently the healthcare industry is moving towards the readiness assessment of the different
healthcare supply chain players, but adoption remains low. The readiness assessment is
voluntary and GS1 healthcare US is providing tools for healthcare supply chain members who
would like to assess their current adoption level. The assessment of technology solution
providers (ChEs HIGPA GS1, 2009) revealed that most of the technology solution providers
could at least store the identifiers; however, the transaction capabilities are still an issue to be
resolved.
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The documents reviewed in this section included documents related to key definitions, however,
case studies were not considered. The review of those cases is out of scope for this research but
its importance is acknowledged. The GS1 system of standards is currently the standard being
promoted, but it could be any standard, for analysis purposes, as long as it is unique. The focus
of this research is not GS1 standards; it is the concept of product and location identifiers
standards adoption along with the required technology to make use of the standards. It is
assumed that technology plays a key role in identification standards adoption.

Others

Within this category a brief exploration of the identification standards adoption concept among
the pharmaceutical supply chain was developed; 6 documents were identified. An earlier
document dated 1996 (Bedard, 1996) presented the fact that even though the barcode technology
was present, it was not widely deployed within healthcare industry, this problem is still
persistent. The GS1 documentation is related to the traceability and electronic pedigree
initiatives within the pharmaceutical supply chain (GS1 US, 2010). The pharmaceutical supply
chain related documentation is a reference point for Bedside Point of Care (BPOC) systems and
Barcode Medication Administration (BCMA) adoption. The report developed by (Grotting,
Yang, Kelly, Brown, & Trohimovich, 2002), presented the benefits and barriers of BPOC
systems in the context of patient safety through the use of case studies. The workarounds to
BCMA adoption are explained by (Koppel, Wetterneck, Telles, & Karsh, 2008) and among the
possible causes is the lack of medications with a barcode. The adoption of BCMA from the end
user perspective is explained by (Patterson, Chapman, Render, & Rogers, 2006), the authors
found that when workaround strategies were used in order to increase efficiency, new potential
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paths for adverse drug events were generated. The end user perspective was studied by (Tian,
Duffy, Birk, Abel, & Hultgren, 2009), in this work the authors use the TAM model to explain
BCMA adoption within hospitals. The penetration of BCMA among hospitals remains low; it is
reported as 10% (Cummings, Ratko, & Matuszewski, 2005).

3.1.2 Findings by topic

This section summarizes the findings related to the benefits and barriers, being the most common
topics referenced in the literature. No conceptual model related document was found. Other
topics such as the healthcare provider perspective and the identification standards definition will
be referenced through the development of the conceptual model.

Benefits of data standards adoption

From the set of identified documents, 22 documents were related to data standards adoption
benefits. The broad benefits of adopting identification standards were related to the increase of
supply chain processes efficiencies and the increase of patient safety. Among these benefits
were: efficient traceability (Rosenfeld & Stelzer, 2006); improved ordering, invoicing and
receiving processes (CSC, 1996); reduced data cleansing efforts (Accenture, 2006); ability to
better monitor product recalls; track expiration dates and product authentication (Hefflin, 2005)
and reduction on medication administration errors (Kohn, Corrigan, & Donaldson, 2000). Most
of the estimations were based on industry predictions and by developing a comparison with the
retail industry. As explained in Chapter 2, when an adoption process is in its early stage, the
benefits are estimated by comparison with other industries and case specific findings (pilot
studies).
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In the case of EDI adoption, the adoption and implementation phases were developed
(Narayanan, Marucheck, & Handfield, 2009), but most of the implementation studies showed
inconclusive results regarding the benefits achieved from its adoption. The adoption of EHR is
in a similar stage as data standards adoption; benefits have been estimated but currently not
realized. In the case of EHR, (Thompson, Osheroff, Classen, & Sittig, 2007) points out that
there is no widely standardized method to estimate or measure EHR adoption benefits. The
authors provided a summary of an analysis conducted on the topic with more than 100 hospitals.
The different methods used estimate the benefits are vendor supplied data, comprehensive
studies, logical modeling, focused studies and site visits; the first option is the most common
one. The authors proposed the development of a national database where hospitals can selfreport best practices, lessons learned as well and costs and benefits. This will take time to
develop but it could ensure the compilation of the information for further use. A similar
structure could be developed for identification standards adoption assessment.

Barriers and challenges

From the set of initial documents, 15 documents were directly related to the barriers or
challenges of data standards adoption. Those documents were fully reviewed and an initial list
of barriers was developed, 34 items were identified. The barriers are grouped in 9 categories as
shown in Table 9. No explicit document dealing with the barriers of data standards adoption was
found.
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3.2 Comparison EDI/EHR (conceptual models and barriers)

As explained in Section 3.1, there are no documents related to any conceptual model developed
to describe the identification standards adoption process. In the absence of a conceptual model
for identification standards adoption, it was not possible to develop a comparison between the
conceptual models found in Chapter 2 which describe the adoption of EDI and EHR and a
conceptual mode for identification standards. In this case a general analysis regarding the
conceptual models was developed along with a comparison based on the identified barriers for
the 3 adoption processes under analysis.

Table 9. Identification standards barriers

Barrier category
1 High cost

2

Organizational
capabilities

3 Lack of a standard
4 Technology
Lack of gov.
intervention
6 Lack of ROI
5

# of items Reference documents
(Garvin 2006) (Barlow d 2009) (Barlow 2009) (Barlow
a 2010) (Murphy 2008) (AHA Survey 2005) (AHA
7
Survey 2007) (CHIL Survey 2009) (HIMSS report
2010)
(Murphy 2008) (AHA Survey 2005) (AHA Survey
7
2007) (CHIL Survey 2009) (HIMSS report 2010)
(Barlow d 2009) (Barlow a 2010) (Belkoski 2008)
6
(CHIL Survey 2009) (HIMSS report 2010) (HIMSS
report 2003) (Hefflin 2005)
(AHA Survey 2005) (AHA Survey 2007) (CHIL Survey
4
2009) (ChES HIGPA Survey 2009)
3

(Barlow b 2009) (Barlow a 2010) (CHIL Survey 2009)

2

7 Interoperability issues

2

8 Supplier reluctance
Lack of solution
9
providers support

2

(Barlow b 2009) (Murphy 2008)
(Barlow d 2009) (Barlow b 2009) (AHA Survey 2005)
(AHA Survey 2007) (CHIL Survey 2009)
(CHIL Survey 2009) (HIMSS report 2010) (ERG 2006)

1

(Barlow b 2009) (Barlow a 2010)
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3.2.1 General comments

The EDI adoption process was characterized by the use of DOI theory. This adoption process
has been mostly studied from the organizational perspective. The adoption and implementation
phases were present on most of the studies. The initial EDI adoption related studies were
conducted in the late eighties.

The review of the EHR adoption process did not show any relevant conceptual model. However
it included the end user (clinician or nurse) perspective when analyzing the adoption problem.

The EHR adoption process is in the initial stage, most of the adoption studies are dated
beginning of 2004.

The identification standards adoption process is in a similar stage as the adoption of EHR,
however, according to the literature the identification standards adoption process started in 2008.
The timeline for EDI, EHR and Identification Standards (IdS) adoption is illustrated in Figure 5.

Figure 5. Innovations introduction timeline

3.2.2 Barriers

As established in Section 2.4, the EDI barriers are summarized in the work of (Arunachalam,
1995), among the barriers to EDI adoption are the interoperability related issues, the lack of a
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standard, technology issues and the lack of ROI. The EHR barriers are cited by (Miller & Sim,
2004),(Ash & Bates, 2005) and (Erdil & Emerson, Modeling the dynamics of Electronic Health
Records adoption in the U.S healthcare system, 2008), among the main barriers to EHR adoption
are the high costs, technology issues and the lack of ROI. There were common facts that appear
along the three adoption processes. Among those were the following: organizational capabilities,
lack of Return on Investment (ROI) and technology related issues. There were some unique
facts related only to identification standards adoption: the lack of government intervention and
solution provider support. The results of the comparison are summarized in Figure 6.

Figure 6. Barriers (comparison)

The review showed that in contrast to the EDI and EHR adoption processes described in Chapter
2, there are no documents related to a conceptual model or mathematical modeling approach for
the identification standards adoption process, or at least those documents were not found.
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Through the literature review the need of a perspective to analyze the identification standards
adoption problem and the need for an operational definition for the concept of data standards
were identified. These two issues are addressed in Section 3.3.1. A conceptual model for data
standards adoption is proposed in Section 3.3.

3.3 Conceptual model for identification standards adoption

As mentioned in Section 3.2 the need for a perspective and an operational definition was
identified in order to proceed with the analysis of the identification standards process and the
development of a conceptual model. This need was also supported by the findings in Chapter 2
that indicate that such definitions are a pre requisite for a conceptual model definition.

The justification of the healthcare provider perspective and the operational definition for data
standards in the context of this research is presented in the following paragraphs.

3.3.1 Basic definitions

Healthcare Provider Perspective

The chicken and egg problem of technology adoption described by many authors such a
(Simpson & Kleinberg, 2009) and (Barlow, Alliance subgroup throws down device data
standards gauntlet, 2010) can be analyzed if a perspective is considered. A specific view point is
required to analyze the problem and would be useful when solutions to the problem are
proposed.

For identification standards adoption, the healthcare provider perspective was defined as the
main element to drive the adoption process; it is assumed that there is a pull effect from the
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healthcare provider to the manufacturer which can speed up adoption. The healthcare provider
perspective is supported by (Barlow, Crafting the supply chain stimulus package, 2009) and
(Burke, Hospitals lessons in data synchronization, 2008). As pointed out in (HIMSS, 2003)
some of the most significant implications of barcode labeling at the point of care and throughout
the supply chain are: the need for industry standards to define the format of the label; the need
for manufacturers and distributors to support barcode labels at the unit required for transactional
purposes; and healthcare providers to implement processes to utilize the barcode products and
systems to improve patient care.

Technology is a key issue in data standards adoption and implementation. Given the fact that
hospitals devote more resources to technologies that support patient care than to the supply chain
(Kowalski, 2009), the problem is even more relevant. Related to supply chain technology two
types of investments are clearly defined: information systems such as a specialized supply chain
module or an ERP supply chain module and also automation technology which could include
point of use systems that track inventory on hand, storage carousels, and warehouse management
systems. According to (Langabeer, 2005), there is a significant gap between healthcare and the
evolution of information systems to support supply chain management processes in other
industries such as retail or manufacturing and healthcare industry.

Operational definition (identification standards)

In the context of this research the terms data standards and identification standards are
equivalent. As explained by (Krohn, 2009), the data standards definition is too broad, so a
definition was needed as an initial step in the analysis of the adoption process. An operational
definition such as the one given by (Bower, The Diffusion and Value of Healthcare Information
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Technology, 2005) in the case of EHR and by (Narayanan, Marucheck, & Handfield, 2009) in
the case of EDI is required. For example, (Bower, The Diffusion and Value of Healthcare
Information Technology, 2005) in his work defined that a healthcare provider had EHR if it has
purchased a set of applications (i.e Clinical decision support systems, Computarized patient
records and Clinical data repository), within a given period of time.

For identification standards the operational definition includes a process-technology based
approach. Three types of processes are defined. Processes type I are external supply chain
processes associated with external supply chain partners. Processes type II are internal supply
chain processes. Processes type III are supply chain processes related to the final product
delivery which includes the patient. The adoption within processes type I is associated to the
presence of the required systems (supporting technologies) to operate with the standards, for
example EDI or a MMIS. For processes type II a level of automation is required this includes
supply chain solutions with barcode enabled capabilities. For processes type III the required
technology is automation at the point of use.

The concept of perfect order as defined by (GS1, 2009) was used as an initial reference point to
define identification standards adoption within the conceptual model scope. The concept of the
perfect order has been around since 2008 and it has its roots in the work of the manufacturer BD
within the scope of the DoD pilot. A perfect order is defined as a purchase order processed
electronically from order to payment without human intervention, delivered to the right location,
on time, undamaged, at the right price, in the desired quantity on the first attempt. According to
this definition a healthcare provider (hospital) with the capability of sending and receiving an
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EDI order which includes product and location identifiers would be recognized as an adopter of
identification standards.

3.3.2 Factors affecting the identification standards adoption process

The proposed conceptual model for identification standards was based on the findings from the
literature review developed in Chapter 2 and the findings of the literature review on data
standards conducted in this chapter. It was assumed that factors which have been found relevant
to other technological innovations (adoption determinants) could help to explain the adoption
process under study.

A conceptual model for identification standards adoption needs to consider the factors that affect
the adoption and use of the innovation (data standards). The extensive literature review
developed in Chapter 2 suggested that the Technology Organization and Environment (TOE)
conceptual model (Tornatzky & Fleisher, 1990) is appropriate to define and study the factors that
influence identification standards adoption.

This conceptual model defines three aspects of an organization that influence the adoption of a
given innovation. The technological context describes the characteristics of the innovation to be
adopted in relationship with the readiness level of the organization. The organizational context
is related to the characteristics of the organization such as size and top management involvement.
The environmental context is related to the external factors that influence adoption, such as
government and industry players. The TOE model is consistent with the innovation diffusion
theory (Rogers E. M., 1983) which defines technological characteristics and both, the internal
and external characteristics of the organization as drivers for technology adoption and diffusion.
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In order to develop the conceptual model, the barriers for identification standards were compared
with the list of adoption determinants established in Chapter 2. An association between the
identification standards adoption barriers shown in Table 6 and the adoption determinants listed
in Table 9 was developed. After the analysis, 8 of the adoption determinants were considered
along with new elements related only to identification standards adoption (identified through the
literature review). The specific elements related to identification standards adoption were
associated to the readiness level of the organization (healthcare provider) process and technology
wise; and the readiness level of the technology solution provider. The final set of eleven factors
that are associated to identification standards adoption was grouped by TOE category as shown
in Table 10.

The proposed conceptual model is illustrated in Figure 7. Each factor within the model is related
to the healthcare provider adoption decision. The factors are grouped by TOE category. The
technology related factors are relative advantage, complexity, compatibility and the
organizational readiness factor in terms of the technological capabilities. These factors are
directly associated with the characteristics of the technology (innovation) under study and the
preparedness of the organization related to its infrastructure to support the adoption. The relative
advantage represents in aggregate terms the gain from its adoption. The environment related
factors are industry pressure, government intervention, vendor support and the technology
solution provider readiness factor in terms of its ability to support the technology to be adopted
by the healthcare provider. These factors are outside of the control of the healthcare provider.
The organization related factors are size, top management support, and organizational readiness
factor. These factors are directly related to key characteristics of the organization (e.g size) and
also to basic elements of the project and team required to lead the adoption process.
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Table 10. Proposed adoption determinants

1
2
3
4
5
6
7
8
9
10
11

TOE
category
T
T
T
T
O
O
O
E
E
E
E

Factors
Relative advantage
Compatibility
Complexity
Organization readiness (technology based)
Top management support
Hospital size
Organization readiness (process based)
Industry influence
Vendor support
Government policy
IT Vendor readiness

3.3.3 Conceptual model validation

The conceptual model was validated with the use of industry expert’s interviews. Two experts
from a medium size medical center; the information technology IT Vice President and the supply
chain manager were interviewed in order to validate the factors proposed by the conceptual
model. The categorization of factors using the TOE model structure was understood and it was
found relevant. Regarding the organization related factors, the top management support and
organizational readiness factors were highlighted as important ones. The organization size was
not perceived as a major factor affecting adoption. The organizational readiness was directly
related to the technological infrastructure and the maturity level of the solution (i.e. data
standards). The return on investment from the adoption of data standards is not seen as an
immediate fact but a result of the collaboration among supply chain partners. According to the
experts that is one of the reasons why healthcare providers have to start pulling in order to drive
the adoption process.
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Figure 7. Proposed conceptual model

For example healthcare providers would benefit from the use of barcode labeled products if
manufacturers are willing to do the task of labeling them; but healthcare providers have to start
implementing barcode enabled processes. The solution’s compatibility and complexity are also
seen as drivers of adoption. In this case the data standards solution should be compatible with
existing systems and the complexity of its implementation should be low. There are external
forces that could drive adoption and certainly the IT vendor readiness is one of them as well as
the pressure from the government and other industry partners.

3.4 Mathematical modeling approach for identification standards adoption

The identification standards literature reviewed in this chapter did not reveal any mathematical
modeling approach. The use of diffusion theory and system dynamics modeling is proposed to
develop an approach to model the identification standards adoption process. The development of
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the model includes the transition from the conceptual modeling phase to the mathematical
modeling of the adoption process.

The factors identified through the conceptual model are used in the causal loop diagram and
simulation model development. The initial mathematical model is proposed as an extension of
the Bass diffusion model and will be used to simulate the behavior of the hospital population
over time and to observe the impact of the external and internal diffusion coefficients in the
adoption rate. The simulation model will allow for the analysis and design of policies to move
the adoption process forward. The development of the modeling approach for identification
standards is presented in Chapter 4.

3.5 Conclusions

This chapter presented the identification standards adoption process from an academic
perspective using the elements provided by the literature review on management of technology
MOT and current findings from data standards adoption literature. The exploration and
identification of the factors affecting the identification standards adoption process is the initial
step toward understanding the adoption of data standards.

The conceptual model proposed in this paper was developed based on an extensive literature
review related to the identification standards adoption literature as well as technology adoption
literature. The conceptual model for identification standards adoption is proposed as a way to
answer the research question defined at the beginning of this chapter and to fulfill the goal of
Phase I.
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4. Modeling Approach

The goal of this chapter is to answer the following research question as established in Chapter 1:


How could existing diffusion models be extended or modified to model the identification
standards adoption process?

A systems dynamics modeling approach is used to model this process. The model is based on
the diffusion of innovations theory; the main factors identified on Chapter 3 are used to develop
the Causal Loop Diagram (CLD). For the model formulation it is assumed that classic diffusion
models can be extended to model identification standards adoption. The developed model will
facilitate the understanding of the system (healthcare supply chain) behavior and allow for the
design and test of policies to move the system forward.

The use of technology diffusion models, such as the Bass Diffusion Model (BDM), for the model
formulation presents some limitations which are explained and a way to overcome those
limitations is presented. One of the most important limitations is the need of data on past
adoptions which is lacking in the case of identification standards. Among the solutions to
overcome this issue is the staged formulation proposed in this chapter. Two model stages are
proposed. The Stage 1 or initial model formulation stays close to the basic BDM and is used to
simulate the behavior of the hospital population over time and to observe the impact of the
external and internal diffusion coefficients in the adoption rate of identification standards’
supporting technologies. The implementation of the formulation for stage 1, the estimation of
the base run, and the model validation are explained in this chapter.
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The Stage 2 of the model formulation includes the process followed to formulate the model
based on the CLD taking into consideration the proposed identification standards definition and
the lessons learned from Stage 1. The model is based on system dynamics and diffusion theory
and provides a model to understand and test interventions to promote adoption of Identification
Standards (IdS). The implementation of the formulation for Stage 2, the estimation of the base
run as well as model validation is explained in the next chapter. The model development and
implementation fulfills the goal established for phase II of the research methodology as
presented in Chapter 1.

4.1 Literature review

The literature review presented in this section compiled information from three different sources.
The first one, the literature review developed in Chapter 2 which was related to technology
adoption within the healthcare and non-healthcare domains. Among the identified documents an
exploration of mathematical approaches to model adoption was performed; within the 41
documents identified in the literature review, 4 documents described a mathematical approach to
technology adoption and diffusion. The main topics identified were the following: diffusion
curves, system dynamics, game theory and agent based modeling (See Section 2.3.2).

The second source, the literature review developed in Chapter 3, which was related to the
identification standards literature, concluded that no modeling approach was found within the
identification standards literature and that there was an absence of a clear definition of the
identification standards concept. These two particular issues are addressed in this chapter. The
proposed modeling approach for identification standards adoption and the proposed definition
are developed in order to explain the identification standards adoption process.
75

The third source, a specific search on System Dynamics SD methodology was extended through
the development of Chapters 4 and 5. The SD methodology and technology diffusion
perspective were also explored in order to understand and justify the methodology. Some of the
references are: the diffusion modeling book by (Mahajan, Muller, & Wind, New Product
Diffusion Models, 2000) provided useful information associated with the estimation of model
parameters. The papers on sensitivity analysis (Ford & Flynn, 2005), (Hekimoglu & Barlas,
2010) describe how sensitivity analysis of system dynamics models can be performed in order to
identify main parameters and key issues. The design of interventions was documented by the
work of (Fisher, Norvell, Sonka, & Nelson, 2000), (Daim, Rueda, Martin, & Gerdsri, 2006) and
(Cui, Zhao, & Ravichandran, 2011).

4.2 Modeling approach for identification standards adoption

As implied by the System Dynamics (SD) methodology described by (Coyle, 1983), the purpose
of a model is to understand the structure of the system and to provide an insights into the
possible solutions to the existing problems. The system dynamics methodology is suitable in the
study of complex systems, where the interaction among factors is the possible cause of the
problematic situation. As explained by (Sterman, 2000) it allows researchers to model the
system at an aggregated level as shown in Figure 8. This level of aggregation facilitates the
understanding and formal analysis of the system under study (Borshchev & Filippov, 2004).
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Figure 8. Modeling levels of aggregation (adapted from Borshcev and Filippov, 2004)

The system dynamics methodology is followed to model the identification standards adoption
process using the steps described below:

1. Definition of the real world symptoms to be understood and improved
2. System description by the use of a causal loop diagram
3. Model formulation and simulation model development (structure)
4. Model implementation and validation
5. Simulation experiments
6. Analysis and results
The steps are followed sequentially but once the model is formulated and Step 6 is reached the
process goes back to Step 3 until a satisfactory level of analysis is achieved. The complete
sequence of the research methodology for Phase II is illustrated in Figure 3.
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4.2.1 Causal loop diagram

The causal loop diagram is a formalization of the findings regarding the possible causes for the
slow adoption process and it contributes to the identification of the feedback structure of the
system under analysis. A causal loop diagram consists of factors connected by arrows denoting
the causal influences amongst them. The causal loop diagram is another representation of the
factors affecting the adoption process, and it is one of the initial steps in the system dynamics SD
methodology. The causal loop diagram was developed to identify the relationships among the
different factors affecting the healthcare provider adoption, and it is a bridge between the
conceptual model proposed in Chapter 3 and the mathematical model proposed to simulate the
identification standards adoption rate.

4.2.2 Model formulation

The Bass diffusion model is defined as the basic formulation for the model. The model
formulation follows a two stage process. Stage 1, or initial approach, in which the Bass
Diffusion Model (BDM) is used to mathematically describe the adoption process. Stage 2 is
based on the causal loop diagram (CLD) and includes most of the empirical relationships within
the factors defined in the CLD.

4.2.3 Model implementation and validation

The model formulation was implemented in Vensim modeling software (version PLE Plus).
This tool was used in this research to develop the causal loop diagram and to implement the
model formulation. The Vensim model or simulation model facilitated the exploration of the
impact of the different factors on the adoption rate over a specified period of time. The
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simulation model was validated using the methods defined by the system dynamics SD
methodology according to (Sterman, 2000). Available industry data was also used to the extent
that was feasible and possible. The model was calibrated to reproduce meaningful results
according to the theoretical development.

4.2.4 Model analysis and results

The sensitivity analysis facilitated the identification of the relevant model parameters. The main
purpose of this phase was to test the impact of different interventions (parameter changes) on the
model in order to improve the system behavior.

This chapter includes the development of the causal loop diagram and the model formulation and
implementation for Stage 1. The model formulation and implementation for Stage 2 is
developed in Chapter 5.

4.3 Causal loop diagram

The causal loop diagram included the main elements identified as factors affecting the adoption.
These factors were identified through an extensive literature review on data standards literature
which was explained in Chapter 3. The factors included in the causal loop diagram are brought
from the conceptual model. The transition from the initial list of factors defined in the
conceptual model including the grouping of the different elements according to the TOE
framework in order to develop the causal loop diagram is explained in this section. The factors
are grouped in three categories: environment, technology and organization. Within the
environment section, the external factors affecting the adoption are considered. Since the model
takes into consideration two perspectives (technology provider and healthcare provider), the
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relative advantage is considered for both stakeholders as well as the readiness. There are two
known positive relationships not included directly (but indirectly) in the causal loop digram, the
size and the top management support; these relationships are considered within the organization
section but as part of the organization readiness. The causal loop diagram provides an
explanation of the factors affecting the healthcare provider adoption rate. The main elements of
the causal loop diagram are shown in Table 11.

Table 11. Causal Loop Diagram factors

Section
Environment

CLD Factors
Vendor support: the support from suppliers and distributors
related to the initiative of identification standards
Government intervention: intervention in the form of a
regulation related to identification standards adoption
Industry pressure: pressure from different industry groups
to adopt identification standards

Technology

Technology provider readiness: readiness level of the
technology solution provider towards adoption
Relative advantage (Technology provider): the relative gain
cost/benefit that can be obtained from adoption
Complexity: complexity of the technology
Interoperability: the ease of integration of the adopting
technology to existing systems

Organization

Organization readiness (P): readiness level of the
healthcare provider related to the processes and the scope
of the adoption
Organization readiness (T): readiness level of the
healthcare provider related to the technological capabilities
associated with the adoption
Relative advantage (Hospital): the relative gain cost/benefit
that can be obtained from adoption

The basic structure of the causal loop diagram is the stock flow representation of the healthcare
provider population. The healthcare provider population is divided into adopters and potential
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adopters, and the transition between the two groups is represented by the adoption rate. Around
the adoption rate a word of mouth model (Sterman, 2000) better known as technology diffusion
model approach is followed to exemplify the structure of the problem. The arrows and its signs
depict the relationships among the factors within the diagram. A positive sign illustrates a
proportional change; a negative sign illustrates the opposite relationship (an increase in one
factor would have a diminishing impact on the other). As mentioned before, the causal loop
diagram takes into consideration two perspectives the healthcare provider perspective and the
technology solution provider perspective, and how they both interact with the environment. The
sections within the causal loop diagram CLD are identified with three colors as shown in Figure
9. The color blue represents section one; the color green represents section two and the color
orange represents section three.

4.3.1 Section one (environment)

Industry pressure

The industry pressure comes from the Group Purchasing Organizations and industry groups. As
pointed out by (Barlow, Premier CIO conducting data synchrony. Alliance pushes harder for
supply chain data standards, 2009) the pressure from the different industry groups could
contribute to speed up the adoption process by increasing the pressure for solution provider
readiness. The industry pressure could increase the awareness of the different stakeholders in
particular healthcare providers through educational programs about the benefits and ways to
adopt the standards.
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Figure 9. Causal loop diagram.
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The awareness is another important component that could drive adoption (Barlow, Sync or swim:
Who should blink first and why?, 2007) along with peer pressure can be a strong motivator
(Barlow, Crafting the supply chain stimulus package, 2009), as more healthcare providers start
realizing the benefits in supply chain operations and patient safety others will follow and the
industry pressure would be higher. The industry pressure can contribute to increase the
technology solution provider readiness which could help to solve interoperability related issues.

Government intervention

The government intervention could be in the form of a regulation such as the UDI system or
through financial incentives provided to stimulate adoption. As pointed out by (Barlow, FDA
Negotiates through device data standards stalemate, 2010) the FDA have authority only over
manufacturers but not over the healthcare providers or any other healthcare supply chain
transacting member. This means that a regulation would be followed by manufacturers and
ultimately would lead to an industry wide adoption if other supply chain members participate in
the adoption effort. There are different positions regarding the endorsement of a unique set of
standards; the government believes that multiple standards could benefit the industry (Barlow,
FDA Negotiates through device data standards stalemate, 2010) while a unique set of standards
is claimed by some industry groups (Barlow, Alliance subgroup throws down device data
standards gauntlet, 2010).

Vendor support

Manufacturers and distributors are transacting members directly related to the product flow and
its actions could have an impact in the healthcare provider’s adoption rate. The way they use the
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technology and the identification standards within their processes and within the processes
related to the healthcare provider can drive the adoption at the healthcare provider level. The
vendor support element has a direct impact on the influence factor and is directly affected by the
industry pressure and government intervention factors.

4.3.2 Section two (technology)

Technology solution provider readiness

Technology solution providers include the MMIS vendor providers and the EDI vendors (for
type I processes). The technology solution provider readiness element is influenced by the
adopters influence and the industry pressure. The developments of the organization (healthcare
provider) regarding its technological capabilities can affect the technology solution provider
readiness.

As pointed out by (Barlow, Alliance subgroup throws down device data standards gauntlet,
2010), (Perrin, 2009) this is one of the most critical links preventing adoption: technology
solution providers are not ready because hospitals are not requesting the fields to be active or to
be transacting with the identifiers, so technology providers are just going to wait. On the other
hand, hospitals will not do it because they do not see the direct benefits of its adoption. The
technology solution provider readiness is related to the complexity and interoperability factors.
In this regard, the technology provider readiness is affected by how complex the solution is to
implement; the more complex the less ready the technology provider is. Likewise, the more
interoperability issues to be solved, the less ready the technology provider can be.
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Relative advantage technology solution provider

The relative advantage of the technology solution provider is influenced by the expected benefits
from adoption and the technology development costs. The relative advantage has a direct impact
on the influence factor and also on the relative advantage of the healthcare provider.

4.3.3 Section three (organization)

The healthcare provider readiness is defined from the process and technology perspectives.

Organizational readiness (P)

The organizational readiness (P) is the level of readiness of the healthcare provider from the
process perspective. It is influenced by the cultural barriers, awareness, the healthcare provider
size, the information technology budget and the top management support. The organizational
readiness (P) has impact on the organizational readiness (T) (Murphy, 2008).

Organizational readiness (T)

The organizational readiness (T) is the level of readiness of the healthcare provider from the
technology perspective. It is associated with the technological capabilities of the organization
towards adoption. It is influenced by the organizational readiness (P) and the percentage of
supporting technology penetration (Shortliffe, 2005).

Relative advantage healthcare provider

The relative advantage is influenced by the expected benefits from adoption and the associated
implementation and development costs (Levine, 2007). The relative advantage of the technology
85

solution provider is also an important factor since the technology providers would benefit by the
investments made by adopting healthcare providers. The relative advantage of the healthcare
provider has a direct impact on the influence factor.

The causal loop diagram considers two main stakeholders: the healthcare provider (healthcare
provider and hospital are equivalent terms) and the technology solution provider. The impacts of
the different elements in the adoption rate along with the relationships among them are illustrated
in the causal loop diagram and the main hypotheses are explicitly presented. For example it is
assumed that the technological readiness level of the healthcare provider defined as the
organizational readiness (T) will have an impact in the technology solution provider readiness,
and this element will also increase the relative advantage for the technology solution provider.
The causal loop diagram is the systemic explanation of the adoption process. It is similar in its
goal to the conceptual model. The CLD provides the starting point for the model formulation
and the simulation model development.

4.4 Definition (Identification Standards)

The literature review developed in Chapter 3 revealed that there is not a clear or formal
definition related to identification standards, neither there is a consensus related to what adoption
means or how an adopter could be defined. The absence of a clear definition could be explained
because the identification standards process is a recent adoption process, started in 2008, and
also because of the nature of the concept and the complexity associated to its definition. In
addition to process changes, the adoption of identification standards accounts for the adoption of
a set of technologies, not the adoption of a single technological component.
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This section establishes the absence of a clear definition of identification standards. In addition,
reference points from the literature are discussed, including the definition of Electronic Health
Records EHR. Major similarities and differences between identification standards adoption and
EHR adoption are presented. Finally, the proposed definition for Identification Standards (IdS)
is explained.

Some examples of the identification standards definitions found from the literature sources are:


A 2% adoption is given by (DeJohn, 2008) but the author does not specify any definition.



The survey by (Nachtmann & Pohl, 2009) summarized information related to adoption of
identification standards but no specific details about the definition used to gather the data
was given in the report.



The report by (Pohl & Nachtmann, 2011) referred to a system of standards, but no
specific definition was given.



Readiness data was provided on the GS1 website. The website presented the result of the
voluntary assessment data dated November 2011 (625 adopting members).

The literature review showed that identification standard was usually referred to as a system of
standards. The system of standards concept can be understood as a set of standards that includes
the location and product identifiers that are used within a given set of processes. In order to be
able to measure to some extent the adoption of identification standards, a clear definition at a
specific level of aggregation and process scope has to be established. The level of aggregation is
related to the perspective, in this case the healthcare provider, and the process scope is related to
the type of processes under analysis.
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4.4.1 Related definitions

The adoption of Electronic Health Records (EHR) can be used as a reference point to analyze the
identification standards situation. In the case of EHR many authors have agreed that in order to
measure the progress of EHR adoption, a consensus must be reached among the main
stakeholders and a clear definition should be established (Jha, DesRoches, Kralovec, & Joshi,
2010). The authors defined a basic EHR as a set of 10 clinical functions deployed in at least one
hospital unit. According to this definition the data was collected and analyzed. A 9.2%
penetration of a basic EHR among hospitals was reported.

There are some similarities, and differences between EHR adoption and identification standards
adoption. Both adoption processes are in the same setting, healthcare, but the healthcare
provider is at the lead of EHR adoption due to its nature. EHR is a software application
exclusive to the healthcare provider. This means that the healthcare provider is the only one
responsible for capturing and storing the EHR related information. This is not the case for
identification standards adoption where any supply chain member could adopt it. Moreover, the
identification standards concept is built into existing software applications used throughout the
supply chain; it cannot be defined as a standalone application. This issue in particular represents
a challenge related its justification from the ROI perspective (Menachemi & Brooks, 2006).

4.4.2 Conceptual definition (proposed definition)

The definition of identification standards in the context of the present research is a processtechnology based definition as it was initially proposed in Section 3.3.1. This definition is based
on the assumption that the supporting technology required to make use of the product and
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location identifiers would have a key role in explaining the adoption of identification standards.
This implies that the adoption of identification standards would be limited by the presence of the
required infrastructure to perform the supply chain transactions within a process of a given
process scope.

From the healthcare provider perspective it is assumed that there is a specific set of processes
performed within the organization using the identifiers. Those processes can be grouped
according to its scope as shown in Table 12. It is assumed that each process is composed of a set
of transactions. Each transaction is supported by a given technological infrastructure, and each
transaction makes use of the identifiers.

Table 12. Identification standards operational definition

Process
type

Scope

List of processes / cycles

Supporting technology

I
II
III

External link
Internal
Patient link

Ordering
Storeroom operations
Medication administration
including supplies

MMIS, EDI
Barcode enabled SCM
BCMA, BPOC

Processes type I. These processes are performed by the healthcare provider in the context of the
external environment. The processes with trading partners include contract/pricing
administration and the purchase order to payment cycle, among others. The transactions are
assumed to be performed by electronic means with the support of EDI and an application such as
the MMIS. The adoption of identification standards in processes Type I assume location and
product identifiers use within the relevant processes related to the external ordering cycle,
contract management and rebates.
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Processes type II. These processes are performed within the healthcare provider and do not
involve any trading partner or patient. These processes are associated to inventory management
control activities within the main storeroom and the hospital floors. The transactions are assumed
to be facilitated by the supporting technology such as a barcode enabled supply chain
management application (BC SCM). The adoption of identification standards in processes type
II assume location and product identifiers use within the relevant processes related to the hospital
internal supply chain.

Processes type III. These processes are related to transactions within the healthcare provider
and directly related to patient care at the point of use. The transactions are assumed to be
facilitated by the use of the supporting technology such as a BPOC or Barcode Medication
Administration (BCMA) application. The adoption of identification standards in processes type
III assume location and product identifiers use within the relevant processes related to the
administration of pharmaceuticals and the use of medical supplies at the point of care.

The concept of the process technology based definition is illustrated in Figure 10. According to
the figure a business process is based on a given set of transactions and within those transactions
the corresponding identifiers are used. An adopter is a healthcare provider performing a given
transaction using the identifiers and the supporting technology (See dashed line in Figure 10).
The operational definition implies that adoption of identification standards can be modeled as the
diffusion (external diffusion) of the bundle identification standards-technology across a given
population.
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Figure 10. Identification standards definition (adapter from Hubner and Elmhorst, 2008)

This definition has the following implications regarding the model scope. According to classic
diffusion theory, the members of a population interact with each other and with the external
environment. One of the underlying assumptions of technology diffusion models is that
technology acceptance is an imitation process. The members of the population get in contact
with each other and with the environment and exchange information related to the innovation
(Majahan & Wind, 1986). The technology is first adopted by a select group of innovators who in
turn, influence others to adopt it. The innovation (technology) is defined in this case as the
supporting technology required to facilitate a set of supply chain related processes within the
healthcare provider.

The behavior of the total population as a whole was considered as opposed to a single hospital.
There is not a detailed process description but the aggregated population behavior over the
proposed set of processes is given. The model does not provide specific details on the identifiers
(product and location) but the projection of the use of identifiers among the processes and
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transactions performed by healthcare providers is estimated. In an aggregated form (by process
group) the adoption of identification standards will be limited to the used of anchored identifiers
as defined by (Buyurgan, Rardin, Jayaraman, Varghese, & Burbano, 2011) within the main
transactions along the medical-surgical supply chain. The aggregation by process group type is
associated to the characteristics of the supporting technology.

As an example of the proposed aggregation, a detail list of processes, basic requirements and
transactions for processes within group type I is shown in Table 13. This table is based on the
EHCR report (CSC, 1996). As of 1996 the need for location and product identification was
explicit, also the basic technological requirements were outlined. For example EDI and MMIS
were defined as basic requirements to support supply chain related processes within processes
type I as well as the need for location and product identifiers.
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Table 13. Identification standards operational definition EHCR
Process set
Contract/Pricing
Administration
cycle

Type
I

Purchase Order to
Payment
cycle

Sales Activated
Settlement

Basic requirements

EDI transactions

Electronic Customer Identification
Electronic Product Identification
EDI Transactions Sets
Policy and process comprehension

816
832
836
840

Member Eligibitily
Negotiations

843
845

Electronic Contract/Pricing Notice
Electronic Sales/Rebate Reporting
Performance Measures
Activity based Costing

867

Organizational Relationships
Price/Sales Catalog
Procurement Notices
Request for Quotation
Response to Request for
Quotation
Price Authorization
Product Transfer and Resale
Report

Electronic Customer Identification
Electronic Product Identification
EDI Transaction Sets
Electronic Order Management
Electronic Shipping and
Receiving
Electronic Billing

810
812
820
822

Invoice
Credit/Debit Adjustment
Payment Order
Account Analysis

832
850

Electronic Funds Transfer
Activity based Costing

855
856

Performance Measures

861

Price/Sales Catalog
Purchase Order
Purchase Order
Acknowledgment
Ship Notice/Manifest
Receiving Advice/Acceptance
Certificate

Electronic Customer Identification
Electronic Product Identification
EDI Transactions Sets
Contract Membership Eligibility
Electronic Contract/Pricing Notice
Shared Databases

810
816
820
832
845
856

Performance Measures
Activity Based Costing

867

Invoice
Organizational Relationships
Payment Order
Price/Sales Catalog
Price Authorization
Ship Notice/Manifest
Product Transfer and Resale
Report
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It could be possible to track adoption over time or progress regarding the identification standards
adoption among hospitals, but a longitudinal study to measure adoption in terms of the previous
definition would be necessary. For example, the perfect order definition could be used, but other
definitions among the finite set of transactions and processes must be defined. Adoption could
be measured by process, taking into consideration how many processes and transactions are
using identification standards. The proposed identification standards definition is ideal because
adoption data related to each one of the processes and its corresponding transactions is currently
unavailable. The ideal definition development and data gathering can be based upon a process
matrix like the one shown in Table 14. Gathering adoption data would require the specification
of the scope of the processes being surveyed along with the longitudinal data (at least 3 years).
A study of such kind is out of the scope of the current research and modeling efforts.

4.5 Model formulation

Following the system dynamics methodology for phase II, a classical technology diffusion model
was selected as the initial model to formulate the adoption process under study. The Bass
Diffusion Model (BDM) is used to represent the adoption process and to mathematically
describe the adoption rate. The model is focused on the time pattern of the spread of innovation.
The BDM and its revised forms have been successfully demonstrated and applied in retail
service, industrial technology, agricultural, educational and consumer durable markets (Majahan
& Wind, 1986). It has been also recognized that one of the most useful inputs to decision
makers, planners and researchers is the temporal pattern of the diffusion process (Sharif &
Ramanathan, 1981).
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Table 14. Identification standards ideal definition
Process
type

Cycle
Purchase Order
to Payment

Basic
requirements
MMIS in
place

Process/area

Tr. Sets

Purchasing

812

Order to
Type I

Payment

820
EDI in place

Accounts
payable

822
832

Materials
management

850
855
856
861

or documents (electronic) GLN
can be
Credit/Debit Adjustment used
Payment
can be
Order/Remittance Advice used
can be
Account Analysis
used
can be
Price/Sales Catalog
used
can be
used
Purchase Order
Purchase Order
can be
Acknowledgment
used
can be
Ship Notice/Manifest
used
can be
Acceptance Certificate
used

GTIN
can be
used
can be
used
can be
used
can be
used
can be
used
can be
used
can be
used
can be
used

Both used
TBD
TBD
TBD
TBD
Perfect
order
TBD
TBD
TBD
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4.5.1 Mathematical formulation

The fundamental diffusion model (Mahajan & Peterson, Models for innovation diffusion:
Quantitative applictions in the social sciences, 1985) can be expressed as the differential
equation:

(1)

, where.

With the boundary condition

= cumulative number of adopters at time

= non cumulative number of adopters at time t, which means

= total number of potential adopters in the system at time t (also equal m)

= rate of diffusion at time t

= diffusion coefficient

= cumulative number of adopters at time

The diffusion coefficient is usually expressed as a function of the number of previous adopters
as:

+....

According to the expression above, the diffusion coefficient can be expressed as:
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Three diffusion models can be obtained by using the previous expressions:

The external influence diffusion model:

(2)

The internal influence diffusion model:

(3)

The mixed influence diffusion model:

(4)

The coefficients

and

are known as coefficients of external and internal influence

respectively. The coefficient of external influence

represents the influence from outside the

system, not related to previous adoptions. The coefficient of internal influence , represents the
influence of the previous adoptions in the form of a contagion rate, and it also represents the
interaction of prior adopters with potential adopters. Coefficients
diffusion models notations as coefficients

and

also appear in some

and , but its meaning is the same.
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The mixed influence diffusion model described in Equation (4) is also known as the Bass
Diffusion model BDM (Sterman, 2000). The work developed by (Teng, Grover, & Guttler,
2002) illustrates the use of the BDM in order to analyze the diffusion of 20 technological
innovations and the relationship of technology characteristics in the different diffusion patterns.
A resemblance to the mathematical structure of this model is found in (Erdil & Emerson,
Simulation modeling of electronic health records adoption in the U.S healthcare system, 2009),
but no explicit reference to it is made by the authors. The BDM model is also used by (Bower,
2005), in the analysis of EHR adoption. In this work the author illustrates the potential use of the
model but does not proceed with any mathematical estimation of the parameters; instead, the
author uses the model to describe the qualitative approximation developed to represent the main
forces affecting EHR adoption.

The BDM and conventional parameter estimations

An equation similar to (1) was presented by (Majahan & Wind, 1986) and is suggested for
parameter estimation purposes. The equation can be used to represent a given diffusion process
as:

(5)

Where

is the cumulative number of adopters at time ,

of innovation and

is the coefficient of imitation. Assuming

is the ceiling,

is the coefficient

/ , where

is

the fraction of potential adopters who adopt the product by time , the BDM can be restated as:
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(6)

1

If

0

0, then simple integration of Equation (6) gives the following distribution

function to represent the time dependent aspect of the diffusion process.

(7)

1
1

Equation (7) yields the s-shaped diffusion curve captured by the BDM. For this curve the point
of inflection, which is the maximum penetration rate

, occurs when:

1
2

∗

1

∗

(8)
2
ln

(9)

And also the equation:

∗

Hence, if

, and

∗

(10)
4

2

4

are known for a particular product, equations (7) – (10) can be used to

represent the product growth curve.

A number of estimation procedures have been used for estimating the model parameters
(Majahan & Wind, 1986).
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Ordinary least squares (OLS)



Maximum likelihood estimation (MLE)



Nonlinear least squares (NLS)



Algebraic estimation

A detailed description of each one of the procedures is presented in (Majahan & Wind, 1986).
The NLS estimation procedure is the one that gives better predictions compared to OLS and
MLS (Mahajan, Muller, & Wind, New Product Diffusion Models, 2000). The Algebraic
Estimation procedure is explained in the following paragraphs as an illustration on how to
estimate the model parameters. This procedure can be used in the absence of sufficient data as in
the case of identification standards adoption.

Algebraic Estimation procedure

This method can generate rough estimates of the parameters from knowledge on the occurrence
of the point of inflection, as described in the equations listed below.

If the BDM is stated as:

1

Since

0

(11)

0, integration of equation (1) yields to:
1

(12)

1

And by definition
100

(13)

If ,

and

are known for a particular product, then equations (12) and (13) can be used to

represent the product’s cumulative adoption over time. Equation (12) yields the S-shaped
cumulative adoption (diffusion) curve captured by the BDM. The point of inflection for this
curve occurs at time

∗

and corresponds to the maximum penetration rate

For simplicity, the case of annual sales data is considered so that

(Majahan & Wind,

1986). The non cumulative number of adopters at the point of inflection
the cumulative number of adopters at

∗

∗

is defined as

.

∗

is defined as

∗

and

. Given those definitions equations (8) –

(10) can be rewritten as:
∗

1
2

(14)
2
1

∗

(15)

ln

∗

(16)
4

If

∗

,

∗

and

∗

2

4

are known, then equations (14)-(16) can be re written as:
∗

2

∗

(17)

∗
∗

(18)
∗

∗

∗

2

∗

ln

(19)
2

∗
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This way, equation (19) can be used to find m numerically. Once m is known, equations (17)
and (18) can be used to estimate p and q. On the other hand if

∗

and

∗

and m are known, then

equation (19) can be solved to find N*; finally p and q can be estimated from equations (17) and
(18).

The algebraic estimation procedure is conceptually simple, but it requires information regarding
the point of inflection. Researchers (Majahan & Wind, 1986) suggest that in the absence of any
data, management can make educated guesses about t*, n* and m (or N*) based on analogous
products so that diffusion curves can be developed for the technology under study.

4.5.2 Bass Diffusion Model parameters and CLD factors

The classic diffusion models represent a way to understand the diffusion process but are limited
by the need for data on past adoptions (Nelson M. J., 1998), (Mahajan & Peterson, Models for
innovation diffusion: Quantitative applictions in the social sciences, 1985). Classic diffusion
models work under the assumption that enough data on past adoptions is available in order to
feed closed forms and thus estimate the parameters following conventional estimation
procedures (Mahajan, Muller, & Wind, New Product Diffusion Models, 2000). This represents a
challenge from the identification standards perspective.

For identification standards (based on the definition given in the previous section) the adoption
data is currently unavailable. In order to collect the information, it would be necessary develop
and deploy and instrument for data collection in order to construct the data set. This research
contributes to the understanding of the identification standards adoption process by proposing a
way to address the problem of lack of adoption data and a consensus on a clear definition. The
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formulation stages are proposed as a way to overcome those challenges and the operational
definition given in the previous section is proposed as a way to guide modeling efforts, in
particular for Stage 2.

The use of system dynamics in diffusion modeling has been attempted in previous studies.
Initial explorations of the use of the methodology are presented by (Finkelstein, Homer, &
Sondik, 1984). The work developed by (Maier, 1998) is specifically related to Stage 1 and the
work developed (Erdil & Emerson, Simulation modeling of electronic health records adoption in
the U.S healthcare system, 2009) and (Nelson, 1998) is related to Stage 2.

4.5.3 Formulation stages

The formulation stages were developed to learn about the behavior of the model parameters and
to overcome the challenges related to the identification standards definition and also the lack of
data on past adoptions. The model formulation follows a two stage process. Stage 1, or initial
approach, in which the BDM is used to mathematically describe the adoption process. Stage 2,
or second stage includes the relationships as established in the CLD and represents the empirical
relationships within all the factors defined in the CLD.

Stage 1 - Initial approach

The initial approach works under the assumption that the diffusion of the supporting
technologies can help to explain identification standards adoption and diffusion.

The goal of this stage is to estimate the BDM parameters, p and q, for the given set of supporting
technologies associated to the identification standards definition. The discrete version of the
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formulation BDM is used to estimate the model parameters and to solve the model analytically
with methods described in Section 4.5.1. It is important to note that the CLD described
relationships are not used in this approach, just the model parameters associated to the internal
and external diffusion coefficients p and q.

Stage 2 – CLD relationships based model

The empirical development of the relationships between the factors and the BDM coefficients
was established, and then the formulation of the factors was developed; in this case, no
mathematical or closed solution exists.

The goal of this stage is to develop a model that simulates the adoption rate over time (diffusion)
and to observe the impact of the internal and external influence coefficients in the adoption rate.
The model is developed to simulate the diffusion of identification standards across the hospital
population over time. The sum (cumulative) adoption through time represents the diffusion. It
has been reported that the estimation of the exact nature of the interactions between the different
factors can be very difficult in many situations (Maier, 1998), (Sharif & Ramanathan, 1981).

Scope

Healthcare provider perspective is considered and a specific definition of the technology to be
defined as “adopted” has to be assumed. In the context of this research (stage 1) adoption is
defined as the level of penetration of a given technology (supporting technology) and diffusion is
defined as the widespread adoption of the technology among the members of a given population.
For stage 2, the level of penetration or adoption (identification standards-technology bundle) has
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to be established using available industry data and the diffusion process is modeled via
simulation.

Limitations/assumptions

The advantages and limitations of the system dynamics modeling approach and the BDM
diffusion model as the basic structure of the model formulation have to be considered. As for the
modeling approach, there is not a detailed level of granularity at the healthcare provider level,
but an aggregation at the population level is assumed. A further breakdown into smaller sets
(large and small hospitals) could be considered, along with the inclusion of additional supply
chain members (e.g. population of distributors and manufacturers).

As for the BDM diffusion model, the healthcare provider population was considered as the main
component of the model. The healthcare population was divided between adopters and potential
adopters, also the impact of the external and internal influence coefficients in the adoption rate
was assumed. The existence of past data (Stage 1) is assumed based on the supporting
technologies due to the lack of data on identification standards past adoptions. The model goal
(Stage 2) is to conceptualize the adoption process of identification standards in a higher level of
abstraction; some of the structural components of the model are presented in an aggregated form.
The advantages of the systems dynamics approach over traditional linear models are that the
model captures the impact of the interventions, it helps to represent the system along with the
causes, and it provides an insight on the behavior of the adoption rate. The purpose is not to
forecast but to understand the system behavior. As explained by (Majahan & Wind, 1986), one
of the most important uses of diffusion models is to provide an analytical approach to describe
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the spread of diffusion phenomena. As such, they can be used in exploratory mode to test
specific diffusion based hypothesis or to explore system interventions.

4.6 Stage 1 – model formulation, implementation and validation

Due to the lack of data on identification standards past adoptions, the supporting technology
approach is used to understand the identification standards adoption process. The healthcare
provider is considered as the population under study for modeling purposes. It is assumed that
the behavior of the diffusion of the technology that supports identification standards use is key to
understand identification standards adoption and diffusion.

4.6.1 Model formulation (Stage 1)

For Stage 1 the basic structure of the Bass Diffusion Model BDM is used. The BDM depicts the
rate of change in the number of adopters over time, and it illustrates the impact of the internal
and external diffusion coefficients in the adoption rate.

The model allows for an analysis of the evolution of the adoption rate over time. Based on the
analysis of this path, the peak (inflection point) can be established as well as the growth and
stabilization periods. The impact of the diffusion coefficients it is also subject to analysis. An
illustration of the model in Vensim is presented in Figure 11. The adoption rate represents the
flow between the potential adopters and the adopters (population under study), and the external
and internal diffusion coefficients are represented by p and q respectively.
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Figure 11. Stage 1 – Vensim Model

Parameter estimation

There are different strategies that can be followed in order to estimate the model parameters. For
this formulation stage, two strategies were followed in order to obtain information related to the
model parameters:

a. By analogy, following the work developed by (Teng, Grover, & Guttler, 2002) and
(Mahajan, Muller, & Wind, New Product Diffusion Models, 2000).
b. With data on adoption of supporting technologies by process (healthcare) and then
following estimation procedures previously defined, using the discrete analog of the
BDM.

4.6.2 Parameter estimation - analogy approach

The analogy approach is based on the assumption that analog technologies could provide an
starting point for parameter estimation due to the lack of available data on identification
standards past adoptions. In order to estimate the model parameters (base run) the parameter
values described by (Teng, Grover, & Guttler, 2002) for technologies within cluster two were
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used. For this type of technologies the average values of p are low (0.003) and the average
values of q are higher (0.38). For the current model p is 0.003 and q is assumed to be 0.25 which
is the median value in the table of page 22 from the reference document (Teng, Grover, &
Guttler, 2002).

The model formulation was implemented in Vensim, and the output results were obtained using
the report options. In order to use the BDM the adopting population was assumed as the total
number of hospitals registered in the AHA (5500 hospitals). The population was considered
homogenous, and no new hospitals were going in or out of the system. The periods within the
model were defined as years. The starting year was assumed as 2008, and the horizon was
defined as 50 periods (years). The values for p and q were used to test the model under for
different scenarios. Scenario 1 (S1) considered the 2% adoption rate given by (DeJohn, 2008)
with an initial population of 110 healthcare providers. Scenario 2 (S2) did not contemplate any
initial population. Scenarios 3 and 4 were variations of the initial year for analysis purposes.
Scenario 3 (S3) included the initial year as 1996 which was the year of the publication of the
EHCR report. This report marked a point in healthcare industry which brought awareness and
established the importance of the required technological infrastructure and identification
standards to improve the supply chain related processes. Scenario 4 (S4) included the initial year
as 2011.

The only relevant difference among scenarios is the change in the time it takes for the adoption
rate to peak. One of the most important observations also is that under the assumed conditions
the current deadlines established by the industry cannot be met. There is a deadline for year
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2012 on product identifiers adoption and the location identifiers deadline adoption of 2010
already passed. The summary of results is presented in Table 15.

By using the parameters (p,q) based on analog technologies and available literature sources it
was observed that the model could be used to assess the current deadlines for data standards
adoption. It would take at least 15 years to reach the saturation point and a critical mass of
approximately 2871 healthcare providers. The critical mass concept was referenced by some
authors (Barlow, Crafting the supply chain stimulus package, 2009), (DeJohn, 2008). According
to (Rogers, Diffusion of Innovations, 1983), the critical mass occurs at the point at which enough
individuals in a system have adopted an innovation so that the innovation's further adoption rate
becomes self-sustaining; under current conditions it was possible to establish what would be the
critical mass for identification standards adoption.

Table 15. Analogy approach results

Scenario

Main
inputs

Main
Outputs

Source
Label
Y0
Horizon
N
A0
P
p
q
Inf. Point (year)
Years to AR
peak
AR max
(H/year)
Critical mass
(H)

initial
(DeJohn)
S1
2008
50
5500
110
5390
0.003
0.25
2022

Analogy approach
EHCR
no A0
date
S2
S3
2008
1996
50
50
5500
5500
0
0
5500
5500
0.003
0.003
0.25
0.25
2026
2014

from
today
S4
2011
50
5500
0
5500
0.003
0.25
2029

15

19

19

19

350.97

352.05

352.05

352.05

2871

2723

2723

2723
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The current results are limited because of the assumptions made regarding the relationship
among the technologies described in (Teng, Grover, & Guttler, 2002). The technologies under
cluster two are not directly related to healthcare but the results from this approach give an
estimate of the time it could take for identification standards adoption to reach a critical mass.
Also provides an indication of the number of healthcare providers per period that would be
required to join the initiative in order to keep the adoption process on track.

4.6.3 Parameter estimation - supporting technology approach

The model parameters (p,q) can be also estimated by the use of analog technologies within the
healthcare domain. The operational definition indicates the required technological infrastructure
to support data standards adoption and use within the healthcare provider. In this section, the
adoption of the technologies required to support supply chain related processes were studied;
those technologies are illustrated in Figure 12.

Each process group type has a set of technologies. For example, processes type I can make use
of EDI, processes type II can make use of barcode enabled applications and processes type III
can make use of BPOC technology. The MMIS is the underlying platform for technology
integration along the internal healthcare provider supply chain.
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Figure 12. Technology map

Baserun values

The data available through the HIMSS academic agreement which gave access the Dorenfest
Institute Data Base was explored. The goal was to estimate the BDM parameters for the
supporting technologies related to each process group type.

The available information was analyzed and categorized according to the similarities of the
explored databases. The information related to technology adoption among hospitals was
collected with an annual survey. It was observed that as the number and scope of questions in
the annual survey was expanded some modifications in the compilation of the information was
required. For example the earliest versions of the database included information related to the
hospital population when the population size was about 3000 hospitals. It was also observed that
the information associated to technology availability by database was also different. These

111

differences led to the categorization of the data bases as shown in Table 16. A detailed list of the
available databases is provided in Appendix B.

Table 16. Databases (information sources)

Data base
description

Date range

3000+ DB

1986 -1994

IHDS DB
Complete DB
2008 DB

1998-2004
2005-2007
2008

Main characteristics
Two sub sets of data, MM year of adoption not software
provider information
Data on several hospital applications, MM year of adoption not
software provider information
MM year of adoption and software provider information
Auto identification use/adoption information

After reviewing the available information and classifying the available databases, Micro Soft
Office (MSO) Access routines were developed in order to design queries that allowed for the
construction of the specific data sets so that BDM model parameters could be estimated. One
data set per technology, according to the technology map given in Figure 12 was developed. The
tool presented in Chapter 12 of the book by (Mahajan, Muller, & Wind, New Product Diffusion
Models, 2000) was used to estimate the BDM parameters. The model parameters were estimated
using Nonlinear Least Squares (NLS) method. The tool is a free student version of ME software
which runs as an MSO Excel add on. A description of the tool and the supporting information
associated with the estimation of the parameters are included in Appendix B.

The model formulation was implemented in Vensim using the model parameters obtained for
each technology in order to model the adoption rate behavior. The Stage 1 Vensim formulation
of the model is described in Appendix C. Patterns for each technology were obtained and the
results are shown in Figure 13.
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Figure 13. Supporting technology adoption patterns

The model check and units check testing functionality of Vensim was used to validate the
models.

The estimation of the model parameters was more reliable for the MMIS technology since there
was enough information to develop more than one data set as shown in Table 17. According to
(Mahajan & Peterson, Models for innovation diffusion: Quantitative applictions in the social
sciences, 1985) at least three data points are required for parameter estimation purposes. The
information related to the use of Auto identification technologies for supply chain management
purposes among hospitals was relevant after the 2005 HIMSS Data Base (DB) version. Previous
versions did not include that type of information. Among the available databases, the 2008
HIMSS DB was the one with the most complete source of information related to the use of Auto
ID DC (barcode and RFID) within the hospital population under study. For the adoption of
technologies that build upon the MMIS, such as BPOC, the available information was not
enough, as there were just three data points available for parameter estimation. Those data
points correspond to the data obtained from the 2008 HIMSS DB.
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Table 17. Supporting technology approach

Source

Main
input

Main
output

HIMMS DB
EDI
AutoID DC
15(19903(20053(20052004)
2007)
2007)
Complete Complete Complete
DB
DB
DB
Data Set 3 Data Set 4 Data Set 5
1990
2008
2008
50
50
50
5500
5500
5500
130
631
831
5370
4869
4669
8.03E-03
8.43E-17
7.93E-17
0.1809
0.4708
0.3155

Data
points

10 (19791988)

MMIS
12 (19902001)

BPOC
3(20052007)
Complete
DB
Data Set 6
2008
50
5500
20
5480
3.03E-02
0.0819

Data base
Label
Y0
Horizon
N
A0
P
p
q
Inf. Point
(year)
Years to
AR peak
AR max
(H/year)

3000+ DB
Data Set 1
1979
50
3000
137
2863
8.94E-18
0.3822

IHDS DB
Data Set 2
1990
50
4500
265
4235
5.08E-03
0.2437

1988

2001

2005

2011

2014

2017

9

11

15

3

6

9

286

284.81

271.22

1032

549

205

The information from the 2008 HIMSS DB was analyzed in order to explore hospital population
characteristics such as hospital size, IT budget, operating expenses and technology penetration
levels. Since this database had the most complete Auto ID DC related adoption data, the
information provided by this database was used to support the development of the formulation of
the model in Stage 2.

4.7 Conclusion

The answer of the research question number four is presented. The BDM was used to explore
the diffusion of analog technologies as well as the supporting technologies adoption and
diffusion (Stage 1). Through this exploration, the groundwork required to estimate internal and

114

external diffusion coefficient parameter ranges is provided in order to move into the
development of the simulation model in the next chapter (Stage 2). Some of the limitations with
the use of diffusion models such as the BDM are the need of extensive amount of data on past
adoptions to better estimate the parameter values and also the need of a clear definition of the
technology to be adopted. A proposed solution to the lack of definition was the operational
definition by process type based on supporting technology assumption. Additionally, the
formulation stages 1 and 2 were proposed to overcome the lack of past data on identification
standards adoptions.

Following the results from the Stage 1 formulation, the adoption patterns for the main
technologies for each supporting technology at each process type grouping were found.

The behavior patterns were developed using the data from the HIMSS DB. This database
provided information related to the state of technology use by healthcare providers. It was
possible to extract relevant data from it by using the tables and designing queries in MSO
Access. The data was analyzed further using MSO Excel. The estimation of the model
parameters followed the Nonlinear Least Squares NLS estimation procedure. The values of the
internal and external diffusion coefficients vary, but certainly p is low and q is higher. The
numerical ranges are close to zero for p and the q range is [0.18-0.38]. There are limitations with
current data for technologies different than MMIS as there are fewer data points which mean that
the results from the parameter estimation are less reliable.

Each one of the supporting technologies exhibits a different adoption pattern or behavior. As
shown in Figure 13a, the MMIS diffusion pattern exhibits a peak at year 15. This timeline is
close to the ten year timeline estimated by (Langabeer II, 2008) for the diffusion of healthcare
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supply chain technologies. Based upon the assumption that an analogy between identification
standards and MMIS technology can be established, it can be inferred that the adoption of
identification standards could take as long as it took hospitals to adopt its main supporting
technology. According to Figure 13b the supporting technologies for processes type I adopt at a
higher rate than the supporting technologies for processes type III. Thus, identification standards
could be adopted sooner within processes Type I compared to processes type III.

A partial answer to research question number five was also addressed in this chapter. As
presented by (Finkelstein, Homer, & Sondik, 1984), the cost is not a relevant issue in the present
model due to the fact that the main technology investment has already been made (supporting
technologies) and it only requires an upgrade. In contrast, the analysis presented by (Erdil &
Emerson, Simulation modeling of electronic health records adoption in the U.S healthcare
system, 2009) for EHR adoption presented the cost as one of the most relevant issues. The
model developed in this research maintains the assumption presented by (Finkelstein, Homer, &
Sondik, 1984), meaning that the costs associated with identification standards adoption are also
associated with investments that were already made by hospitals, in particular the MMIS
investment. There is a challenge in the estimation of the ROI of most healthcare related
investments as presented by (Menachemi & Brooks, 2006). The purpose of the model is to
understand the adoption process over a time horizon (50 years) taking into consideration the
aggregated benefits that could be obtained from identification standards use within processes at
the healthcare provider level.

This research extends the work of (Erdil & Emerson, Simulation modeling of electronic health
records adoption in the U.S healthcare system, 2009) related to the adoption of EHR, in the sense
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that presents a formal treatment to the mathematical structure that supports the model
development. It introduces the system dynamics SD methodology using the information from
the conceptual model and develops the mathematical structure of the model based on the
available data and the proposed identification standards definition, which poses a challenge.
This research brings the results of phase I into a model for phase II, which is a first model of its
kind.
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5. Model formulation, implementation and validation (Stage 2)
5.1 Model formulation (Stage 2)
The purpose of the model in this formulation stage is to gain insight into the factors that might
influence the pattern of identification standards diffusion among healthcare providers
(population) and how that pattern could be modified or influenced, as opposed to making
predictions or forecasting the future. According to (Rogers, Diffusion of Innovations, 1983)
adoption is defined as specific point in time measurement of technology use (usually percentage
of adopters), and diffusion is generally understood as the widespread use over time. The goal of
the simulation model is to simulate the diffusion (assumed implementation and use over time) of
the proposed definition of identification standards. In the context of this research, identification
standards adoption is defined as the adoption of location and product identifiers within
transactions and processes at the healthcare provider level according to the definition given in
Section 4.4. The use of such identifiers would improve the process efficiency; which means less
error and fewer resources would be devoted to the processes. There could be also an increase in
patient safety due to an improved product administration.

Data in numerical form, industry experts’ knowledge and the author’s experience are important
elements in the formulation development. The primary source of data is the HIMSS DB (2008
version) and information from the literature review on identification standards adoption
developed in Chapter 3. That information was used to develop the model assumptions in the
form of graphical functions with the support of Vensim functionality. That information was also
used to develop the input parameters (base run) as described in the model implementation
section.
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5.1.1 Simulation model structure

There is a connection between the factors defined in the causal loop diagram (CLD) and the main
elements of the simulation model, as shown in Table 18. The factors defined in the CLD were
used as a main guideline for the formulation of each simulation model component. For example,
the formulation of Component 1 (C1) represents an interpretation of the factors within the
environment section which attempts to mathematically express the effect of the external factors
on the adoption rate. There are four model components. The factors from the environment
section of the CLD were used to formulate Component 1 (C1) of the simulation model. In a
similar way, the factors within the technology section were used to formulate Component 2 (C2)
and the organizational factors were used to formulate Component (C3). The basic structure of
the simulation model is the healthcare population which was included in the model as
Component (C4).

Generic model

The generic model is illustrated in Table 19. The formulation of each component was developed
taking into consideration the main relationships within the model elements which can be adjusted
according to the specific requirements of the population to be analyzed (e.g. hospitals within a
network or single hospitals). The models in Stage 1 were developed taking into consideration a
single population and each one of the technologies within each process group type. For example,
one model for EDI was developed based on BDM parameters estimated as explain in Section
4.6.1. For Stage 2, two populations can be considered although just one of the populations
(H>2) is considered for model development and analysis purposes, the assumption of the
population size is considered within Component 4 (C4). Component 1 (C1) represents the
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environment related factors as a whole while Component 2 (C2) and Component 3 (C3)
represent the effect of the average technology provider and healthcare provider respectively.

Table 18. Transition table

Causal Loop Diagram
Factors affecting adoption
E 1
E 2
E 3
T 4
T 5
T 6
T 7
O 8
O 9
O 10

Industry pressure
Government intervention
Vendor support
TP readiness
TP Relative advantage
Interoperability
Complexity
H Relative advantage
Organization readiness (P)
Organization readiness (T)

Simulation model
Graphical functions and parameters
gf
gf
gf
gf
gf
p
gf
gf
gf
gf
p
gf
gf
gf
p
p
p
p
p
p
p
gf
p
p
p
p

C1
C1
C1
C1
C1
C1
C2
C2
C2
C2
C2
C3
C3
C3
C3
C3
C3
C3
C3
C3
C3
C4
C4
C4
C4
C4

distributors and GPOs
distributors and GPOs influence
industry pressure
manufacturer influence
manufacturers
government intervention
technology providers
TP expected costs
TP readiness
TP relative advantage
complexity and interoperability issues
H relative advantage
process fraction
productivity improvement factor
average H operating expenses
average H revenue
awareness
H technology penetration factor
IdS factor
increase SCM expending
IS Budget
H IdS Use
A initial
external influence N
internal influence N
P initial
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Challenging issues with data

Currently there is no data on past adoptions for identification standards nor information related to
the factors as defined in the CLD. The data on past adoptions of identification standards could
be used to estimate the BDM parameters (Stage 1) but since the data is not available the
estimation and quantification of the model (Stage 2) initial conditions was supported by literature
sources and available data. This process was difficult due to the qualitative nature of some of the
factors identified in the CLD and in general the data availability (Glöber, Thun, & Milling,
2008). For this reason, gathering and finding qualitative and quantitative data to support the
factors in order to describe them in a mathematical form was challenging.

This modeling stage presented a way to analyze the identification standards adoption process,
taking into consideration the challenges posed by the data availability, and then proposed a way
to overcome those challenges. Since there is no data on the factors, the main factors were
transformed into graphical functions (variables) defining a set of parameters to conceptualize and
develop the simulation model with the use of the Vensim functionality. The information
required to specify the shape and the values for the graphical functions can be obtained from
different sources such as industry reports, fieldwork and expert interviews (Sterman, 2000). The
graphical functions and parameters are shown in Table 18.
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Table 19. Generic model
Stage 1
Models Assumptions

MMIS
EDI
BC
SCM
BPOC

Parameters BDM

one
population
one
population
one

p
q
p
q
p

Proxy= IdS
MMIS as the
underying
infrastructure
proxy type I
EDI
proxy type II

population
one
population

q
p
q

BC SCM
proxy type III
BPOC

Stage 2 (generic)
Model Model components and assumptions
IdS

C4

H>2

N=3056

IdS

C4

H=1

N=2112

C1 (General)
C2 (Average tech.
provider)
C3 (Average hospital )
assumptions = gf

C1 (General)
C2 (Average tech.
provider)
C3 (Average hospital )
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A cross sectional analysis (survey), at one point in time, could be used to validate the proposed
functional relationships (graphical functions) and the model parameters but a questionnaire based
on the qualitative nature of the factors could be developed along with the transformation of such
qualitative information into a numerical form via fuzzy logic as proposed by (Liu, Triantis, &
Sarangi, 2011). Such a project is out of the scope of the current research. A preliminary
validation of the proposed model structure and the behavior of the main functional relationships
was performed with industry experts. In general the model structure was found coherent and no
factors were considered out of the scope.

5.1.2 Model components (formulation)

In this section each component, its main variables (graphical functions), intermediate variables
and important parameters are explained. The process followed to implement the simulation
model is described in the next section. The main model components are illustrated in Figure 14.
The graphical functions and parameters within each component are shown. The description of
the graphical functions and parameters is given in Appendix C. The components are used to
illustrate the implicit relationships of the CLD factors with the adoption rate.
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Figure 14. Model components

Component 1 – Environment

This model component is related to the external forces affecting the adoption; it is also related to
the stakeholders that make decisions that are out of the control of the healthcare provider.

According to Table 18, the main factors of the environment section in the CLD diagram are the
following: vendor support, industry pressure, and government intervention. Those factors are
considered within this component as 3 main graphical functions and one parameter. There are
two additional graphical functions which are used to represent the manufacturer and the
distributor and GPOs populations.

According to the CLD, the vendor support is related to the support of the identification standards
initiative from the trading partners such as manufacturers, distributors and GPOs. The vendor
support is formulated as a function of the number of healthcare supply chain members adopting
the solution. For the simulation model, two separate functions were defined. The first one, is the
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manufacturer influence and the second one, is the distributor and GPOs influence. This was
done due to the fact that the manufacturer population is the only one to be directly affected by
any government regulation and the other supply chain members have the option to follow the
regulation or to wait until manufacturers implement the required changes. This way the
manufacturer population can be affected by a government intervention since manufacturers are
the only supply chain members that the government can affect directly via a FDA regulation.

Figure 15. Manufacturer influence

It is assumed that the number of vendors increases over time and so does the influence. The data
to support the population size for the manufacturers, the distributors and GPOs was gathered
from the Health Industry Distributors Association (HIDA) website and it represents the general
medical surgical supply chain. There are about 7000 companies within the US medical
equipment and supplies industry, and there are about 200 distributors and GPOs. An increase in
the output (influence) was estimated as the number of members joining the initiative increases.
The influence is formulated as an increasing function over time but never reaching the limit of 1
as a total output.
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Figure 16. Distributors and GPOs influence

The industry pressure reflects the impact that the pressure of industry groups could have on the
healthcare provider adoption. It is formulated as a graphical function in Vensim using the
influence exerted by distributors and GPOs as the main input. The industry pressure is
formulated as an increasing function related to the influence exerted by the distributors and
GPOs.

Figure 17. Industry pressure
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The government intervention factor is related to the pressure that can be exerted through a FDA
regulation. Such regulation will have a direct impact on the manufacturers but an indirect impact
on healthcare providers via vendors and industry groups.

Currently, the FDA UDI rule is pending. This rule would require the identification of the
product in the form of a barcode using either standard (GS1 or HIBCC) and it should also be
human readable. This regulation will have an impact only on manufacturers. To notice also that
the effect of the regulation would make manufacturers work on product identifiers by product
class, starting with the most critical ones. The change will not happen overnight, even if the
ruling is released in the near future, it would take time for the manufacturers to comply. It is
assumed that even if product identifiers could be available tomorrow (product shipped out of the
manufacturer’s warehouse with product identifier labels), it will take as long as it took healthcare
providers to adopt the supporting technology (MMIS), for identification standards to be used at
the healthcare provider level. This assumption is based on the association identification standards
- supporting technology which was made in order to analyze the adoption process since no data
associated to identification standards past adoptions exists.

The government intervention is formulated as a STEP function in Vensim. This function is
defined with two parameters the size of the jump and the period. It is assumed in the model that
the regulation will be in effect within the next 5 years.

Component 2 - Technology

This model component is related to the technology solution provider and the technologies they
provide (supporting technologies) and how the implementation of these technologies would

127

affect the adoption of identification standards. Identification standards is not a standalone
application but a complex concept that requires the incorporation of a set of technologies among
a given set of processes at the healthcare provider level as explained in the identification
standards definition (Section 4.4).

According to Table 18, the main factors of the technology section within the CLD diagram are
the following: technology provider readiness, technology provider relative advantage,
complexity and interoperability.

Those factors are considered within this component and formulated using four graphical
functions and one parameter. The graphical functions are associated with the technology
provider readiness (TP readiness), the technology provider relative advantage (TP relative
advantage), the technology provider expected costs (TP expected costs) and the technology
provider population (technology providers). The complexity and interoperability factor defined
in the CLD is formulated as one parameter affecting the technology provider readiness (TP
readiness).

The technology provider readiness (TP readiness) is defined as the preparedness level from the
technology solution provider perspective. This factor is related to the willingness to implement
the requests made by healthcare providers regarding product enhancements and improvements
related to transaction capabilities using identification standards. TP readiness is formulated as a
function of the number of technology providers joining the initiative over time. It is assumed
that the number of technology providers joining the identification standards initiative increases
over time and in the same way the readiness increases. The data to support the technology
provider population size was gathered from the analysis of the reports developed using
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information extracted from the 2008 HIMSS DB. There were about 70 technology solution
providers according to the report of solution providers within the supply chain related technology
market.

Figure 18. Technology provider readiness

From the technology provider perspective, the technology provider relative advantage is related
to the costs and benefits that could be obtained when delivering technology products that meet
the requirements associated with identification standards use in the industry. The costs are
related to the development costs. It is expected that the costs of development decrease with time.
The benefits are related to upgrades of IT products offered to healthcare providers. It is expected
that the benefits increase with time. It is assumed that the benefit for the technology provider is
the implementation cost for the healthcare provider.

In general the relative advantage is associated with the expected gain that the technology
provider could obtain from the delivery of products meeting the requirements. As the gain
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increases, the relative advantage increases as well. The gain is defined as the difference between
the benefits and the costs.

Figure 19. Technology provider relative advantage

The expected costs for the technology provider are assumed to decrease as the hospital use of
identification standards increases over time. This assumption considers the costs of the upgrades
and maintenance of the applications associated with identification standards adoption and use.

Figure 20. Technology provider expected costs
130

Complexity and interoperability are considered as a single element in the simulation model to
represent the level of commitment of technology solution providers in addressing complexity and
interoperability related issues. It is assumed that initially those issues are not addressed by
technology providers but as the adoption process moves forward, the issues are solved in order to
support adoption. This factor, complexity and interoperability issues, was defined as a parameter
within the model using a numerical scale to represent low or high effort from the technology
provider to solve these issues.

Component 3 - Organization

According to Table 18, the main factors of the organization section within the CLD are the
following: organization readiness (P), organization readiness (T) and hospital relative advantage.

Within this component those factors are considered using 3 graphical functions and 7 parameters.
The graphical functions represent the hospital relative advantage (H relative advantage), the
fraction of processes within the hospital using the identifiers (process fraction) and the level of
improvement due to identification standards adoption and use (productivity improvement factor).

The parameters are used to support the formulation of the hospital relative advantage and the
organization readiness as it is explained in the following paragraphs.

From the healthcare provider perspective, the relative advantage includes the difference between
the gains and the costs associated with the adoption and use of identification standards. For this
factor, as the gain increases, the relative advantage also increases. The gain is related to the
difference between the benefits and the costs of adopting identification standards.
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The benefits are associated with the reduction of process inefficiencies, increased productivity
and reduction of errors due to the use of identification standards. The costs are associated with
the implementation and maintenance costs incurred when adopting identification standards
(CSC, 1996). The benefits and implementation costs are different by process group type but it
can be aggregated as shown in Table 20.

The following are the assumptions associated to the cost benefit estimation:


There are challenges on measuring ROI on health IT related investments (Menachemi &
Brooks, 2006). Identification standards adoption builds over already existing
infrastructure and the IT investment has been completed, in particular for healthcare
providers. The adoption of identification standards would require upgrades to the current
infrastructure given the fact that more than 95% of the hospitals have an MMIM in place.
The replacement of such an application is not assumed.



It is assumed that adopting identification standards is beneficial.



Cost is not as big of an issue for identification standards adoption as it is for EHR
adoption, for which large investments in IT solutions have to be budgeted. The cost of
the upgrade is assumed.



The supply chain perspective is considered, in particular, the processes within the MMIS
scope.

According to the generic model shown in Table 19, an average healthcare provider is considered
in order to define the benefits and the costs in aggregated terms since specific data on benefits
and implementation costs by process type was not available. Data from the HIMSS DB 2008
related to the hospital revenue and operating costs as well as the IS Budget allocation proportion
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was used to support parameter development. The following parameters were developed in order
to formulate the hospital relative advantage (H relative advantage):

-

average H revenue and average H operating expenses, representing the available
resources at the healthcare provider level.

-

IS Budget, representing the proportion of the revenue allocated to information technology
related investments.

-

IdS factor, representing the allocation of the available resources to the identification
standards initiative.

-

H SCM operating costs, representing the costs associated to internal supply chain related
processes.

-

H IdS implementation costs, representing the costs associated to the upgrades to the
current technological infrastructure to support identification standards adoption and use.
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Table 20. Identification standards costs and benefits
Process
Group

I

II

III

Anticipated Outcomes (benefits)

Cost
Implementation

Improved fill rates
Increased customer satisfaction
Increased data accuracy
Increased productivity
Reduced costs
Reduced cycle time
Reduced errors
Reduced paperwork
Reduced product returns
Reduced rework

Investment costs

Improved productivity
Increased customer satisfaction
Increased data accuracy
Increased reliability
Lower inventory levels
Overall process improvement
Reduced back orders
Reduced cycle time
Reduced labor
Reduced mis-picks
Reduced paperwork
Reduced product returns
Reduced rework

Investment costs

Effective communication
Eliminated paperwork
Improved productivity
Increased customer satisfaction
Increased data accuracy
Reduced cycle time
Reduced product returns

Anticipated Outcomes
summary
Effective communication

Maintenance costs Eliminated paperwork
Improved fill rates
Improved productivity
Increased customer satisfaction
Increased data accuracy
Increased productivity
Increased reliability
Lower inventory levels

Maintenance costs Reduced back orders
Reduced costs
Reduced cycle time
Reduced errors
Reduced labor
Reduced mis-picks
Reduced paperwork
Reduced product returns
Reduced rework
Overall process improvement

Investment costs
Maintenance costs

Source: EHCR Report 1996
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The hospital relative advantage is formulated as a function of the expected gain obtained by the
healthcare provider due to identification standards use. This gain is formulated as the difference
between the expected benefits and the expected costs.

Figure 21. Hospital relative advantage

The expected benefits are formulated as the result of a reduction of the hospital operating costs
due to productivity improvements related to identification standards adoption. The expected cost
was formulated as the technology implementation costs associated to the upgrades of current
supply chain management related applications. The resources are allocated according to the IdS
factor, which represents the proportion of resources allocated to the identification standards
initiative, either via budget or operating expenses. The available resources are the hospital’s
revenue and operating expenses which values provide an estimate of the hospital size.

The productivity improvement factor was defined as an intermediate variable in order to develop
the hospital relative advantage formulation. It is defined as the increase in productivity within
the healthcare providers supply chain related processes due to the use of identification standards.
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Figure 22. Productivity improvement factor

In general, readiness is defined as the level of preparedness of the healthcare providers towards
identification standards adoption. The organizational readiness (T) is associated to the
technology penetration (supporting technology) and the number of processes using the
identifiers. It is assumed that a healthcare provider would be more or less ready, depending
primarily upon the penetration of the supporting technology and the internal use of the
identifiers. The internal use of the identifiers is formulated as the organizational readiness (P).
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Figure 23. Process fraction

The organizational readiness (P) is defined as a function of the process fraction which is defined
as the fraction of processes within the healthcare provider using the identifiers according to the
identification standards definition. This process fraction is assumed to increase over time. The
process fraction is affected by the awareness. The awareness is associated to the number of
pilots or industry initiatives that can increase the willingness of the healthcare provider to initiate
projects related to identification standards use within internal processes. This parameter is
defined on a low to high numerical scale.

Component 4 – Basic population structure

The healthcare provider population is divided among adopters and non-adopters. It is assumed
that once a hospital adopts it does not reverse the decision. The adoption rate represents the flow
of hospitals from non-adopters to adopters. The basic population structure follows a similar
structure as the BDM. The intermediate variable H IdS Use is defined as the increase over time
on hospital use of identification standards due to the evolution of the hospital population
(adopter influence).
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Figure 24. Hospital IdS use

The H IdS use variable plays a key role in the integration of Component 3 (C3) and Component 2
(C2) since this variable represents the incremental use of identification standards of the average
healthcare provider considered within the generic model. The productivity improvement factor
and the process fraction at the healthcare provider level, and the cost for the technology provider
(TP costs) are related to this variable.

5.1.3 Generic model structure

As described in the BDM formulation a given population (healthcare provider) is influenced by
external and internal factors (Maier, 1998). The external factors are out of their control and not
directly related to the healthcare provider population. The internal factors are related directly to
the healthcare provider population and are influenced by the adoption of other population
members. The model components are related to the internal and external diffusion coefficients
in the following way. As shown in Figure 25, Component (C1) is related to the external
diffusion coefficient and Components (C2) and (C3) are related to the internal diffusion
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coefficient. The main parameters within Component 4 (C4) are the ones related to the
population and the initial values of the diffusion coefficients that are to be affected by the
formulation of the different factors by component. Those initial values were estimated based on
the analysis of the model parameters developed in Stage 1. In the simulation model each
component is defined by a set of multipliers which have an effect on the hospital adoption rate.
Within each component the average effect of the multipliers is considered. The adoption rate is
formulated as the sum of the external and internal influences. The generic model structure is
illustrated in Figure 25.
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Figure 25. Simulation Model
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5.2 Model formulation structure implementation
This section describes the process followed in order to implement the model formulation
structure proposed in the previous section. This implementation was performed using the
simulation tool Vensim PLE Plus version 5.11A.

5.2.1 Implementation steps

The simulation model was developed by first testing each component (including graphical
functions and parameters) individually and then adding one at a time trying to stay close to the
reference model pattern. The MMIS adoption pattern developed in Section 4.6 was followed as a
reference model. The testing and addition sequence in Vensim started with the organization
component (Component 3); this component was added to the basic structure of the simulation
model (Component 4) trying to develop a stable model close to the reference model. The same
step was followed for Components 2 and 1. The parameters within Component 4 (C4) remained
unchanged during the testing and development process.

The graphical functions and parameters listed in Appendix C are part of the final version of the
model. During the model development ten integrated test models were developed and tested by
comparing the exhibited behavior for the main output variable to the reference model. For
example earlier model versions included the integration of Component 4 (C4) with Component 3
(C3), once the fitting to the reference model was achieved another component was added to the
test model. A sequential adjustment (testing and development) process was performed until a
stable model behavior related to the reference model was obtained. During the testing and
development process, different types of adjustments were identified. There were adjustments
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related to the range and function shape of the graphical functions, adjustments related to the
range of the parameters; and adjustments related to the formulation of each one of the component
multipliers. Each one of those changes was addressed component by component until a final
integrated model formulation was developed. The model that fitted the reference model more
closely was selected as the model baserun. At each step of the model implementation, the model
was verified using the Vensim PLE Plus tools: model check and units check in order to identify
and correct any errors.

5.2.2 Base run development

One of the main challenges developing the base run was to obtain data to feed the model. For
the reference model (Stage 1) it was not difficult to collect and analyze the data directly from the
HIMSS DB in order to estimate the model parameters; however, for the model in Stage 2 the
parameter estimation was not as straightforward and the only way to obtain reference data for the
model base run was to rely on the available sources, such as the HIMSS DB, literature sources,
expert’s interviews and the researcher’s judgment. This approach to parameter estimation is
supported by (Glöber, Thun, & Milling, 2008). Some of the parameter definitions of similar
models, such as the ones described in (Maier, 1998) and (Erdil & Emerson, 2009), were revised
in order to guide the model adjustment. The model base run values were developed in parallel
while developing and implementing the model structure.

The model initial conditions consist of a set of conditions that can be grouped in two categories:
graphical functions and parameters. The graphical functions guide the behavior of the
components and those were described in Section 5.1. The graphical functions are the model
assumptions and were used to configure the model parameters. The parameters are classified
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into four groups according to their characteristics and numerical values. The first group includes
the parameters related to the external forces that affect the adoption rate. The parameters that are
related to the availability of resources at the healthcare provider level are included in group two.
The third group of parameters includes those related to values that control the allocation of
resources as well as the technology availability. The last group includes the parameters directly
related to the composition of the healthcare population. The classification of the parameters and
the base run values are presented in Table 21.

Table 21. Model baserun

group
1

2

3

4

parameter
governmentintervention
complexity and
interoperabilityissues
awareness
average H operating expenses
average H revenue
IS Budget
H technologypenetration factor
IdS factor
increase SCM expending
A initial
externalinfluence N
internalinfluence N
P initial

IM Baserun
initial
1
1
1
262,364,000
270,826,000
0.03
0.4
0.05
0.01
500
0.02
0.32
2500

The complete model formulation is presented in Appendix C.

5.2.3 Validation

Validation can be viewed as a process of establishing confidence in both the behavior and the
structure of a model (Finkelstein, Homer, & Sondik, 1984). The validation process was
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performed using the base run values defined in the previous section and considering the
assumptions contained in the graphical functions. The model was tested under the following
validation tests (Sterman, 2000):


Behavior reproduction



Dimensional consistency



Parameter assessment



Sensitivity analysis (See section 5.3)

Behavior reproduction

The model’s main output was compared with one or more historical data series available for
similar adoption processes. In this particular case the MMIS reference model is followed. It was
also useful to compare the different patterns obtained under different input assumptions with
diffusion patterns of similar technologies. The model was able to produce outputs that
corresponded to past historical trends (Stage 1 reference model), and the results were within a
reasonable range.

Dimensional consistency

The model was tested for dimensional consistency by using the Vensim model check and units
check options. The model was verified for consistency at each step of the implementation
process, and the corresponding adjustments were made until consistency was achieved and no
errors were reported.
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Parameter assessment

The different model components were used to test each one of the parameters within the
component. The components were used as submodels to test the consistency and also to partially
test and adjust the parameters. The parameter assessment was followed at each step of the model
implementation process, and the adjustments to the model parameters were made until a stable
model behavior was achieved.

5.2.4 Simulation results (base run)

The numerical results of the output of the simulation are presented in Table 22. The model was
run over a period of 40 years, with the year 2008 as the initial year. This starting year was
selected since it was the year that the main initiative related to identification standards adoption
started (DeJohn, 2008).

Table 22. Simulation baserun results

Main
input

Main
output

Baserun
Y0
Horizon
N
A0
P
p
q
Years to AR peak
Inf. Point (year)
AR max (H/year)
Critical mass (H)
Saturation point
(year)
End year

results
2008
40
3000
500
2500
0.02
0.32
14
2022
185
2014
2038
2048
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Although different starting dates could have been analyzed, thereby shifting the year the
adoption rate would reach its maximum level, in general the span of the adoption process and the
number of healthcare providers required for the inflection point (critical mass) would be the
same. The results from running the model under the assumed initial conditions, gives a 14 year
period for the adoption rate to peak or reach its inflection point which is estimated at about 2014
hospitals (critical mass).

The main behavior output measures of the model are the behavior of the adoption rate and the
behavior of the adopter population. The behavior patterns of the main outputs of the simulation
model are presented in Figure 26.

Figure 26. Simulation base run results (output measures)

Behavior of the Adoption rate AR

One of the measures of the adoption rate behavior is the time to peak (Hekimoglu & Barlas,
2010). The behavior of the adoption rate is illustrated in Figure 26a. The time of peak is year
14, which represents the highest point of the adoption rate at 185 healthcare providers per year.
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The adoption rate of 185 at its peak would mean that the adoption at the healthcare provider level
would have to perform at a faster pace. This adoption rate is equivalent to 6.17% (adopters per
year/total population), which seems high compared to the 2% reported by (DeJohn, 2008).

Behavior of the Adopter population A

One of the measures of the behavior of the adopter population is the inflection point along with
the time to reach equilibrium (Hekimoglu & Barlas, 2010). The inflection point occurs at the
peak of the adoption rate, which is year 2022, as shown in Figure 26b. At this point the critical
mass of the adopter population has enough inertia to continue the adoption process, and the
equilibrium level is reached after the limit of the adopter population is reached. This behavior
implies that it would take about 2014 healthcare providers (critical mass) to reach the inflection
point.

Using the BDM as the underlying model to describe the identification standards adoption process
impose that the external diffusion coefficient is low compared to the internal diffusion
coefficient. This means that in the identification standards adoption model most adoptions occur
through internal adoptions. The behavior of the hospital population is crucial to drive adoption.
This observation is supported by (Fibich & Gibori, 2010). The authors provide an explanation
on how the diffusion process develops according to the ratio between the diffusion coefficients
. If the ratio is less than one, most adoptions occur through external adoption. When the
ratio is greater than one, most adoptions occur through internal adoptions. In this case of the
identification standards adoption model, the ratio is greater than one (0.32/0.02) which means
that most adoptions occur through internal adoptions or factors related to the healthcare provider
population.
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Under the given baseline, the projected timeline for identification standards adoption is 29 years
with a peak at year 14. This information can provide an assessment for the proposed industry
deadline of December 2012 for product identifiers. By comparing the timeline given by the
model, it can be inferred that the deadline is not going to be met.

Even though no data on past adoptions was found, the literature review provides an indication of
the current situation regarding identification standards adoption. According to (DeJohn, 2008)
the penetration of identification standards in 2008 was about 2%. A report by (O'Daffer, Shaffer,
& Lefebure, 2011) provided an estimate of 625 members joining the identification standards
initiative in 2011 but it did not provide an estimate by supply chain member category. The
survey by (Pohl & Nachtmann, 2011) shows an increasing participation of all healthcare supply
chain members in the identification standards initiative in particular for location identifiers. The
use of such identifiers among healthcare providers grew from 10% in 2010 to 22% in 2011. The
use of product identifiers was reported as 5% in 2011 mainly by large healthcare providers. The
GS1 readiness reports posted in the GS1 website (GS1, 2012) provide an estimate of the number
of healthcare providers committed to the identification standards initiative which in 2011 was
745 healthcare providers able to transact using a location identifier in a purchase order via EDI.

The analysis of the previous facts indicates that there is a trend in the evolution of identification
standards reported use. The current trend can be compared to the baserun output (See Appendix
E). The current trend results are similar compared to the trend indicated by the baserun which
gives an estimated timeline of 14 years. These findings provide an indication about the adoption
pattern for identification standards and highlight the importance of understanding the factors that
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could drive the change and accelerate the process. The sensitivity analysis developed on the next
section provides an indication of those factors.

5.3 Model analysis
Sensitivity analysis is important to establish the parameters to which the model output is
sensitive; this could lead to improvements in the model formulation, increased data collection
efforts and definition of policies to change the model behavior pattern (Ford & Flynn, 2005).
This section presents a review on the different methods used for sensitivity analysis of system
dynamic models and explains the proposed approach for the sensitivity analysis of the
identification standards adoption model (Stage 2).

5.3.1 Sensitivity analysis and SD models

A preliminary step in developing policies is the identification of high leverage parameters and
structures which determine the influential model components that could drive the system
behavior. There are different methods for sensitivity analysis of system dynamic models, among
the most important ones (Hekimoglu & Barlas, 2010) are:

-

One at a time approach

-

Multivariate approach
o Statistical screening
o Behavior pattern analysis
o Taguchi methods (Design of experiments)
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One at a time approach

The variation of one parameter at a time is the most commonly used sensitivity analysis method
(Erdil & Emerson, 2009), (Nelson, 1998). It is performed by selecting a critical set of
parameters and identifying an output measure. Then by varying each parameter, one at a time,
the changes on the output measure are observed. Critical issues are identified, but the analysis is
limited because just one parameter is allowed to vary and the other parameters remain fixed.

Statistical screening

Statistical screening (Ford & Flynn, 2005) allows for the identification of high leverage model
parameters for further analysis and policy development. Statistical screening is developed in six
steps as described below:

1. Select a specific set of model parameters and a performance measure (output variable).
Define the range, the percentage of variation and the distribution function for the model
parameters.
2. Perform statistical screening of the model to calculate the correlation coefficients. Plot
the correlation coefficients and the behavior of the performance measure for all
simulations in another graph.
3. Select a time period for analysis by examining the time series of the correlation
coefficients and the performance measure behavior.
4. Identify high influence parameter(s) during the selected period as those with the highest
magnitude of correlation coefficient values.
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5. Identify high level model structures (components) as those that are directly driven by the
high influence parameter(s) identified in the previous step.
6. Use additional structure-behavior analysis methods to explain how the high leverage
model structures identified in step 5 which drive behavior.

High leverage parameters identified by the use of statistical screening can be used to design
policies. However, a better use of statistical screening is to exploit the results to identify the link
between the identified parameters and specific model structures that can be further analyzed,
decomposed or expanded in order to improve the model validity. That information can also be
used to improve the understanding of how the model structure drives behavior and how potential
extensions improve model validity and policy testing (Ford & Flynn, 2005).

Behavior pattern sensitivity

Behavior pattern sensibility is focused on examining the effect that changing the value of defined
model inputs could have in the output patterns of the model (Hekimoglu & Barlas, 2010).

As with most of the sensitivity analysis methods, the selection of the model parameters to be
analyzed and the distribution function for each one must be defined. Then a sampling strategy
must be selected (e.g random sampling or Latin Hypercube Sampling) in order to run the model
and collect the data related to the output pattern. A multiple regression model can be used to
estimate the regression coefficients and to establish the relationships between the selected
parameters and the output measure. One of the limitations of this approach relies on the
assumption of the linear relationship between the output measure and the regression coefficients.
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Taguchi methods

According to (Clemson, Tang, Pyne, & Unal, 1995) Taguchi methods provide a more systematic
way to conduct experimentation for sensitivity analysis purposes, but it would require the
estimation of a single measure as the output of the simulation model. The authors compare
Taguchi methods and Latin Hypercube Sampling (LHS). For a full factorial approach a ten
parameter model with 3 levels would require 310 trials (59,047). The LHS scheme ensures that
all regions for the sample space are represented. LHS combines many of the advantages of
simple random sampling and full factorial designs but requires far fewer trials. As an alternative,
Taguchi methods of experimental design could provide a more efficient way to conduct the
experiment. In this case, the ten parameter model with three levels can be studied with 27 trials
using a Taguchi L27 orthogonal array.

5.3.2 Model analysis – evaluation of different approaches

After the review of different methods, it was observed that for most models the sensitivity
analysis was performed by varying parameters one at a time. The one at a time approach would
not be useful for the model developed in this chapter because it was assumed that there are
different parameters interacting.

Taguchi and regression models used in behavior pattern sensitivity analysis methods would
require the estimation of a single output measure as a result of each simulation run. In the case
of the present model, the estimation of a quantitative value related to the total output of the
simulation is not feasible (or would not prove useful), since the goal of the model is not to
estimate a total output but to describe an adoption pattern.
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For the sensitivity analysis of the present model, a combination of statistical screening (Ford &
Flynn, 2005) and behavior pattern sensitivity (Hekimoglu & Barlas, 2010) is proposed. The
statistical screening facilitates the analysis of the behavior over time of an output variable due to
changes in a given set of parameters. The analysis is performed via the estimation of the
correlation coefficient between a given parameter and the output variable at each step of the
simulation (Ford & Flynn, 2005). The Correlation Coefficient (CC) ranges from -1 to +1 and
illustrates the strength of the relationship between two variables without accounting for other
variables that could be influential. The formula of the correlation coefficient is:
∑
∑

(20)
∑

For example, if a model is run for a period of 10 years and there are 3 parameters and 1 output
variable, the correlation coefficient for each parameter with the output variable would need to be
estimated for each one of the time periods.

The steps proposed by the statistical screening method (Ford & Flynn, 2005) are followed and
complemented by the definition of the model output measures as behavior patterns. As
explained by (Hekimoglu & Barlas, 2010), the behavior patterns of model variables are more
important than their numerical values. In the specific case of this research, the identification
standards simulation model exhibits an S-shaped growth for the adopter population; in this case
the exact value of the variable at a specific time is not as important as it is the inflection point,
the equilibrium level or the time to equilibrium. This is the reason why the behavior pattern of
the adopter population is considered as one of the main output measures of the model for
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sensitivity analysis purposes along with the behavior of the adoption rate. These are the two
main output variables of the model although the adoption rate will be used more frequently.

5.3.3 Sensitivity Analysis

The model was initially analyzed with the support of the SyntheSim Vensim functionality in
order to observe the behavior of the main output variables. This functionality allows for the
researcher to test the model with considerable interactivity. The changes made to the model
while in this mode will cause the model to be re-run automatically (Ventana, 2007). The
parameters defined in the baserun were tested for sensitivity by parameter group. The
parameters listed by group and the corresponding values are presented in Table 23.

Table 23. Sensitivity analysis parameters

1

2

3
4

parameter
IM Baserun
Low
High
distribution
government intervention
1
1
3
RANDOM_UNIFORM
complexity and interoperability issues
1
1
3
RANDOM_UNIFORM
awareness
1
1
3
RANDOM_UNIFORM
average H operating expenses
262364000 174909333 349818667 RANDOM_UNIFORM
average H revenue
270826000 180550667 361101333 RANDOM_UNIFORM
IS Budget
0.03
0.02
0.04
RANDOM_UNIFORM
H technology penetration factor
0.4
0.24
0.56
RANDOM_UNIFORM
IdS factor
0.05
0.03
0.07
RANDOM_UNIFORM
increase SCM expending
0.01
0.006
0.014
RANDOM_UNIFORM
A initial
500
400
600
RANDOM_UNIFORM
P initial
2500
2000
3000
RANDOM_UNIFORM

The parameters within group one are related to external forces influencing each of the main
model components. These forces are out of the control of the healthcare provider. Under current
conditions those parameters are set to one. The parameters within group two are related to the
availability of resources. The parameters within group three are related to the allocation of the
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resources and technology infrastructure. The parameters within group four are related to the
population size.

A period of 30 years was defined as the horizon to run the model sensitivity analysis tests. For
each parameter group a sensitivity analysis test was performed leaving the parameters within the
other groups unchanged. Four tests were performed:


Test 1, sensitivity analysis test for parameters within group 1, remaining parameters were
kept unchanged.



Test 2, sensitivity analysis test for parameters within group 2, remaining parameters were
kept unchanged.



Test 3, sensitivity analysis test for parameters within group 3, remaining parameters were
kept unchanged.



Test 4, sensitivity analysis test for parameters within group 4, remaining parameters were
kept unchanged.

The following steps were followed to perform each sensitivity analysis test:

1. Define the range, variation and distribution function for the parameters under analysis.
2. Load parameters into the Vensim PLE Plus sensitivity analysis module.
3. Select the sampling strategy (LHS) and the number of runs (50 runs).
4. Run sensitivity analysis for each output measure (behavior patterns) and save the data.
5. Export data to MSO Excel and develop correlation coefficient (CC) plots according to the
template provided by (Ford & Flynn, 2005).
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6. Analyze. The period of analysis for the adoption rate pattern was defined as the period
before the adoption rate peak. This period was used because the goal is to establish the
main parameters influencing the adoption rate and the identification of main model
components of greater leverage in order to speed up the adoption process. For the
sensitivity analysis of the adopter population, the complete span of the simulation was
considered.

The Vensim sensitivity analysis reporting functionality offers the option of displaying sensitivity
analysis graphs as the ones shown in Figure 27. For example Figure 27 shows the sensibility
analysis graph for the adoption rate which includes the results of the simulation runs in the form
of confidence bounds; the 50% region includes all the runs that felt within that range. This
illustration provides an indication of the variation of the output variable regarding the parameters
associated with a given sensitivity analysis test.

Figure 27. Sensitivity analysis results (Vensim graph)
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After exporting the Vensim sensitivity analysis results to MSO Excel, the main parameters were
identified by analyzing the threshold range (Ford & Flynn, 2005) for the Correlation Coefficient
(CC) plots which is (+0.2, -0.2). The parameters that fall outside of the threshold range are
considered to have an impact in the output measure under analysis.

After analyzing the results of the sensitivity analysis (CC plots) for the adoption rate behavior
pattern and the adopter population pattern, it was found that the relevant parameters within each
test are the same for both output measures. This can be explained by reviewing the discrete
version of the BDM (See Equation 5) in which the adoption rate is formulated as a function of
the cumulative number of adopters.

Within test 1, the result of the analysis of the CC plots shows that complexity and
interoperability issues is a relevant parameter. Within test 2, the analysis of the CC plots shows
that the IS Budget and the Average H revenue are relevant parameters. Within test 3, the analysis
of the CC plots shows that the IdS factor is a relevant parameter. Within test 4, the analysis of
the CC plots confirmed what is already known about the impact of this type of parameters. The
analysis showed that the P initial parameter has an increasing correlation and the A initial
parameter has a decreasing correlation; these results were expected as they confirmed what is
already known about the impact of these type of parameters (Ford & Flynn, 2005). For the main
component (C4), changes related to the parameters can have an impact on the adoption rate
however those changes are not considered for sensitivity analysis purposes since only one
population size is considered in the simulation model.

After reviewing the results of the tests, a fifth test (test 5) that includes the combination of the
parameters within groups 1, 2 and 3 is proposed. The analysis of the results of test 5 indicated
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that the following factors have a correlation with the adoption rate: IdS factor, average H
operating expenses, complexity and interoperability issues and awareness. For group one
parameters such as the awareness and the complexity and interoperability issues at the healthcare
provider and the technology provider level respectively, can play a role in facilitating
identification standards adoption. For parameters within groups 2 and 3, these results indicate
that the availability and allocation of resources at the healthcare provider level considering that
the average H operating expenses and the IdS factor may have an impact on the adoption
process. The results for the sensitivity analysis are summarized in Table 24.

Table 24. Sensitivity analysis results

group
1

2

3

Relevant parameters test 5
government intervention
complexity and interoperability issues
awareness
average H operating expenses
average H revenue
IS Budget
H technology penetration factor
IdS factor
increase SCM expending

As the underlying BDM formulation suggests, the internal adoption influence is stronger than
external influence. An analysis of the relevant parameters by component shows that for
Component 1 (C1) the parameter government intervention did not appear on any of the aspects
of the analysis as a relevant parameter, so the contribution of Component 1 (C1) is low. For
Component 2 (C2) the parameter complexity and interoperability issues appear as a relevant
parameter, which indicates that actions directed to solve those types of issues could have an
impact in the adoption rate. For Component 3 (C3), there are three parameters that can play a
158

role on speeding the adoption process; those are awareness, average H operating expenses and
the IdS factor. The analysis by group indicates that parameters associated to the healthcare
provider can be important when considering the design of the interventions. The result of the
Correlation Coefficient CC plot for test 5 is shown in Figure 28.

Correlation Coefficients
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0.4
0.2
E-16
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IdS factor
IS Budget

average H revenue
complexity and interoperability issues
H technology penetration factor
increase SCM expending

Figure 28. Correlation coefficient plot (test 5)

The threshold range of (-0.2,+0.2) illustrates how the parameters that fall outside of the threshold
are the ones included in the analysis as relevant parameters and are highlighted in bold in Table
24. The complete report of the sensitivity analysis tests including both output measures is
presented in Appendix D.
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The results of the sensitivity analysis provide an indication of the relevant model parameters. It
also provides information related to the model behavior and how the model can be improved.
The improvements can lead to the evaluation of data collection efforts and the definition of
policies to change the model behavior pattern. Based on this information, an interpretation of
those results in the context of real world can be developed but the interpretation will be limited
by the assumptions and scope of the model. The model does not attempt to make a prediction of
what is going to happen in the future but to provide a test bed for interventions testing.

5.4 Model interventions (design and implementation)
This section presents the answer to the following research question:

What actions are required to increase the number of healthcare supply chain members and
healthcare providers adopting identification standards?

The answer to this research question is presented under the scope of the model defined and
analyzed in this chapter. The model includes the hospital population, but other members besides
the technology providers were not explicitly considered due to the limitations on data
availability. A literature review regarding policy design interventions development for system
dynamics models in the form of policy design or scenario testing is presented, and then the
proposed interventions for the present model are developed.

5.4.1 Review

For system dynamics models, the interventions or changes in the system are usually introduced
in the form of policies or scenarios.
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Policy design

The adoption of Electronic Health Records (EHR) modeled by (Erdil & Emerson, 2009), using a
system dynamics model, presented 4 policies. These policies were related to the cost, which was
identified as one of the main factors affecting the EHR adoption. The policies included the
addition of subsections to the original model in order to reflect the policy intervention in the
form of subsidies, free grant products, a tax break and paying for performance. The model
developed by (Otto & Simon, 2009) on EHR adoption, illustrated how policies can be defined as
a set of changes on parameter values. The policies were defined as a 20% variation on the
selected parameters (financial incentives, awareness and education) to show the impact in the
adopter population.

Scenario testing

The adoption of technologies in agricultural business was studied by (Fisher, Norvell, Sonka, &
Nelson, 2000), and the scenarios tested different combinations of profit levels to observe the
impact on the speed of diffusion. The adoption of food safety technologies was studied by
(Daim, Rueda, Martin, & Gerdsri, 2006), and the scenarios were used to establish the most likely
set of parameters that could explain the adoption process within a reasonable timeframe. The
scenarios developed by (Cui, Zhao, & Ravichandran, 2011) for the new product launch allowed
researchers to test a combination of launch strategies and market size in order to evaluate the
speed of diffusion of a new product.
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5.4.2 Interventions within the present research model

Intervention design

For the present model the interventions are defined as a set of policies and scenarios. The
interventions are designed based on the following sources: the sensibility analysis results from
the previous section and a set of future events.

The results from the sensitivity analysis emphasize the importance of the organization related
Component (C3) and suggest that the external Component (C1) is not so relevant. The fact that
the Component 1 (C1) is not relevant can be understood under the BDM model structure
assumption since the external diffusion coefficient is small and it drives that portion of the
adoption process which has a small impact in the adoption rate. As for Component 2 (C2), the
complexity and interoperability issues parameter was found as a relevant one. As for
Component 3 (C3), the IdS Factor and the average H operating expenses were relevant
parameters which are associated with the resource allocation and availability. Also for this
component the awareness was found as a relevant parameter which is directly linked to the
organizational readiness factor. Policies and scenarios that include these model parameters
could have an impact in the main output measure (Hospital adoption rate).

There are a set of future events that could have an impact in the current model. The design of the
interventions considered the following: the impact of the FDA UDI regulation, the impact of the
enforcement of the minimum use requirements for hospital EHR implementation and the impact
of the increased participation of the technology providers in the identification standards adoption
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process. These events were identified through the extensive literature review developed in
Chapters 2 and 3.

Intervention evaluation

The model allows for the testing responsiveness of the main variable such as the hospital
adoption rate to the proposed interventions. The impact of the intervention (policy or scenario)
is measured as the shift of the adoption rate curve relative to the baseline (adoption rate peak),
the adoption rate (adopters per year at the peak) increase, and the critical mass change.

5.4.3 Interventions by component (design and implementation)

Based on the sensitivity analysis results and the events related to a given model component a set
of policies for each component is proposed.

Component 1

As revealed by the sensitivity analysis of the parameters within group 1 and the combined
analysis (test 5), none of the parameters within Component 1 (C1) were relevant. The different
factors defined within the external environment could have an impact in the adoption rate. The
values that those parameters represent are the current status of the system if no other change is
introduced.

Assuming that the UDI regulation could take place at the end of 2012, the model would consider
that the regulation has an effect at the manufacturer level. The model takes into consideration
the members of a given population; it does not consider the granular effect of products flowing
through the system. Under the current model the number of manufacturers joining the initiative
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is considered. The model assumed a parallel development from the manufacturer side on the
deployment of barcode labels for all product classes.

The configuration of the model by product would require distinguishing among the three product
classes. Such a model could provide an estimation of the evolution of the number of product
identifiers over time but not of the use of product identifiers within the processes and
transactions at the healthcare provider level, as the current model does. The immediate pressure
for UDI adoption would be for manufacturers of products Class III. Products Class III are the
ones that could represent a potential risk to the patient, while products Class I represent no harm
(Hefflin, 2005). It is estimated by the industry that it would take about two years for
manufacturers of products Class III to fully comply with the regulation. It could take five years
or more for manufacturers of products Class I to fully comply with the FDA regulation. Even if
the product came with barcodes from the manufacturer to the hospital, the technology, processes
and procedures required to make use of those identifiers would have to be in place. This means
that, even if the UDI rule effect is immediate, and product identifiers are available tomorrow on
all products in the form of the GTIN minimum level of AIDC marking (GS1 Healthcare US,
2010), which does not consider secondary information, it will take hospitals as long as it took
them to adopt the underlying technological infrastructure, to use identification standards within
the described processes under the identification standards definition.

As shown in Figure 25, Component 1 (C1) is linked to the adoption rate via the external
diffusion coefficient. For policy 1a, a change in this structure is proposed in the form of a single
coefficient. Policy 1a was defined as a change in the model structure to illustrate the impact of
the consolidation of the internal and external diffusion coefficients into a single one. The impact
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of this change is significant given the fact that the adoption rate peak gets delayed to year 20
when the Component 1 (C1) effect is considered jointly.

Policy 1b is defined as a change in the manufacturers function (gf), representing one third of the
population members adopting by year 15 and a STEP function for the government intervention
parameter with a height of 5 and a step of 2. The details of policy development are shown in
Appendix E. This policy shifts the adoption rate peak from year 14 to year 11. The result of the
implementation of both policies is shown in Figure 29.

Figure 29. Policies Component 1 (C1)

In the context of the real world the implementation of Policy 1b indicates that increasing the
number of manufacturers joining the initiative as well as introducing an intervention by the
government could help to shift the adoption rate curve to the left. This policy can be associated
to the effect of the UDI FDA rule over manufacturers.
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Component 2

The technology provider plays a role in identification standards adoption by facilitating the
upgrades required for the supporting technology currently in place at the healthcare provider
level. The complexity and interoperability issues parameter appears as a relevant one in the
sensitivity analysis; this means that changes in this factor could have an impact on the adoption
rate. The policies related to the technology provider can be aimed to increase the technology
provider readiness (TP readiness) in order to solve complexity and interoperability issues
associated to identification standards adoption. The results of the policy implementation are
shown in Figure 30.

Figure 30. Policy Component 2 (C2)

Policy 2 was defined as a change in the technology provider readiness to illustrate the impact that
the number of technology providers joining the initiative could have on the adoption process. It
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was assumed that one third of the technology providers were joining the initiative by year 10.
The details of policy development are shown in Appendix E. It can be observed that the
adoption rate peak shifted from year 14 to year 10 and the number of healthcare providers per
year (at the peak) also increased from 184 to 234.

In the context of the real world the implementation of Policy 2 represents a shift of the adoption
rate curve to the left due to the increased involvement of the technology providers in the
identification standards initiative.

Component 3

According to the results from the sensitivity analysis, awareness is a relevant parameter in the
model, as well as IdS Factor and average H operating expenses, which means that changes in
those parameters could have an impact in the adoption rate. An increase in the awareness would
represent an increase in the healthcare provider readiness. An increase in the IdS Factor would
represent the fact that more resources are allocated to the identification standards initiative.
Changes in resource availability are not included in this policy since the average H operating
expenses factor which is linked to the resource availability, thus the size, is associated in the
present model to one population size (H>2).

Although the H technology penetration factor did not show a significant impact, it can play a
role in identification standards adoption. The model takes into consideration only the supporting
infrastructure from the supply chain perspective but other technological components have to be
integrated, especially as the product flows through different units within the hospital and are
used at the point of care. Additionally, the presence of EHR minimum use requirements in the
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form of financial incentives could represent a way to drive the adoption. An increase in the H
technology penetration factor is proposed as a way to represent the required technological
integration to meet the EHR minimum use requirements and its associated incentives.

For Policy 3, it is assumed that in order to increase the healthcare provider readiness, the event of
an increase in the level of technological integration can be represented by a value of 0.8 for the H
technology penetration factor and an increase in the awareness can be represented by a value of
3 for this parameter. The IdS factor is set to 0.06 to represent an increase in the resource
allocation and the average H operating expenses was kept unchanged. The implementation of
this policy gives a shift of the adoption rate peak from year 14 to year 9.

Figure 31. Policy Component 3 (C3)

In the context of the real world the implementation of Policy 3 represents the effect of an
increase in the healthcare provider readiness due to an increase in the awareness which can be
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associated to an increased number of pilots of the early adopters. The implementation of the
policy explores an increase in the healthcare provider technological integration due to the
implementation of EHR minimum use requirements. This policy also includes an increase in
resource allocation which could represent the fact that more resources are allocated to upgrade
the existing applications to meet the identification standards requirements.

A summary of the policies is presented in Table 25. Among the different policies, the one that
provides the earliest adoption rate peak (year 9) is Policy 3. This policy directly affects
Component 3 (C3) and reflects an increase healthcare provider readiness via an increase in the
awareness regarding the identification standards initiative. This policy also included an increase
in the H technology penetration factor due to the EHR minimum requirement implementation
pressure and an increase in resource allocation due to the increase of the IdS factor.

Table 25. Policy implementation summary

AR
max
184
171

Year
peak
14
20

Critical
mass
2014
1892

End
year
29
38

182

11

1793

28

IM Baserun initial Policy2

Increased number of
technology providers

234

10

1831

26

IM Baserun initial Policy3

Technological integration,
awareness and increased
resources

248

9

1851

21

Policy (Vensim model)

Description

IM Baserun initial
IM Baserun initial Policy1a

IM Baserun initial Policy1b

Inital conditions
Single diffusion coefficient
Government intervention
and increased number of
manufacturers

Given the fact that each policy represents an effect on a single component, the combination of
different policies is proposed as a way to explore the impact of such interventions in the model.
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Four policy combinations are proposed as shown in Table 26. The first policy combination
includes the parameter changes proposed for Policy 1b and Policy 2. This policy combination
represents an increase in government intervention and also an increase in the number of
manufacturers and technology providers joining the identification standards initiative. The
second policy combination includes the parameters changes proposed for Policy 2 and Policy 3.
This policy combination represents an increase in the number of technology providers joining the
identification standards initiative as well as an increase in the readiness at the healthcare provider
level.

Table 26. Policy combinations

Policy combination

Description

(1) Policy 1b and
Policy 2

Government intervention and increased number of technology providers
joining the initiative
Increased number of technology providers joining the initiative and
increased technological integration at the healthcare provider level as
well as an increase in the awareness and resources
Government intervention and increased technological integration at the
healthcare provider level as well as an increase in the awareness and
resources
Participation of all stakeholders

(2) Policy 2 and
Policy 3
(3) Policy 3 and
Policy 1b
(4) Combined policy

The third policy combination includes the parameter changes proposed for Policy 3 and Policy
1b. This policy combination represents efforts by the healthcare provider regarding the
identification standards initiative as well as an increase in government intervention and the
number of manufacturers joining the identification standards initiative. The last combination is
the combined policy which includes the main parameters within each policy. This policy
combination represents the joined effort of all the stakeholders. For this combined policy the
government intervention parameter is set at 3, complexity and interoperability issues parameter is
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set at 2, awareness parameter is set at 3, the hospital technology penetration factor is set at 0.6
and the IdS factor is set at 0.07. As proposed by (Glöber, Thun, & Milling, 2008) the values for
the different parameter changes can be supported by information gathered through literature
sources, sensitivity analysis testing and the researcher’s experience.

The result of the implementation policy combinations is shown in Table 27. The policy
combinations that provide the earliest adoption rate peak are policy combination (2) and (4). By
analyzing the information provided in Table 27, it can be observed that the interventions that are
associated with Policy 3 provide a better performance regarding the adoption rate peak as well as
the duration of the adoption process.

Table 27. Policy combinations results

Policy combinations (Vensim model)
(1) IM Baserun initial Policy1b and 2
(2) IM Baserun initial Policy2 and 3
(3) IM Baserun initial Policy3 and 1b
(4) IM Baserun initial combined policy

AR
max
242
353
263
352

Year
peak
9
7
8
7

Critical
mass
1871
2007
1799
1819

End
year
24
17
21
16

The Vensim graph for the policy combinations is shown in Figure 32. The implementation of
policy combinations (2) and (4) generate an adoption rate peak at year 7.
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Figure 32. Policy combinations graphical output Vensim

The results of the implementation of the proposed policies contribute to the understanding of the
system behavior and provide an indication about the impact of the proposed changes in the
system. The information that supports policy analysis and development is presented in Appendix
E.

5.4.4 Interventions by scenario definition

The scenario definition is determined by the combination of the main parameters identified in the
sensitivity analysis and their corresponding levels. The parameters are complexity and
interoperability issues, awareness, average H operating expenses and IdS factor. The levels
were defined within the range of the numerical scale previously assigned to the parameter. Three
levels were defined for each parameter: High, Medium and Low. The parameters and the levels
are shown in Table 28.
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Table 28. Parameters and levels for scenario analysis

Parameter
complexity and interoperability
issues
awareness
average H operating expenses
IdS factor

label
A
B
C
D

1

Level
2

3

1
2
3
1
5
10
174,909,333 262,364,000 349,818,666
0.03
0.05
0.07

In order to test the different combinations of model parameters, the basic structure of an
orthogonal array was defined (Clemson, Tang, Pyne, & Unal, 1995). In this case the orthogonal
array represents a matrix that ensures a balanced comparison of levels of any parameter (factor).
A L9 (34) experiment for 9 tests, 4 factors and 3 levels was used. There are nine scenarios
according to the L9 (34) experiment template as shown in Table 29.

The scenarios were tested in Vensim PLE Plus, and the output of the simulations were saved and
analyzed in MSO Excel. There were two experimental results that were not considered within
the analysis because the lack of stability of the results (Scenarios 8 and 9).

Table 29. Scenarios

Scenarios
1
2
3
4
5
6
7
8
9

A
1
1
1
2
2
2
3
3
3

B
1
5
10
1
5
10
1
5
10

C
174,909,333
262,364,000
349,818,667
262,364,000
349,818,667
174,909,333
349,818,667
174,909,333
262,364,000

D
0.03
0.05
0.07
0.07
0.03
0.05
0.05
0.07
0.03
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The results are summarized in Table 30. There are two scenarios that show an adoption rate peak
at year 7; those are scenario 4 and scenario 7.

Table 30. Scenario results

Scenarios (Vensim model)
IM Baserun initial
IM Baserun initial scenario1
IM Baserun initial scenario2
IM Baserun initial scenario3
IM Baserun initial scenario4
IM Baserun initial scenario5
IM Baserun initial scenario6
IM Baserun initial scenario7

AR max
184
143
230
334
326
376
403
368

Year
peak
14
21
12
8
7
15
8
7

Critical
mass
2014
1800
2009
1900
1667
2043
2025
1819

End
year
29
30
23
17
18
22
14
17

For scenario 4 the complexity and interoperability issues are partially solved. The allocation and
availability of resources is high according to the values of the IdS factor and the average H
operating expenses; the level of awareness is low. For scenario 7 the complexity and
interoperability issues are fully addressed, and the resource allocation and availability is also
high; the level of awareness is low.

By analyzing the characteristics of these scenarios an indication of the possible effective
interventions can be established. The participation of the technology provider in order to solve
complexity and interoperability issues as well as the allocation and availability of resources at
the healthcare provider level are observed as important interventions to consider. The analysis
by policy did not include a change in the parameter associated with the availability of resources;
in the scenario testing this factor appears high as well as the resource allocation factor. The
allocation of resources is associated to the fact that financial resources can be provided to the
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identification standards initiative within the healthcare provider. The availability of resources is
associated with the size; so it seems that hospitals with more resources, could adopt faster.

Figure 33. Scenarios Vensim output

The Vensim graph of the scenario testing is shown in Figure 33. By comparing the parameters
included within Scenario 4 and Scenario 7, it can be observed that the most likely scenario is the
one that includes actions associated to solve complexity and interoperability issues as well as an
increase in resource availability and allocation at the healthcare provider level. The information
that supports scenario analysis and development is presented in Appendix E.

5.5 Conclusions
This chapter presented the second stage of the modeling approach to identification standards
adoption. The proposed model is an answer to research question number 4. In this regard, the
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challenges posed by the use of classical diffusion models which were discussed in the previous
chapter were addressed. The proposed model developed in this chapter is an answer to those
challenges. The model uses the information configured in the model parameters and graphical
functions to show the current status of the system and to project the adoption pattern of
identification standards diffusion over time. Under the initial conditions it would take 14 years
for identification standards adoption to reach its peak and 29 years to complete the adoption
process. The model results are limited to the available information and model assumptions but it
provides a way to assess current industry deadlines for identification standards adoption and
provides an answer to the problem described in Chapter 1. As explained in Section 4.5.3 the
goal of the model is not to forecast but to provide an explanation of the current situation and to
understand the system behavior.

Within this modeling stage, the answer to research question number 5 is developed. The answer
to this question is incorporated within the formulation of the main elements of Component 3
(C3) (See section 5.1.2). It is assumed that the adoption of identification is beneficial for the
healthcare provider and the productivity improvements will represent a gain for the healthcare
provider. Since ROI data was not available the justification of identification standards benefits
or the estimation of the ROI is out of the scope of this research

The sensitivity analysis of the model allowed for the identification of the factors affecting the
identification standards adoption process; it also facilitated the understanding of the system
behavior and allowed for the design and test of interventions to move the system forward.
Among the relevant parameters are the ones associated with Component 3. Since the baserun
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results indicate that the industry deadline of December 2012 is not going to be met, the
sensitivity analysis results provide information to guide interventions design.

Finally, the model analysis presented in this chapter contributes to answer the research question
number 6. The question is related to the required interventions to increase the number of
healthcare providers adopting identification standards. The proposed interventions were
designed in accordance to the results from the sensitivity analysis and the most likely future
events. Two types of interventions were considered: policies and scenarios.

Among the different policies, when analyzed independently the ones that act directly over
Component 3 (C3) are the most effective, producing an adoption rate peak at year 9. The
implementation of policy combinations (2) and (4) produce an adoption rate peak at year 7 as
well as implementation of Scenarios 4 and 7.

Given the results of the implementation of the proposed interventions, the adoption (adoption
rate peak) of identification standards can be shifted to year 7 if the conditions proposed by the
policy combinations (2) or (4) or the Scenarios 4 or 7 are assumed.

The policy combinations associated to the earliest adoption rate peak are characterized by efforts
at the healthcare provider level. Policy combination (2) included a joined effort from technology
providers as well as healthcare providers; similarly policy combination (4) included a joined
effort of all stakeholders.

The scenarios associated to the earliest adoption rate peak (Scenarios 4 and 7), are characterized
by a low level of awareness and high level of resource allocation and availability at the
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healthcare provider level. The participation of the technology providers in order to solve
complexity and interoperability issues is also a characteristic of these scenarios.

This model provides an illustration of the use of system dynamics models and diffusion theory to
understand a problem reported in the literature and not yet solved. This model is an
approximation of the real world system that allows the identification of the main factors affecting
the system and facilitates the design and testing of policies to explore the change in the system
behavior. This approximation is proposed as a way to understand the problem and shed light to
real world practitioners and also to the academic community on issues like the lack of data and
other challenging aspects of empirical research which can be addressed with the proposed model
and methodology.
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6. Conclusions
6.1 Contributions
The contributions from this research are related to each one of the expected contributions
presented in Chapter 1.

The contributions from Phase I are associated with the classification of the major barriers
affecting the identification standards adoption process. The literature review related to
technology adoption and diffusion within the healthcare domain was developed, and the adoption
of Electronic Health Records (EHR) was identified as one of the main adoption processes within
that category. The literature review related to the technology adoption and diffusion outside the
healthcare domain was developed, and the adoption of Electronic Data Interchange (EDI) was
identified as one of the main adoption processes within that category. The results of the
literature review on identification standards literature illustrated the lack of academic literature
related to identification standards adoption and supported the need for a conceptual model to
explain it.

The researcher developed a conceptual model that is an original contribution to the literature.
The classification of the factors identified through the extensive literature review provided the
basis for the development of the conceptual model for identification standards adoption. The
conceptual model illustrates the factors affecting the adoption of identification standards from
the healthcare provider perspective (Burbano, Rardin, & Pohl, Exploring the Factors Affecting
the Identification Standards Adoption Process, 2011). Those are categorized as environment,
technology and organization related factors.
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The technology related factors are relative advantage, complexity, compatibility and the
organizational readiness factor in terms of the technological capabilities. These factors are
directly associated with the characteristics of the technology (innovation) under study and the
preparedness of the organization related to its infrastructure to support the adoption. The relative
advantage represents the benefit associated with the technology, and it is used instead of the cost
in order to express the gain from technology adoption in aggregate terms. The environment
related factors are industry pressure, government intervention, vendor support and the
technology solution provider readiness factor in terms of its ability to support the technology to
be adopted by the healthcare provider. These factors are outside of the control of the healthcare
provider. The organization related factors are size, top management support, and organizational
readiness factor. These factors are directly related to key characteristics of the organization (e.g
size) and also to basic elements of the project and team required to lead the adoption process.

The contributions from Phase II are associated with the development and implementation of the
proposed modeling approach for identification standards adoption. This research makes a first
attempt to model identification standards adoption by bringing system dynamics modeling and
diffusion theory together. The proposed model provides insights on relevant factors affecting the
adoption process and illustrates how policies and scenarios are designed to modify the system’s
behavior.

The initial step of the proposed modeling approach is the Causal Loop Diagram (CLD). This
CLD is another representation of the factors affecting the adoption process, identified in the
conceptual model, but in the form of a relationship (Burbano, Pohl, & Rardin, Modeling the
Adoption of Identification Standards in US Hospitals: A Systems Dynamics Approach, 2011).
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The CLD was used to conceptualize the model formulation. The use of classical diffusion
models was explored as a way to mathematically formulate the model, and the Bass Diffusion
Model (BDM) was proposed as the underlying structure for the formulation. Due to the lack of
information on past adoptions related to identification standards, a staged model formulation was
proposed.

The first stage of the model formulation used the BDM to analyze the adoption of the technology
required to support identification standards use. It was assumed that the analysis of the adoption
of supporting technologies for identification standards such as the MMIS could provide valuable
information to model the identification standards adoption process, since identification standards
cannot be used in isolation but require the existence of an underlying platform to be of any value
for the organization. This stage facilitated the estimation of the model coefficients for each of the
supporting technologies, according to the identification standards definition. It also facilitated
the characterization of the diffusion curves for MMIS, BPOC and EDI for the hospital
population using the HIMSS DB available data.

The second stage of the model used most of the factors defined in the CLD to develop a
simulation model, which was validated using the steps suggested by the system dynamics
methodology. The sensitivity analysis identified the relevant model parameters that facilitated
the design of interventions to move the adoption process forward. This model provides an
illustration of the use of system dynamics models and diffusion theory to understand a problem
reported in the literature and not yet solved. This model is an approximation of the real world
system that identified the main factors the system and facilitated the design and testing of
policies to explore the change in the system behavior. This approximation is proposed as a way
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to understand the problem and inform real world practitioners and also the academic community
on issues like the lack of data and other challenging aspects of empirical research that can be
addressed with the proposed model and methodology.

6.2 In general (research questions, limitations and challenges)
As presented in Chapter 1, the research questions were grouped into two phases. Phase I was
related to questions 1, 2 and 3. Phase II was related to questions 4, 5 and 6. For each phase the
main objective was achieved and the research questions were answered.

For Phase I the main objective was to identify the main barriers affecting the data standards
adoption process (research question number 3). The barriers were identified and the adoption
process was explained via a conceptual model. The research shows that the identification
standards adoption process can be understood and explained using the information provided in
the comparative analysis of findings and the proposed conceptual model. The findings of Phase I
are limited to the scope of the literature review, which was extensive and covered more than 100
papers, but it cannot be assumed that all the available documentation was revised.

For Phase II the main objective was to develop a theoretical model to investigate the dynamics of
the adoption of identification standards in the U.S healthcare supply chain (research question
number 4). The model was developed and tested. A systems dynamics modeling approach was
used to model this process, and the model was based on technology diffusion theory. The
research showed that technology diffusion models can be used to explain and model the adoption
of identification standards, but with certain limitations. Classic diffusion models such as the
BDM are limited to data availability and the definition of the technology to be adopted.
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To overcome those limitations, a two stage formulation was proposed. The first stage comprised
the modeling of identification standards supporting technologies, such as MMIS, BPOC and
EDI, by using the BDM. It was established that the adoption of at least the underlying platform,
the MMIS, was necessary to support identification standards adoption and further use. The
second stage comprised the model formulation, implementation and testing using the
assumptions developed in Section 5.1.

According to the results of the sensitivity analysis the following factors were found to have a
positive correlation with the adoption rate: IdS factor, average Hospital operating expenses,
complexity and interoperability issues and awareness. These results indicate that the availability
and allocation of resources at the healthcare provider level considering the average H operating
expenses and the IdS factor may have an impact on the adoption process. The implementation of
the interventions defined in Section 5.4 indicated that the adoption rate for identification
standards can be accelerated up to year 7.

The model (Stage 2) allowed the researcher to model interactions and facilitated the development
of assumptions when no data exists or is available yet. The model provides a platform or test
bed that can be extended to include other healthcare supply chain stakeholders. Even though
there are different stakeholders in the healthcare supply chain, this model’s main focus is the
healthcare provider and its interaction with technology providers. The findings from this phase
are limited to the validity of the model parameters and assumptions.

The development of the first phase was challenging due to the lack of a consensus on
identification standards adoption definition. An operational definition was proposed. The
development of the second phase of the research was challenging due to the fact that classical
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diffusion models rely on the existence of enough data on past adoptions in order to estimate
model parameters. Since identification standards were defined as a recent adoption process
(2008), the lack of data on past adoptions represented a challenge for modeling purposes. The
staged formulation was proposed as a way to overcome this challenge.

6.3 Research opportunities
Some of the challenges described in the previous section represent an opportunity for further
research and exploration.

The study of the identification standards adoption process from the Management of Technology
(MOT) perspective provided an opportunity to enhance the understanding of the adoption
process by exploring related adoption processes such as EDI and EHR. That exploration led to
the development of the conceptual model for identification standards adoption at the healthcare
provider level. The extension of this work in order to develop a conceptual model for other
healthcare supply chain members such as distributors, Group Purchasing Organizations GPOs
and manufacturers could be considered. These conceptual models can be tested ona broader
scale with a data collection technique (survey). A longitudinal study can be developed based on
the operationalization of the conceptual model (survey results). This study can be done over a
three to five year period to collect data on adoption and follow up on the industry evolution.

The simulation model (Stage 2) can be improved with the refinement of the data gathering and
validation process. The use of fuzzy set theory in order to operationalize the qualitative variables
of the model is an avenue for future exploration.
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The generic simulation model structure can be further developed to include the specific
characteristics of the healthcare population (size, revenue) and also to consider other industries
for example the pharmaceutical supply chain.

The methodology used to develop the simulation model can be revised, and Agent Based
Modeling ABM can be applied to study individual entities instead of a population. These entities
can be modeled as individual hospitals, and spatial considerations associated with geographical
characteristics can be considered as well as network membership.

In general, the proposed modeling approach of Stage 2 and the groundwork information provided
in Stage 1 can be followed and improved in the study of adoption processes with similar
characteristics in a different setting, for example a different country.
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Appendix B. Parameter estimation
B.1 Tool

Figure B.1.1 Software request
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Figure B.1.2 Software access page

198

B.2 Available information

Figure B.2.1 HIMSS Dorenfest Data Base agreement
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Figure B.2.2 Access to the Dorenfest Institute

B.2.3 List of available information
Library of Dorenfest 3000+ Databases™ and Dorenfest Integrated Healthcare Delivery System
Databases™ for the period 1986 through 2006
http://www.himss.org/DorenfestInstitute/DatabaseListing.aspx
Last access 4/14/2011 4:58 PM

2008 HIMSS Analytics Database (derived from the Dorenfest IHDS+ Database) (Access 2003)
 Demographic and IT data from over 33,000 facilities:
o 5,168 Hospitals
o 2,733 Sub Acute Care Facilities
o 21,796 Ambulatory Facilities
o 2,293 Home Health Care Facilities
o 177 Free Standing Data Centers
 Market share and purchasing plan data for over 95 software applications and technologies
 New for 2008:
o Applications: Bed Management, Single Sign-On
o Statistics
o Number of Births
o Number of Outpatient Visits at the Hospital
o Total Number of Discharges
o Total Number of Patient Days
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New Types of Physicians (both the hospitals and systems)
Number of Hospitalists
Number of Residents
New IT FTEs
RCM Support
EMR Support
Chief Medical Officers, Chief Nursing Heads, HR Head and OB Head Contacts
CPOE Usage Details By Order Type
% of Medical Records that are Electronic
% of Physicians Using Structured Templates in the CDSS
Use of Consumer Dashboards
By Component of a Dashboard the % of Physicians Accessing
Patient Revenue By Percentage at the Hospital
Consolidation of Bar Coding and RFID Data
Details about Items Tagged for Medication Administration
Details on Systems Taking Advantage of the Relaxation In the Stark Law To
Offer
o EMRs to Non-Owned Clinics
o Software Being Remote Hosted (e.g. Perot is remote hosting the Mckesson
software)
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o

2007 HIMSS Analytics Database (derived from the Dorenfest IHDS+ Database) (Access 2003)
 Demographic and IT data from over 33,000 facilities:
o 5,073 Hospitals
o 2,940 Sub Acute Care Facilities
o 50,458 Ambulatory Facilities
o 2,128 Home Health Care Facilities
o 178 Free Standing Data Centers
 Market share and purchasing plan data for over 90 software applications and technologies
 New for 2007:
o Applications: Radiology - Orthopedic, Single Sign-On
o IT Director and Quality Head
o Next Generation RCM
o Construction Plans
o IV Pump Safety Software
o Plans for Telecommunication

2006 HIMSS Analytics Database (derived from the Dorenfest IHDS+ Database) (Access 2003)
 Demographic and IT data from over 32,000 facilities:
o 5,082 Hospitals
o 3,017 Sub Acute Care Facilities
o 19,714 Ambulatory Facilities
o 2,055 Home Health Care Facilities
o 286 Free Standing Data Centers
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Market share and purchasing plan data for over 90 software applications and technologies
New for 2006:
o Ambulatory Laboratory, Ambulatory Pharmacy, Ambulatory Radiology ,
Document
o Management- Business Office, Document Management- HIM, Document
o Management- HR, Electronic Forms- Business Office, Electronic Forms- HIM,
o Electronic Forms-HR, Outsourced Transcription, Browser, DBMS, Email,
Interface
o Engine, Turnkey Portal and Web Development Tool Applications
o Chief Medical Information Officer and Head of Cardiology
o Information Exchange Initiatives
o IV Pumps
o PC Blades
o Additional information in Clinical Decision Support
o Expanded Bar Coding Information
o Added Breakdown of Physicians

2005 HIMSS Analytics Database (derived from the Dorenfest IHDS+ Database) (Access 2000)
(Access 2003)
 Demographic and IT data from over 30,000 facilities:
o 4010 Hospitals
o 2875 Sub Acute Care Facilities
o 17,846 Ambulatory Facilities
o 1,853 Home Health Care Facilities
 Market share and purchasing plan data for over 100 software applications and
technologies
 New for 2005:
o Data Center hardware installation information
o Disaster Recovery Plans
o Details on Physician Use of IT
o Data Storage Environment details
o Expanded Wireless and Mobile Device information

The Seventh Dorenfest Complete IHDS+ Database (2004 Data) (Access 2000) (Access 2003)
 Medical Administration and Bar Coding
 CPOE has 2 levels: Prescription Only and Prescription and most other orders
 Annual operating expense for each acute care hospital and the % of the anual hospital
operating expense spent on I.T.
 New Software Applications:
o HIS System
o Electronic Medication Administration Record (EMAR) System
o Cardiology PACS System
o Ambulatory Electronic Medical Record (EMR) System
o Ambulatory PACS System
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The Sixth Dorenfest Complete IHDS+ Database (2003 Data) (Access 97) (Access 2000)
 5 Additional Contact Names and Email Addresses for each IHDS
 17 Additional Contact Names and Email Addresses for each Hospital
 Software Installation Information for 8 PACS Modalities, including imaging volume,
data storage and purchase plans
 Strategies surrounding CPOE, Patient Safety, and HIPAA

The Fifth Dorenfest Complete IHDS+ Database (2002 Data) (Access 97) (Access 2000)
 Updated Records From 2001
 HIPAA Compliance
 Patient Safety Initiatives
 Physician Usage of IT

The Fourth Dorenfest Complete IHDS+ Database (2001 Data) (Access 97) (Access 2000)
 Updated Records From 2000
 Location of Hardware
 Technological (LAN/WAN) Plans
 Telemedicine

The Third Dorenfest Complete IHDS+ Database (2000 Data) (Access 97) (Access 2000)
 Updated Records From 1999
 Additional Information on IT Budgets and FTEs

The Second Dorenfest Complete IHDS+ Database (1999 Data) (Access 97) (Access 2000)
 Updated Records From 1998
 Additional Information on the Parent-Child Relationship
 Handheld Devices

The First Dorenfest Complete IHDS+ Database (1998 Data) (Access 97) (Access 2000)
 Updated Records From 1994-1995
 Parent-Child Relationships between approximately 1500 IHDS and 35,000 Facilities
 Collaborative Relationships
 Additional Demographic Information
 Enterprise-wide Systems
 Servers
 IT Department Data (Budget, FTEs, etc.)
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The 1994-1995 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1993-1994
 Networking Information
 Detailed Data on Computerized Patient Record
 Computing Architecture
 Imaging Systems
 Physician usage of IT
 Electronic Links
 Integrated Healthcare Delivery System Affiliation
 Systems Integration
 Overall Changes in IT Strategy and Healthcare Reforms
 Additional Hardware Data
 Application Status
The 1993-1994 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1992-1993
 Additional Consulting Information
 Additional Key Personnel
 Ambulatory Facility Demographic and IT Data
 Information on External Service Providers
 Summary of Hardware Data
 Managed Care IT

The 1992-1993 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1991-1992
 Additional Key Personnel
 Additional Demographic Sizing Data
 The 1991-1992 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1990-1991
 Application Integration
 Hospital-wide Integration
 Private Branch Exchange
 Patient Care Technology
 The 1990-1991 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1989-1990
 Hardware Purchasing Plans
 Hospital Connectivity

The 1989-1990 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1988-1989
 Additional Budget Information
 Additional LAN Detail
204







The 1988-1989 Dorenfest 3000+ Database (Access 97) (Access 2000)
Updated Records From 1987-1988
Additional Key Personnel
Detailed Software Plan Data
LAN Use

The 1987-1988 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Updated Records From 1986-1987
 Names and Titles of Key Personnel
 Names and Titles of Steering Committee Members
 Computers and Printers in Use
 The 1986-1987 Dorenfest 3000+ Database (Access 97) (Access 2000)
 Demographic Information for Approximately 3000 Hospitals
 Software Vendors and Products in Use or Planned Use
 Hardware Data
 Consultants Used
foundation@himss.org | © HIMSS Foundation 2010 | 312-915-9523
Database Listing http://www.himss.org/DorenfestInstitute/DatabaseListing.aspx
Last access 4/14/2011 4:58 PM

B.3 Results ME for Excel output
The tables are associated to the Data Sets shown in Table 17.

Figure B.3.1 Parameter estimation Data Set 1
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Figure B.3.2 Parameter estimation Data Set 2

B.3.3 Table for parameter estimation Data Set 3
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B.3.4 Table for parameter estimation Data Set 4

B.3.5 Table for parameter estimation Data Set 5
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B.3.6 Table for parameter estimation Data Set 6
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Appendix C. Formulation

C.1 Vensim model formulation output – Stage 1
Formulation for MMIS diffusion model Data Set 3
(01)Adopters A= INTEG (Hospital AR, Initial adopters)
Units: member
(02)Adopters influence Type I=Adopters A/Total Population N
Units: 1
(03)external influence=p coefficient*Potential Adopters P
Units: member/Year
(04)Hospital AR= external influence + internal influence
Units: member/Year
(05)Initial adopters= INITIAL(130)
Units: member
(06)internal influence=Adopters influence Type I*q coefficient*Potential Adopters P
Units: member/Year
(07)p coefficient=0.0080293
Units: 1/Year
(10)Potential Adopters P= INTEG (-Hospital AR,Total Population N-130)
Units: member
(11)q coefficient=0.180904
Units: 1/Year
(12)Total Population N=5500
Units: member

C.2 Vensim model formulation output – Stage 2
(01) A initial=500
Units: member [0,3000,150]
(2) adopter influence=Adopters A/Total Population N
Units: 1
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(3) Adopters A= INTEG (Hospital AR,A initial)
Units: member
(4)average H IS budget=IS Budget*average H revenue
Units: dollars/Year
(5) average H operating expenses=2.62364e+008
Units: dollars/Year
(6) average H revenue=2.7e+008
Units: dollars/Year [0,2e+009,1e+006]
(7) awareness=1
Units: Dmnl [0,10,1]
(8) complexity and interoperability issues=1
Units: Dmnl [0,3,1]
(9) distributors and GPOs = WITH LOOKUP (Time,([(0,0)(50,200)],(0,0),(0,0),(1,5),(3,23),(11,89),(15,120),(20,150),(25,160),(30,170),(40,180),(50,190) ))
Units: 1 [0,?]
(10) distributors and GPOs influence = WITH LOOKUP (distributors and GPOs,([(0,0)(200,1)],(0,0),(1,0.2),(14.6789,0.5),(50,0.7),(100,0.75),(150,0.8),(200,0.9) ))
Units: Dmnl
(11) expected gains by process=productivity improvement factor*H SCM operating costs
Units: dollars/Year
(12) external factors influence=(m5+m6)/2
Units: Dmnl
(13) external influence N=0.02
Units: 1/Year [0,1,0.01]
(14) external source=external factors influence*external influence N*Potential Adopters P
Units: member/Year
(15) government intervention=1
Units: 1 [0,10,1]
(16) H expected benefits=expected gains by process
Units: dollars/Year
(17) H expected costs=H IdS implementation costs*EXP(increase SCM expending*Time )
Units: dollars/Year
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(18) H expected gain=H expected benefits-H expected costs
Units: dollars/Year
(19) H IdS implementation costs=IdS factor*average H IS budget
Units: dollars/Year
(20) H IdS Use = WITH LOOKUP (adopter influence,([(0,0)(1,1)],(0,0),(0,0),(0,0),(0.25,0.3),(0.5,0.5),(0.7,0.6),(1,1) ))
Units: Dmnl
(21) "H organizational readiness (P)"=process fraction*awareness
Units: Dmnl
(22) "H organizational readiness (T)"=("H organizational readiness (P)"+H technology
penetration factor)/2
Units: Dmnl
(23) H relative advantage= WITH LOOKUP (H expected gain,([(0,0)(1.5e+007,1)],(0,0),(94117.6,0.0106762),(845066,0.170819),(1.2676e+006,0.252669),(2.51172e
+006,0.423488),(3.8028e+006,0.594306),(4.9765e+006,0.715302),(6.10325e+006,0.790036),(7.
48822e+006,0.882562),(8.6854e+006,0.939502),(9.97647e+006,0.95),(1.5e+007,1) ))
Units: Dmnl
(24) H SCM operating costs=average H operating expenses*IdS factor
Units: dollars/Year
(25) H technology penetration factor=0.4
Units: Dmnl [0,1,0.05]
(26) Hospital AR=external source+internal source
Units: member/Year [0,?]
(27) IdS factor=0.05
Units: Dmnl [0,1,0.01]
(28) increase SCM expending=0.01
Units: 1/Year [0,1,0.01]
(29) industry pressure = WITH LOOKUP (distributors and GPOs influence,([(0,0)(1,1)],(0,0),
(0.189602,0.307018),(0.3,0.45),(0.400612,0.539474),(0.5,0.7),(0.620795,0.789474),(1,0.9) ))
Units: Dmnl
(30) internal influence N=0.32
Units: 1/Year [0,1,0.01]
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(31) internal source=internal influence N*Potential Adopters P*organization related factors
influence*technology related factors influence
Units: member/Year
(32) IS Budget=0.03
Units: Dmnl [0,1,0.01]
(33) m1="H organizational readiness (T)"
Units: Dmnl
(34) m2=H relative advantage
Units: Dmnl
(35) m3=TP relative advantage
Units: Dmnl
(36) m4=TP readiness*complexity and interoperability issues
Units: Dmnl
(37) m5=industry pressure
Units: Dmnl
(38) m6=government intervention*manufacturer influence
Units: Dmnl
(39) manufacturer influence = WITH LOOKUP (manufacturers,([(0,0)(7000,1)],(0,0),(0,0),(214.067,0.267544),(1000,0.4),(3000,0.5),(3831.8,0.605263),(4067.28,0.65
3509),(4752.29,0.701754),(6000,0.780702),(7000,0.9)))
Units: Dmnl
(40) manufacturers = WITH LOOKUP (Time,([(0,0)-(50,6000)],(0,0),(1,5),(2,150),
(4,160),(10,236),(15,368),(20,1000),(25,2000),(32,3631.58),(50,6000) ))
Units: 1
(41) organization related factors influence=((m1)+m2)/2
Units: 1
(42) P initial=2500
Units: member [0,3000,150]
(43) Potential Adopters P= INTEG (-Hospital AR,P initial)
Units: member
(44) process fraction = WITH LOOKUP (H IdS Use,([(0,0)-(1,0.6)],(0,0),(0.1,0.005),(0.2,0.01),
(0.3,0.1),(0.4,0.15),(0.5,0.2),(0.6,0.3),(0.7,0.4),(1,0.5) ))
Units: Dmnl
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(45) productivity improvement factor = WITH LOOKUP (H IdS Use,([(0,0)-(1,0.8)],(0,0),(0,0),
(0.1,0.02),(0.251765,0.116726),(0.348235,0.182206),(0.404706,0.239146),(0.458824,0.301779),
(0.496471,0.335943),(0.536471,0.387189),(0.6,0.449822),(0.649412,0.492527),
(0.703529,0.543772),(0.762353,0.600712),(0.858824,0.680427),(1,0.8) ))
Units: 1
(46) technology providers = WITH LOOKUP (Time,([(0,0)(50,80)],(0,0),(0,0),(0,0),(1,1),(3,2),(5,4),(10,8),(13,13),(18,23),(27,42),(40,60),(50,70) ))
Units: member
(47) technology related factors influence=(m3*m4)
Units: 1
(48) Total Population N=Adopters A+Potential Adopters P
Units: member
(49) TP expected benefits=H expected costs
Units: dollars/Year
(50) TP expected costs = WITH LOOKUP (H IdS Use,([(0,0)-(1,1e+006)],(0,1e+006),
(0.0447059,832740),(0.202353,302491),(0.334118,231317),(0.44,199288),(0.607059,160142),
(0.717647,131673),(0.809412,124555),(0.882353,124555),(1,100000) ))
Units: dollars/Year
(51) TP expected gain=TP expected benefits-TP expected costs
Units: dollars/Year
(52) TP readiness = WITH LOOKUP (technology providers,([(0,0)(70,6)],(0,0),(5,1),(10,1.5),(18.4098,2.18421),(30,3),(40,3.5),(50,4),(60,4.5),(70,5) ))
Units: Dmnl
(53) TP relative advantage= WITH LOOKUP (TP expected gain,([(0,0)(2e+006,1)],(0,0),(10000,0.1),(20000,0.1),(50000,0.2),(100000,0.3),(200000,0.4),
(564706,0.654804),(1.00235e+006,0.779359),(2e+006,0.9) ))
Units: 1
C.3 Formulation description
C.3.1 Graphical functions (by model component)
The graphical functions are the main model assumptions regarding the main variables within the
simulation model. For each graphical function different function shapes and distributions were
tested following the steps described in Section 5.2. For example the range for the graphical
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functions associated with the manufacturer population as well as distributors and technology
providers was supported by industry reports from HIDA.
Component 1 graphical functions
(40) manufacturers = WITH LOOKUP (Time,([(0,0)-(50,6000)],(0,0),(1,5),(2,150),
(4,160),(10,236),(15,368),(20,1000),(25,2000),(32,3631.58),(50,6000) ))
Units: 1
(9) distributors and GPOs = WITH LOOKUP (Time,([(0,0)(50,200)],(0,0),(0,0),(1,5),(3,23),(11,89),(15,120),(20,150),(25,160),(30,170),(40,180),(50,190) ))
Units: 1 [0,?]
(10) distributors and GPOs influence = WITH LOOKUP (distributors and GPOs,([(0,0)(200,1)],(0,0),(1,0.2),(14.6789,0.5),(50,0.7),(100,0.75),(150,0.8),(200,0.9) ))
Units: Dmnl
(29) industry pressure = WITH LOOKUP (distributors and GPOs influence,([(0,0)(1,1)],(0,0),
(0.189602,0.307018),(0.3,0.45),(0.400612,0.539474),(0.5,0.7),(0.620795,0.789474),(1,0.9) ))
Units: Dmnl
(39) manufacturer influence = WITH LOOKUP (manufacturers,([(0,0)(7000,1)],(0,0),(0,0),(214.067,0.267544),(1000,0.4),(3000,0.5),(3831.8,0.605263),(4067.28,0.65
3509),(4752.29,0.701754),(6000,0.780702),(7000,0.9)))
Units: Dmnl
Component 2 graphical functions
(46) technology providers = WITH LOOKUP (Time,([(0,0)(50,80)],(0,0),(0,0),(0,0),(1,1),(3,2),(5,4),(10,8),(13,13),(18,23),(27,42),(40,60),(50,70) ))
Units: member
(50) TP expected costs = WITH LOOKUP (H IdS Use,([(0,0)-(1,1e+006)],(0,1e+006),
(0.0447059,832740),(0.202353,302491),(0.334118,231317),(0.44,199288),(0.607059,160142),
(0.717647,131673),(0.809412,124555),(0.882353,124555),(1,100000) ))
Units: dollars/Year
(52) TP readiness = WITH LOOKUP (technology providers,([(0,0)(70,6)],(0,0),(5,1),(10,1.5),(18.4098,2.18421),(30,3),(40,3.5),(50,4),(60,4.5),(70,5) ))
Units: Dmnl
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(53) TP relative advantage= WITH LOOKUP (TP expected gain,([(0,0)(2e+006,1)],(0,0),(10000,0.1),(20000,0.1),(50000,0.2),(100000,0.3),(200000,0.4),
(564706,0.654804),(1.00235e+006,0.779359),(2e+006,0.9) ))
Units: 1
Component 3 graphical functions
(44) process fraction = WITH LOOKUP (H IdS Use,([(0,0)-(1,0.6)],(0,0),(0.1,0.005),(0.2,0.01),
(0.3,0.1),(0.4,0.15),(0.5,0.2),(0.6,0.3),(0.7,0.4),(1,0.5) ))
Units: Dmnl
(23) H relative advantage= WITH LOOKUP (H expected gain,([(0,0)(1.5e+007,1)],(0,0),(94117.6,0.0106762),(845066,0.170819),(1.2676e+006,0.252669),(2.51172e
+006,0.423488),(3.8028e+006,0.594306),(4.9765e+006,0.715302),(6.10325e+006,0.790036),(7.
48822e+006,0.882562),(8.6854e+006,0.939502),(9.97647e+006,0.95),(1.5e+007,1) ))
Units: Dmnl
(45) productivity improvement factor = WITH LOOKUP (H IdS Use,([(0,0)-(1,0.8)],(0,0),(0,0),
(0.1,0.02),(0.251765,0.116726),(0.348235,0.182206),(0.404706,0.239146),(0.458824,0.301779),
(0.496471,0.335943),(0.536471,0.387189),(0.6,0.449822),(0.649412,0.492527),
(0.703529,0.543772),(0.762353,0.600712),(0.858824,0.680427),(1,0.8) ))
Units: 1
Component 4 graphical functions
(20) H IdS Use = WITH LOOKUP (adopter influence,([(0,0)(1,1)],(0,0),(0,0),(0,0),(0.25,0.3),(0.5,0.5),(0.7,0.6),(1,1) ))
Units: Dmnl
C.3.2 Parameters (by model component)

The parameters are the simulation model initial conditions. For each parameter different range
values were tested following the steps described in Section 5.2. The parameters were developed
based on industry reports and information extracted from the 2008 HIMSS DB. For example the
information associated to the hospital revenue and operating expenses extracted from the 2008
HIMSS DB was used to develop parameters (5) and (6). Technology penetration data also
extracted from this database was used to estimate the value of the parameter (25). The
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parameters within Component 4 (C4) were based on previous results from Stage 1 and
information provided in AHA reports.

Component 1
(15) government intervention=1
Units: 1 [0,10,1]
Component 2
(8) complexity and interoperability issues=1
Units: Dmnl [0,3,1]
Component 3
(5) average H operating expenses=2.62364e+008
Units: dollars/Year
(6) average H revenue=2.7e+008
Units: dollars/Year [0,2e+009,1e+006]
(7) awareness=1
Units: Dmnl [0,10,1]
(25) H technology penetration factor=0.4
Units: Dmnl [0,1,0.05]
(27) IdS factor=0.05
Units: Dmnl [0,1,0.01]
(28) increase SCM expending=0.01
Units: 1/Year [0,1,0.01]
(32) IS Budget=0.03
Units: Dmnl [0,1,0.01]
Component 4
(13) external influence N=0.02
Units: 1/Year [0,1,0.01]
(30) internal influence N=0.32
Units: 1/Year [0,1,0.01]
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(01) A initial=500
Units: member [0,3000,150]
(42) P initial=2500
Units: member [0,3000,150]
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Appendix D. Sensitivity analysis results
D1. Sensitivity analysis tests
The sensitivity analysis was developed based on a series of tests. Four tests were initially
developed and a fifth one completed the set. The steps followed to perform the sensitivity
analysis tests are described in Section 5.3.3 and include the following tests:


Test 1, sensitivity analysis test for parameters within group 1, remaining parameters were
kept unchanged.



Test 2, sensitivity analysis test for parameters within group 2, remaining parameters were
kept unchanged.



Test 3, sensitivity analysis test for parameters within group 3, remaining parameters were
kept unchanged.



Test 4, sensitivity analysis test for parameters within group 4, remaining parameters were
kept unchanged.



Test 5, sensitivity analysis test for parameters within groups 1,2 and 3 remaining
parameters were kept unchanged.

D.2 Vensim sensitivity analysis output
The results for the Adopters A (output variable) for tests 1, 2 and 3 are shown in the following
figures.
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Figure D.2.1 Sensitivity analysis graph test 1

Figure D.2.2 Sensitivity analysis graph test 2
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Figure D.2.3 Sensitivity analysis graph test 3

D.3 Correlation Coefficient plots
The data associated to each one of the sensitivity analysis tests was exported to MSO Excel in
order to develop the CC plots. The CC plots for both output measures, the adoption rate and the
adopter population are included in this section.
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Figure D.3.1 Correlation Coefficient plot for Adopter population – test 1
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Figure D.3.2 Correlation Coefficient plot for Adoption Rate – test 1
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Figure D.3.3 Correlation Coefficient plot for Adopter population – test 2
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Figure D.3.4 Correlation Coefficient plot for Adoption Rate – test 2
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Figure D.3.5 Correlation Coefficient plot for Adopter population – test 3
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Figure D.3.6 Correlation Coefficient plot for Adoption Rate – test 3
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Figure D.3.7 Correlation Coefficient plot for Adopter population – test 4
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Figure D.3.8 Correlation Coefficient plot for Adoption Rate – test 4
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Figure D.3.9 Correlation Coefficient plot for Adopter population – test 5
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Figure D.3.10 Correlation Coefficient plot for Adoption Rate – test 5
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Appendix E. Policy design and testing
E.1 Policies proposed changes
Table E.1.1

Policy 2

Policy (Vensim
model)
IM Baserun initial
Policy1b
IM Baserun initial
Policy2

Policy 3

IM Baserun initial
Policy3

Policy
combination 1

IM Baserun initial
Policy1b and 2

Includes changes for Policy 1b and Policy 2

Policy
combination 2

IM Baserun initial
Policy2 and 3

Includes changes for Policy 2 and Policy 3

Policy
combination 3

IM Baserun initial
Policy3 and 1b

Includes changes for Policy 3 and Policy 1b

Intervention
Policy 1

Policy
combination 4

IM Baserun initial
combined policy

Proposed changes
Government intervention STEP function (5,2) and
change in manufacturer’s graphical function
Change in technology provider’s graphical function
H technology penetration factor = 0.8
Awareness = 3
IdS Factor = 0.06

H technology penetration factor = 0.6
Awareness = 3
IdS factor = 0.07
Government intervention = 3
Complexity and interoperability issues = 2
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Figure E.1.2 Manufacturer’s graphical function proposed change

Figure E.1.3 Technology provider’s graphical function proposed change

E.2 Detailed description policies supporting data
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t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

IM Baserun initial Policy1a IM Baserun initial Policy1b
AR
A
AR
A
0
500
0.00
500
1.79
502
19.00
519
5.43
507
53.42
572
8.11
515
71.20
644
13.13
528
87.87
731
19.13
548
110.78
842
25.11
573
130.16
972
30.35
603
143.92
1116
35.86
639
155.69
1272
42.10
681
166.42
1438
49.47
730
173.54
1612
60.93
791
181.59
1794
70.90
862
181.20
1975
80.55
943
173.40
2148
91.92
1035
165.01
2313
105.76
1141
157.65
2471
121.81
1262
138.79
2610
139.05
1401
112.62
2722
154.78
1556
86.96
2809
165.55
1722
64.41
2874
170.80
1893
45.70
2919
168.18
2061
31.12
2950
157.80
2219
20.11
2971
150.55
2369
12.48
2983
139.75
2509
7.49
2991
120.20
2629
4.35
2995
98.11
2727
2.44
2997
77.27
2804
1.32
2999
58.35
2863
0.68
2999
42.90
2906
31.08
2937
21.97
2959
15.08
2974
9.96
2984
6.44
2990
4.07
2994
2.47
2997
1.46
2998
0.84
2999

Table E.2.1 Policies Component 1
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t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

IM Baserun initial
Policy2
AR
A
0
500
19.16
519
48.22
567
73.65
641
95.32
736
122.77
859
146.48 1006
169.5 1175
197.06 1372
224.39 1597
234.47 1831
227.19 2058
206.78 2265
191.7 2457
163.2 2620
124.91 2745
89.45 2834
61.17 2895
40.37 2936
25.8 2962
15.88 2977
9.552 2987
5.634 2993
3.261 2996
1.852 2998
1.033 2999
0.5653 2999

IM Baserun initial
Policy3
AR
A
0
500
32.62
533
56.77
589
75.31
665
111.84
777
157.71
934
194.45
1129
226.07
1355
247.96
1603
248.95
1852
237.7
2089
228.44
2318
215.61
2533
167.94
2701
121
2822
80.51
2903
48.51
2951
26.21
2978
12.87
2990
5.815
2996
2.389
2999
0.8868
3000

Table E.2.2 Policies Components 2 and 3
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IM Baserun initial IM Baserun initial
Policy1b and 2
Policy3 and 2
AR
A
AR
A
0 500
0 500
19.00 519
32.62 533
66.81 586
92.24 625
103.51 689
161.48 786
132.03 821
229.32 1016
163.78 985
291.19 1307
190.43 1176
347.92 1655
216.05 1392
352.79 2008
238.07 1630
318.95 2327
241.77 1871
277.21 2604
229.76 2101
184.52 2788
204.84 2306
108.57 2897
188.54 2495
57.77 2955
156.22 2651
27.35 2982
117.00 2768
11.5 2993
83.14 2851
4.399 2998
56.27 2907
1.518 2999
36.56 2944
0.4766 3000
23.02 2967
14.08 2981
8.32 2989
4.82 2994
2.74 2997
1.52 2998
0.83 2999

t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Table E.2.3 Policy 1b and 2; Policy 3 and 2
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IM Baserun initial IM Baserun initial
Policy3 and 1b
combined policy
AR
A
AR
A
0 500
0 500
32.46 532
40.66 541
75.27 608
81.05 622
104.20 712
112.24 734
144.81 857
176.24 910
190.73 1047
244.58 1155
230.70 1278
312.97 1468
258.63 1537
352.19 1820
262.87 1800
336.11 2156
250.31 2050
294.64 2451
226.34 2276
241.95 2693
217.14 2493
159.18 2852
175.81 2669
87.55 2939
127.82 2797
39.89 2979
87.75 2885
15.14 2994
55.22 2940
4.48 2999
31.40 2971
0.97 3000
16.03 2987
7.47 2995
3.20 2998
1.24 2999
0.43 3000

t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Table E.2.4 Policy 3 and 1b and combined policy
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E.3 Detailed description scenarios supporting data

t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

IM Baserun initial
IM Baserun initial
scenario1
AR
A
AR
A
0.00
500
0.00
500
19.16
519
11.01
511
34.82
554
21.49
532
42.51
596
22.91
555
56.36
653
23.70
579
73.86
727
24.48
604
92.21
819
24.93
629
105.66
925
25.18
654
115.99
1041
25.34
679
128.05
1169
26.42
705
140.40
1309
39.50
745
161.73
1471
43.45
788
176.23
1647
51.61
840
182.44
1829
61.49
902
184.26
2014
73.36
975
177.53
2191
83.02
1058
169.85
2361
94.74
1153
158.51
2520
107.19
1260
134.22
2654
121.69
1382
106.25
2760
134.51
1516
79.92
2840
140.45
1656
57.30
2897
143.01
1799
38.91
2936
141.57
1941
25.34
2961
136.95
2078
15.96
2977
130.24
2208
9.73
2987
129.13
2337
5.75
2993
125.53
2463
3.29
2996
112.76
2576
1.81
2998
95.90
2672
0.97
2999
78.60
2750
62.95
2813
Table E.3.1 Baserun and Scenario1
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t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

IM Baserun initial
scenario2
AR
A
0.00
500
19.63
520
36.11
556
45.64
601
63.94
665
89.86
755
120.87
876
141.47
1018
159.97
1177
179.97
1357
199.23
1557
221.76
1778
230.41
2009
223.50
2232
222.20
2455
197.39
2652
144.45
2796
93.94
2890
55.41
2946
29.67
2975
14.40
2990
6.34
2996
2.51
2999
0.91
3000

IM Baserun initial
scenario3
AR
A
0.00
500
29.87
530
54.36
584
77.08
661
127.09
788
200.68
989
264.27
1253
312.91
1566
333.62
1900
318.32
2218
291.53
2510
240.73
2750
142.92
2893
69.56
2963
27.14
2990
7.99
2998
1.68
3000
0.23
3000

Table E.3.2 Scenario 2 and Scenario 3
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t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

IM Baserun initial
scenario4
AR
A
0
500
39.33
539
68.94
608
95.08
703
148.75
852
212.52 1065
276.11 1341
325.70 1666
321.02 1987
287.45 2275
248.23 2523
193.98 2717
129.51 2847
78.41 2925
42.78 2968
20.22 2988
8.17 2996
2.77 2999
0.80 3000

IM Baserun initial
scenario5
AR
A
0
500
11.01
511
21.49
532
22.91
555
23.70
579
24.48
604
24.93
629
25.18
654
25.34
679
29.69
709
86.25
795
120.37
915
183.31 1099
245.69 1344
323.26 1668
375.66 2043
355.85 2399
331.12 2730
177.89 2908
70.64 2979
17.95 2997
2.97 3000
0.30 3000

Table E.3.3 Scenario 4 and Scenario 5
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t
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

IM Baserun initial
scenario6
AR
A
0
500
25.73
526
48.84
575
71.39
646
123.79
770
216.60
986
300.15
1286
368.26
1655
403.37
2058
380.59
2439
341.11
2780
170.61
2950
45.39
2996
4.25
3000
0.08
3000

IM Baserun initial
scenario7
AR
A
0
500
40.74
541
72.88
614
102.32
716
166.30
882
244.52
1127
323.66
1450
368.31
1819
344.69
2163
295.04
2458
228.04
2686
153.68
2840
88.79
2929
43.85
2973
18.61
2991
6.42
2998
1.74
3000
0.35
3000

Table E.3.4 Scenario 6 and Scenario 7
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